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Abstract 
 
Fibroblasts are in close contact with lymphocytes both in lymphoid organs and in peripheral 
tissues. In lymphoid organs, fibroblasts have been reported to regulate the development, 
tolerance, survival, and migration of lymphocytes besides their role in maintaining the organ 
structure. However, how these fibroblasts react to lymph node swelling and whether they 
maintain their original function is not yet fully understood. In this thesis, we investigated the 
phenotype and function of fibroblasts at two sites of ongoing immune response, in acutely 
inflammed lymph nodes (LN) and in the intestinal lamina propria were immune responses are 
constantly ongoing.  
 
Adaptive immunity is initiated in T cell zones of secondary lymphoid organs where dendritic cells 
and recirculating T cells meet and where T cell activation and differentiation occur. These zones 
are organized by a rigid 3-dimensional network of fibroblastic reticular cells (FRC) that are a rich 
cytokine source. In response to lymph-borne antigens, draining LN expand several fold in size 
but the fate and role of the FRC network during immune response is not fully understood. Here 
we show that T cell responses are accompanied by the rapid activation and growth of FRC, 
leading to an expanded but similarly organized network of T zone FRC that maintains its vital 
function for lymphocyte trafficking and survival. In addition, new FRC-rich environments were 
observed in the expanded medullary cords. FRC get activated within hours after onset of 
inflammation in the periphery. Surprisingly, FRC expansion depends mainly on trapping of naïve 
lymphocytes that is induced by both migratory and resident dendritic cells. Inflammatory signals 
are not required as homeostatic T cell proliferation was sufficient to trigger FRC expansion. 
Activated lymphocytes are also dispensable for this process but can enhance the later growth 
phase. Thus, this study documents the surprising plasticity but also the complex regulation of 
FRC networks allowing rapid LN hyperplasia that is critical for mounting efficient adaptive 
immunity. 
 
The second study looked at the lamina propria (LP) of the small and large intestine which are 
sites constantly exposed to microbiota and therefore harbor many effector cells. However, these 
immune cells are scattered and therefore organized very differently than inside LN. In addition, 
there needs to be a stromal microenvironment which dampens reactivity of immune cells toward 
the normal flora while allowing their response to pathogenic microorganisms. Currently we have 
a poor understanding of the stromal cells that may act as organizing principle of the LP, and that 
may influence the balance between tolerance and immunity. To that end I investigated the 
frequency, phenotype, organization and function of fibroblasts in the LP. We found collagen and 
gp38 to mark a dense fibroblast network throughout all parts of the gut lamina propria. A 
digestion protocol for isolating intestinal fibroblasts was established and sorted cells were found 
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to express COX-1, COX-2, APRIL, BAFF, and CXCL12, and therefore could contribute to 
immune tolerance or plasma cell function in the intestines during homeostasis. 
 
In conclusion, FRC networks develop at sites rich in lymphocytes and dendritic cells. They are 
not restricted to tissues containing naïve T cells like in secondary lymphoid organs but can be 
also observed in tissues rich in effector lymphocytes like in activated LN and the gut LP. 
Besides serving most likely as scaffold for adhesion and migration, I propose that FRC also 
influence adaptive immunity in several ways which still need further exploration. 
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Résumé 
 
Les fibroblastes sont en contact étroit avec des lymphocytes,  à la fois dans les organes 
lymphoïdes et dans les tissus périphériques. Dans les organes lymphoïdes, les fibroblastes, en 
plus de leur rôle dans le maintient de la structure de l’organe, agiraient comme régulateurs du 
développement, de la tolérance, de la survie et de la migration des lymphocytes. Cependant, la 
façon, dont ces fibroblastes réagissent à un gonflement des ganglions lymphatiques et qu'ils 
conservent leur fonction d'origine n'est pas encore entièrement comprise. Dans cette thèse, 
nous avons étudié le phénotype et la fonction des fibroblastes au niveau de deux sites: les 
ganglions lymphatiques (lymph node en anglais, LN) lors d’une inflammation aiguë et la lamina 
propria intestinale, où des réponses immunitaires sont constamment en cours. 
L'immunité adaptative est initiée dans les zones T des organes lymphoïdes secondaires, où les 
cellules dendritiques et les cellules T recirculantes se rencontrent et où l'activation et la 
différenciation des cellules T se produisent. Ces zones sont formées d’un réseau tridimentionnel 
rigide de cellules réticulaires fibroblastiques (fibroblastic reticular cells en anglais, FRC), qui 
constituent une source importante de cytokines. En réponse à des antigènes qui sont drainés 
par la lymphe dans un LN particulier, le LN va fortement accroître sa taille, mais le sort et le rôle 
du réseau de FRC pendant la réponse immunitaire ne sont pas entièrement compris. Ici nous 
montrons que les réponses des cellules T sont accompagnées par l'activation rapide et la 
croissance des FRC, aboutissant à un réseau élargi des FRC de la zone T, mais organise de 
manière similaire, qui conserve sa fonction vitale pour le traffic et la survie des lymphocytes. En 
plus, nous avons observe de nouveaux environnements riches en FRC dans les cordons 
médullaires élargis. Les FRC se sont activés dans les heures suivant l'apparition de 
l'inflammation en périphérie. De manière surprenante, l'expansion des FRC dépend 
principalement de la capture des lymphocytes naïfs, qui est induite par les cellules dendritiques 
résidentes et migratrices. Les signaux inflammatoires ne sont pas indispensables car la 
prolifération homéostatique des cellules T est suffisante pour déclencher l'expansion des FRC. 
Les lymphocytes activés ne sont pas nécessaires pour ce processus, mais peuvent améliorer la 
phase de croissance ultérieure. Ainsi, cette étude documente l'étonnante plasticité, mais aussi 
la complexité de la régulation du réseau FRC permettant l’hyperplasie rapide du LN, qui est 
essentielle pour la mise en place d’une immunité adaptative efficace. 
 
La deuxième étude a examiné la lamina propria (LP) du petit et du grand intestin qui sont des 
sites constamment exposés aux bactéries commensales et donc arborant de nombreuses 
cellules effectrices. Cependant, dans la LP ces cellules immunitaires sont dispersées et 
présentent donc une organisation très différente de celle observée à l'intérieur des LN. En outre, 
il est nécessaire d’avoir un micro-environnement stromal qui limite la réactivité des cellules 
immunitaires envers la flore normale, tout en permettant leur réponse contre les micro-
organismes pathogènes. Actuellement, nous avons une compréhension insuffisante du rôle des 
 6	  
cellules stromales en tant que principe organisateur de la LP, ainsi que leur rôle dans 
l’établissement de l'équilibre entre la tolérance et de l'immunité. C’est pour celà que j'ai étudié la 
fréquence, le phénotype, l'organisation et la fonction des fibroblastes dans le LP. Nous avons 
identifié le collagène et gp38 qui permettent de marquer un réseau dense de fibroblastes dans 
toutes les parties de l'intestin. Un protocole de digestion pour isoler les fibroblastes intestinaux a 
été établi et les cellules identifiées ont montré une expression de COX-1, COX-2, APRIL, BAFF, 
et CXCL12, et donc pourraient être susceptibles de contribuer à la tolérance immunitaire, ou à 
la fonction des cellules de plasma dans l'intestin au cours de l'homéostasie. 
 
En résumé, les réseaux de FRC se développent aux endroits riches en lymphocytes et cellules 
dendritiques. Ils ne sont pas limités aux tissus qui contiennent beaucoup de lymphocytes T 
naïfes comes des organes lymphoïdes secondaires, mais sont aussi retrouvés dans les tissus 
contenant beaucoup de lymphocytes effecteurs, comme dans un ganglion activé ou la LP 
intestinale. En plus de leur fonctionnement probable comme échaffaudage pour l’adhésion et la 
migration des lymphocytes, je propose que les FRC influencent l’immunité adaptative par 
plusieurs voies qui nécessitent des études supplémentaires. 
 
 7	  
 
1. Introduction 
 
The immune system is a very complex system dedicated to the defense against invasion of the 
body by foreign organisms. While the innate immunity evolved very early and can be seen in 
almost every species, the more sophisticated adaptive immunity can only be seen in higher 
vertebrates and is characterized by its diversity, specificity, self-recognition, and memory. 
Except for some immune-privileged sites, including cornea, central nervous system, testicles, 
and placenta/fetus, the whole body is guarded by immune cells against pathogen invasion. 
Some are tissue resident while some circulate through the blood and lymph stream to search for 
foreign antigens (Ag) or danger signals.  
 
The immune system comprises various types of cells and organs/tissues to establish multiple 
layers of protection. The primary lymphoid organs are sites where immune cells are generated, 
including bone marrow (BM) and thymus. The secondary lymphoid organs (SLOs) are sites 
where adaptive immune responses are elicited, including lymph nodes (LN), spleen, and various 
mucosal-associated lymphoid tissues (MALT), such as Peyer’s patches (PP) in the small 
intestine. Although they localize differently, all SLO have similar structures and function to 
sustain the survival of immune cells and to facilitate their encounter with antigens	   (Junt et al., 
2008). All SLO are composed of B cell-rich zones and T cell-rich zones that are surrounded by 
an antigen-sampling zone. The first part of the thesis is focusing on the LN and the second part 
on the intestine. The stromal cells of these two organs will be discussed in more details.  
 
Secondary lymphoid organs develop during embryogenesis or in the early postnatal period and 
this process occurs independently of antigen or pathogen recognition at predetermined sites 
throughout the body as a result of complex interactions between various hematopoietic, 
mesenchymal, and endothelial cells	   (Randall et al., 2008). Development of different SLO starts 
at different time point in mice, as mesenteric LN start at E9 - 10, PP between E12.5 - 15.5, and 
popliteal LN at E17, etc.	  (Randall et al., 2008). The development of LN occurs concurrently with 
the process of lymphatic vascularization since LN are encapsulated by lymphatic endothelium. 
The lymphatic endothelial cells (LEC) form lymph sacs which buds from veins and differentiate 
in this process from blood endothelial cells (BEC) to LEC under the control of the master 
transcription factor, Prox-1 (prospero homeobox protein 1)	   (Wilting et al., 2002). Retinoic acid 
(RA) is produced around the sac, probably due to the stimulation by neurons	   (van de Pavert et 
al., 2009), and thereby induces CXCL13 expression on a specific population of mensenchymal 
cells named lymphoid tissue organizer cells (LTo cells) that express VCAM-1, ICAM-1, and 
lymphotoxin beta receptor (LTβR). The CXCL13 produced by LTo cells attract a population of 
CD45+CD4+CD3-IL-7Rα+RORγτ+CXCR5+ cells, named lymphoid tissue inducer cells (LTi cells) 
to aggregate around the LTo cells and in turn induce LTo cells or mesenchymal cells to express 
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other chemokines and adhesion molecules needed for further retention and attraction of 
hematopoietic cells	  (Roozendaal and Mebius, 2011). IL-7, RANKL (receptor activator of nuclear 
factor kappa-B ligand) and lymphotoxin αβ (LTαβ) are key factors in this interaction with IL-7 
and TRANCE from LTo cells up-regulating LTαβ expression on LTi cells, which then trigger 
LTβR+ LTo cells to produce more CXCL13, CCL19/21 and adhesion molecules like vascular 
cell-adhesion molecule 1 (VCAM-1) and Intercellular Adhesion Molecule 1 (ICAM-1) that attract 
and possibly retain more LTi cells and later on T and B cells. Gene defects in these signaling 
pathways as well as transcription factors essential for LTi cell development, like RORγτ, will 
impair the development of SLO to different degrees (Figure 1.1)	  (Junt et al., 2008)	  (Randall et al., 
2008).  
 
Figure 1.1 mechanism of SLO organogenesis 
Lymphoid organogenesis is initiated by the interaction of RORγτ+CD3–
CD4+CD45+ IL-7Rα+ LTi cells with mesenchymal organizer cells. As a first step, 
LTi cells are attracted to mesenchymal LTo through CXCR5 and they adhere 
to the inductive sites through interactions between VCAM-1 and α4β1 integrin. 
As a consequence, inductive interactions are formed, in which LTαβ expressed 
by LTi cells ligates LTβR expressed by LTo cells. This induces the local 
expression of CCL19, CCL21 and CXCL13, which, in turn, attract B and T cells 
to the activation site. As B and T cells also express LTαβ, a positive feedback 
loop is generated that leads to the local accumulation of more B cells and T 
cells, and eventually to the formation of the defined microenvironments in 
secondary lymphoid organs.	  (Junt et al., 2008) 
 
 
 
 
 
 
 
 
 
1.1 Stromal compartment in the peripheral LN 
 
LN are secondary lymphoid organs where primary T and B cell responses against lymph-borne 
pathogens or tumor antigens are induced most efficiently. LN contain three compartments (T 
zone, B zone, and medulla) that are characterized by distinct hematopoietic cells and resident 
stromal cells	  (Mueller and Germain, 2009)	  (Turley et al., 2010). The B cell zone (cortex, follicle) 
is composed of follicular dendritic cells (FDC) that produce CXCL13 to attract B cells. The T cell 
zone (paracortex) is rich in gp38+ fibroblastic reticular cells (FRC), known as T zone FRC (TRC) 
that express CCL19 and CCL21 to attract naive T cells and dendritic cells (DC)	   (Link et al., 
2007). Under the subcapsular sinus (SCS), there are also gp38+ FRC named marginal reticular 
cells (MRC) that selectively express CXCL13, RANKL, and MAdCAM-1	   (Katakai et al., 2008). 
Both FRC and MRC form the conduit system in the T zone and to a limited extent inside the 
outer B zone, respectively (Figure 1.2)	   (Mueller and Germain, 2009). Blood endothelial cells 
(BEC), including the high endothelial venules (HEV), are also located mostly in the outer T zone. 
Finally, the medulla is rich in efferent lymphatic vessels and serves as the exit zone of naive and 
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activated lymphocytes. It expands during immune response to accommodate short-lived plasma 
cells	  (Angeli et al., 2006)	  (Mohr et al., 2009)	  (Abe et al., 2012).  
 
Figure. 1.2 Lymphocyte migration on stromal networks in secondary lymphoid organs.  
(a) B and T cells enter lymph nodes through high endothelial venules (HEV) and immediately contact the (FRC) 
stromal network. B cells migrate along FRC at the edge of B cell follicles and traffic into these regions in response to 
CXCL13. T cells move along the FRC conduit network into the T cell zone of the lymph node paracortex. Resident 
and recently arrived DC attach themselves to the FRC network near HEV and deeper in T cell zones. (b) On entering 
B cell follicles, B cells expressing CXCR5 make their way into the CXCL13-rich FDC network, where they migrate 
along the stromal network in search of cognate antigen (arrows). B cells also traffic towards the periphery of B cell 
follicles, where MRC stromal networks form under the subcapsular sinus (SCS). MRC also express CXCL13. Antigen 
can enter B cell follicles through conduits formed by the MRC and be delivered to the FDC network. (c) In T cell 
zones, T cells traffic along FRC networks that are rich in CCL19 and CCL21 and interact with DC that adhere to FRC. 
The DC can then present antigens to T cells as they migrate past. Antigens can enter the conduit network from the 
lymph or blood and drain through the T cell zones. DC can sample antigens from the conduits and present them to T 
cells.	  (Mueller and Germain, 2009) 
 
 
1.1.1 Blood endothelial cells 
 
LN are connected to both blood and lymph circulation that are channeled by blood and 
lymphatic vessels, respectively. The blood capillaries inside the LN are composed of a single 
layer of blood endothelial cells (BEC) that express CD31 and some of them differentiated into a 
special structure called high endothelial venules (HEV) that serve as the entry site of naïve 
lymphocytes to the LN	  (von Andrian and Mempel, 2003). The BEC of HEV are characterized by 
their cuboidal morphology compared to the usual flat shape of regular BEC and their expression 
of different adhesion molecule for lymphocyte interaction. HEV express PNAd (peripheral node 
addressin; which includes molecules like CD34) and ICAM-1 (intercellular adhesion molecule 1) 
that interact with CD62L and αLβ2, respectively, on lymphocytes to facilitate their extravasation. 
HEV can be found in all SLO except the spleen. In different tissues, BEC express either 
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MAdCAM-1 (in GALT and urogenital tract; binds α4β7) or VCAM-1 (such as BALT, bone 
marrow, and skin; binds α4β1) or both (mammary gland) which contribute to the homing of 
effecter cells to different organs	  (Kunkel and Butcher, 2003). BEC also produce CCL21, and to a 
less extent CCL19, CXCL12, and CXCL13 to attract lymphocytes and to induce the arrest of 
rolling lymphocytes	  (Miyasaka and Tanaka, 2004)	  (Stein et al., 2000).  
 
DC have been reported to be important in modulating HEV function, T cell homing and LN size	  
(Girard et al., 2012). It seems that DC can express vascular endothelial growth factor (VEGF) to 
induce the proliferation of HEV cells, similar to TRC	   (Webster et al., 2006)	   (Wendland et al., 
2011). On the other hand, DC are also required for maintenance of the HEV phenotype as 
CD11c+ DC depletion causes the loss of the MECA-79 ligand GlyCAM-1, and the enzymes 
GlcNAc6ST2 and FuT7 but up-regulates MAdCAM-1 on LN HEV. LTαβ signals provided by DC 
were proposed to be important for this function	  (Moussion and Girard, 2011).  
 
 
1.1.2 Lymphatic endothelial cells 
 
Lymphatic vessels are lined by a single layer of lymphatic endothelial cells (LEC) with valves 
that collect lymph throughout the whole body and eventually drain it back to the blood circulation 
via thoracic duct. The afferent lymphatic vessels are open-end capillaries draining interstitial 
fluid of a defined area and transport it passively to the local LN. Besides interstitial fluid, lymph 
can also contain soluble antigens and intact pathogens as well as signaling molecules like 
inflammatory cytokines produced in the periphery	  (Randolph et al., 2005). LEC in the periphery 
can express CCL21 to attract local CCR7+ DC to enter the lymphatics	   (Randolph et al., 2008). 
The drained lymph enters the LN via afferent lymphatics in the subcapsular sinus (SCS) of the 
LN, where the lymph is prevented from freely entering the LN parenchyma and either enters the 
conduit system or flows toward the medullary sinus through intranodal and subcapsular 
lymphatics	  (Cyster, 2005)	  (Cyster and Schwab, 2012a).  
 
Efferent lymphatics are abundant in the medullary zone which is the exit site of LN for 
lymphocytes. The efferent lymphatics either later link up with another LN or connect to a larger 
lymphatic vessel or join to the vein (via thoracic duct). The exit of both T and B cells is controlled 
by sphingosine-1-phosphate (S1P) and its G protein-coupled receptor S1PR1. S1P is abundant 
in blood and efferent lymph	  (Cyster, 2005). S1P is generated in vivo by sphingosine kinases and 
mice deficient in one of these kinases in LEC showed significant loss of S1P in the lymph and 
impaired exit of lymphocytes from LN	  (Pham et al., 2010). Naïve lymphocytes express S1PR1 to 
sense and migrate towards the high concentration of S1P in the medulla. T cells seem to cross 
the lymphatics and enter the cortical sinus at multiple locations while B cells migrate directly 
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from follicle to adjacent cortical sinuses	  (Girard et al., 2012). Binding of S1P to S1PR1 probably 
counteracts the retention signal mediated by Gαi-coupled receptors, CCR7 and CXCR5. Indeed, 
pertussis toxin treatment that inactivates Gαi restores the egress of lymphocytes in the absence 
of S1P-S1PR1 signaling	  (Sinha et al., 2009)	  (Pham et al., 2008). 
 
Besides the endothelial marker, CD31, LEC also express gp38, Lyve (lymphatic vessel 
endothelial hyaluronan receptor) -1, and Prox-1. Prox1 is a master transcriptional factor 
regulating LEC differentiation. Gp38 (also called podoplanin) also contributes to the proliferation, 
migration, and tube formation of LEC in vitro	  (Navarro et al., 2008)	  (Navarro et al., 2011). CLEC-
2, ligand of gp48, is expressed on plateletes and has bee shown to mediate proper lymphatic 
vessel formation the migration, proliferation, and in vitro tube formation of LEC	   (Osada et al., 
2012).  
 
 
1.1.3 Follicular dendritic cells (FDC) 
 
Follicular dendritic cells are the major stromal cells in the B zone and play a fundamental role in 
B cell immune response. They produce CXCL13 to attract CXCR5+ B cells and thus form the B 
cell zone. During homeostasis, FDC also provide BAFF to support B cell survival	  (Aguzzi et al., 
2014). FDC can capture and retain immune complexes on their surface via complement 
receptor 1/2 (CD35/21) or Fc receptors and then present the antigens to activate cognate B 
cells	   (Tew et al., 2001). Upon TLR signals and retinoic acid (RA) stimulation, FDC up-regulate 
the expression of CXCL13, BAFF and TGFβ that enhance the recruitment, survival, and class-
switch of germinal center B cells (GCB), respectively	   (Aguzzi et al., 2014). FDC produce a 
molecule called milk fat globule-EGF factor 8 (Mfge8) that binds to phosphatidylserine (PS) on 
the surface of apoptotic cells as an ‘eat-me’ signal. These Mfge8-opsonized apoptotic cells are 
then recognized and cleared by tingible body macrophages (TBM)	   (Hanayama et al., 2002)	  
(Kranich et al., 2008). FDC thus may avoid autoimmunity by contributing to rapid clearance of 
dying cells	  (Hanayama et al., 2004).  
 
FDC has been shown to express intracellular adhesion molecule (ICAM)-1, vascular cell 
adhesion molecule (VCAM)-1, mucosal addressin-cell adhesion molecule (MAdCAM)-1, LTβR, 
and tumor necrosis factor receptor (TNFR)-1	   (Aguzzi et al., 2014). During spleen homeostasis, 
FDC are differentiated from a population of ubiquitous perivascular precursors that express 
PDGFRβ, Mfge8, CXCL13, ICAM-1, MAdCAM-1, but not CD21/35. Their development to 
mature FDC depends on lymphoid tissue inducer cells and lymphotoxin	   (Krautler et al., 2012). 
Other papers have shown that B cells expressing TNFα and LTαβ are required for 
mesenchymal cells to differentiate into FDC	   (Roozendaal and Mebius, 2011)	   (Gonzalez et al., 
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1998)	   (Endres et al., 1999)	   (Fu et al., 1998). Recently, Jarjour et al. showed by means of a 
multicolor fate mapping system that LN FDC which get newly generated either during 
inflammation or B cell reconstitution in RAG KO mice, differentiate from proliferating marginal 
reticular cells (MRC) that line the follicular side of the SCS	  (Jarjour et al., 2014).   
 
 
1.1.4 Marginal reticular cells (MRC) 
 
Marginal reticular cells (MRC) were first described by Katakai et al. and form a thin layer of 
reticular structure in the outer follicular region immediately underneath the subcapsular sinus of 
lymph nodes	   (Katakai et al., 2008). MRC express ICAM-1 and VCAM-1, but unlike other FRC 
also MAdCAM-1 and RANKL, a phenotype reminiscent of LTo cells during LN organogenesis. 
However, they don’t express CCL21 or CD21/35, indicating they are distinct from FRC or FDC	  
(Katakai, 2012). Reticular cells similar to MRCs are also found in the back the B cell follicle in 
the spleen and in the subepithelial dome (SED) region just under the basement membrane of 
the follicle-associated epithelium (FAE) in mucosal-associated lymphoid tissue (MALT)	  (Katakai 
et al., 2008).  
 
The immune functions of MRC are still poorly understood. However, the conduit network 
constructed by MRC has been shown to transport soluble antigens from SCS to central B zones 
where FDC reside and where antigen can get deposited	   (Bajenoff and Germain, 2009) 
(Roozendaal et al., 2009). MRC might serve as a local FDC progenitor cells during acute LN 
swelling as shown by Jarjour et al. (Jarjour et al., 2014). Indeed, besides their similar expression 
of markers to LTo cells, Katakai et al. also showed that LTo cells are more concentrated in 
marginal zone of LN anlagen and this layer of LTo cells later expands outward with growth of 
the anlagen to become the MRC layer (Katakai et al., 2008). This data suggests that MRC are 
the direct descendants of LTo cells that preserve LTo markers such as MAdCAM-1 and RANKL 
(Katakai, 2012). Furthermore, RAG KO mice still exhibit a subcapsular MRC layer in atrophic LN 
and shrunken periarterial MRC sheaths in the spleen, indicating that MRC development occurs 
independently of B and T cells and is programmed before their colonization	   (Katakai et al., 
2008). 
 
 
1.1.5 Fibroblastic reticular cells (FRC) 
 
The fibroblastic reticular cells in the T zone (TRC) as described by Anderson et al.	   (Anderson 
and Anderson, 1975), form a sponge-like reticular network throughout the T zone in the LN. 
With electron microscopy, microchannels were visualized within the network that are wrapped 
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by FRC and connect the subcapsular sinus (SCS) to the HEV (Gretz et al., 1997) (Ushiki et al., 
1995). The so-called ‘conduit system’ consists of a core of collagen-I fibers that are surrounded 
by ECM including fibrillin-1, -2, and a component stained by antibody, ER-TR-7. These fibers 
are then wrapped by a layer of basement membrane composed of laminin, collagen-IV, and 
fibronectin. FRC tightly enwrap these ECM fibers and form the FRC network serving as a 
backbone in the T zone that eventually stabilizes the LN architecture	  (Sixt et al., 2005) (Kaldjian 
et al., 2001). The function of the conduit system is shown to allow for rapid transport of small 
soluble molecules (<70 kD), including antigens and cytokines, to the T zone and HEV (Gretz et 
al., 2000). Substances that are bigger cannot enter the conduit system and will be trapped by 
SCS macrophages instead. A similar conduit system is also found in the spleen that allows 
small molecules to enter the conduit of the white pulp via the marginal zone	  (Nolte et al., 2003). 
 
Besides providing structural stability, FRC have been shown to produce CCL19 and 21 that 
attract CCR7+ naïve T cells and DC to the T zone (Luther et al., 2000). The production of these 
homeostatic chemokines is partially induced by LTβR and TNFR-I signaling (Ngo et al., 1999). 
Beyond just producing the chemokines that define the boundary of the T zone, the FRC network 
also serves as a highway for T cells to crawl on, as shown by two-photon laser scanning 
microscopy (Bajenoff et al., 2006). The motility of T cells seems at least partially dependent on 
CCL21-CCR7 interaction (Worbs et al., 2007)	  (Okada and Cyster, 2007)	  (Asperti-Boursin et al., 
2007). On the other hand, antigen presenting cells (APC) have been shown to interact with the 
FRC network. In LN, resident DC, especially the CD8+ DC subset, adhere to the FRC and thus 
form a network closely associated with FRC network (Katakai et al., 2004a) (Sixt et al., 2005). 
Acton et al., showed that FRC and LEC interact with CLEC-2+ DC via gp38 (podoplanin) to 
promote DC mobility from peripheral sites through lymphatic vessels to the T zone of the LN 
(Acton et al., 2012). Local expression of CCL19/21 by FRC may help immune responses by 
promoting DC maturation	   (Marsland et al., 2005), endocytosis and antigen presentation 
(Yanagawa and Onoe, 2003), evoking their extension and probing of dendrites (Yanagawa and 
Onoe, 2002), increasing the probability of APC and T cell encounter (Friedman et al., 2006), 
and co-stimulating T cell activation (Flanagan et al., 2004).  
 
FRC also contribute to T cell homeostasis by producing the T cell survival factor, IL-7 (Link et al., 
2007). The population of T cells is maintained at a constant number that is balanced by newly 
generated T cells and the death of T cells in the periphery. The survival of T cells is controlled 
by competing for IL-7 and MHC complex recognition (Goldrath et al., 2000) (Schluns et al., 
2000). Blocking the entry to the LN will reduce the life span of T cells, indicating the source of 
IL-7 is inside the LN. By isolating FRC from the LN, Link et al showed that FRC are the main 
source of IL-7 in the LN (Link et al., 2007). Besides TRC and MRC, LEC were also shown to be 
the possible source of IL-7 in the LN	  (Repass et al., 2009) (Onder et al., 2012). 
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FRC also contribute to peripheral tolerance during homeostasis. However, unlike DC that 
acquire self-antigens from tissues, FRC were shown to express the autoimmune regulator 
(AIRE) and a range of tissue-derived self-antigens (TSA), thus contributing to peripheral 
tolerance (Fletcher et al., 2010)	   (Magnusson et al., 2008) (Lee et al., 2007). However, the 
expression of TSA by FRC may not be controlled by AIRE (Cohen et al., 2010) and FRC 
express another transcriptional regulator, deformed epidermal autoregulatory factor 1 (DEAF1) 
that have been shown to up-regulate approximately 300 genes in pancreatic lymph nodes, 75% 
of which are classed as peripheral tissue-restricted antigens	  (Yip et al., 2009). AIRE and DEAF1 
control distinct groups of TSA, which partially explains the differential expression of TSA in 
different stromal cells (Yip et al., 2009) (Cohen et al., 2010)	   (Fletcher et al., 2010). FRC could 
also promote tolerance by up-regulating programmed cell death ligand (PD-L1) after polyI:C 
treatment (Mueller et al., 2007). Comparison of FDC, FRC, and MRC are listed in Table 1.1	  
(Mueller and Germain, 2009). 
 
Table 1.1 Stromal cell subsets in secondary lymphoid organs (Mueller and Germain, 2009) 
 
 
 
1.2 Immune response and swelling of peripheral LN 
 
1.2.1 Activation of lymphocytes and LN swelling 
 
Speed is crucial to efficiently fight the spread of pathogens. Upon infection, the damaged 
epithelial cells will produce IFNα/β within minutes to recruit innate immune cells continuously 
patrolling the body. These cells have immediate effector function and generate a local 
inflammatory response that helps activating local APCs. At the same time, pathogens are taken 
up by skin-resident DC and digested into peptide fragment (8-15 amino acids in length) for 
presentation on MHCI or MHCII molecules at the APC surface. Upon antigen uptake and 
danger signal activation, APC become activated and mature to up-regulate surface CCR7 and 
start to migrate to the draining LN via afferent lymphatics. Matured migratory DC (mDC) can be 
detected in the LN starting from12-24 hours after infection and are very crucial for the induction 
of adaptive immune response.  
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However, it also has been shown that some small pathogen-derived molecules or viral particles 
(<200 nm) can be drained via the lymph to the SCS of LN and then be taken up by SCS 
macrophages, B cells, or further go into the T zone via the conduit system and be taken up by 
LN-resident DC. This can happen as early as 10 minutes after infection (Junt et al., 2008). The 
conduit system has also been shown to transport pro-inflammatory chemokines and cytokines 
from the peripheral site of inflammation to the T zone and the lumen of HEVs	  (Palframan et al., 
2001). This may lead to the recruitment of inflammatory cells like monocytes to the LN, further 
enhancing inflammation. 
 
The precursor frequency of antigen-specific T cells is actually extremely low. It is estimated that 
around 50-200 T cells with high affinity exist for a given antigen in an entire adult mouse	  (Moon 
et al., 2007). In order to increase the probability of successful encounters between naïve T cells 
and DC presenting their cognate antigen, the draining LN receives danger signals which starts a 
process named LN shutdown and HEV activation, that together cause the trapping of a large 
number of naïve lymphocytes thereby inducing LN swelling.  
 
Shortly after infection, HEVs change their properties within hours with an increase in number 
and size in the following days	  (Soderberg et al., 2005) (Webster et al., 2006) (Chen et al., 2006). 
It was shown that the HEV diameter increases by 50% and the blood flow rate by 500% 3 days 
after infection	   (Hay and Hobbs, 1977)	   (Steeber et al., 1987) (Soderberg et al., 2005). 
Comparably, afferent lymphatic vessels proliferate, inducing increased recruitment of DCs from 
the periphery to the draining LN	   (Angeli et al., 2006). On the other hand, LN shutdown was 
achieved by blocking the exit of lymphocytes via IFNα/β which reduces the lymphocyte 
responsiveness to S1P as early as 6-18 hours after infection	  (Hall and Morris, 1965)	  (Matloubian 
et al., 2004) (Lo et al., 2005). Consequently, these events concentrate as many Ag-bearing APC 
and lymphocytes as possible in a single LN to facilitate the encounter of antigen and its cognate 
lymphocytes. How LN swelling is induced is only partially understood. Besides the S1P pathway, 
blocking of TNF or mast cells also partially reduced the LN hypertrophy	   (Jawdat et al., 2006)	  
(McLachlan et al., 2003) suggesting their role in LN swelling. On the other hand, direct injection 
of TLR ligands, LPS and CpG, is sufficient to trigger LN swelling	   (Soderberg et al., 2005). 
However, LN swelling upon viral infection seems to be independent of TNF and MyD88	  
(Soderberg et al., 2005). These data suggests that multiple redundant pathways exist to induce 
LN swelling.  
 
After recognizing cognate peptide-MHC complexes via their TCR, T cells become activated with 
the help of co-stimulatory signals provided by APC such as CD28 interactions with CD80/86. 
This Ag-MHC-TCR interaction is reinforced by cytokines and lead to full activation of T cells 
including up-regulation of CD69 and CD44. Later T cells (and DC) start to produce IL-2 and IFN-
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γ to further stimulate T cells that have up-regulated the IL-2 receptor CD25. Finally, T cells 
dissociate from DC and undergo rapid proliferation and differentiation before leaving the LN	  
(Mempel et al., 2004) (Henrickson and von Andrian, 2007). The clonal T cell expansion can be 
detected as early as 30 hours after activated DC arrived in the LN. Naïve CD8 T cells only 
require short interaction with antigen to initiate their proliferation and differentiation into cytotoxic 
T cells while naïve CD4 T cells need longer exposure to Ag to differentiate into different types of 
helper T cells, including TH1, TH2, TH17, follicular T helper cells (TFH) and induced regulatory T 
cells (iTreg). TFH cells are unique for their expression of CXCR5 that drives them to migrate to 
the T-B border and assist T-dependent B cell activation.  
 
B cells can be activated by antigens plus T cell help (T-dependent antigens) or just by repetitive 
antigens alone (T-independent antigens). Soluble antigens drained to the SCS of LN can be 
taken up directly by B cells or by SCS macrophages that later translocate the antigens into the 
follicle where B cells can capture it (Junt et al., 2007). Soluble antigen can also be drained to 
central B zones via MRC-associated conduits and be taken up directly by FDC to present it to B 
cells (Bajenoff and Germain, 2009)	   (Roozendaal et al., 2009). T-independent antigens activate 
B cells by cross-linking the BCR leading to B cell activation and differentiation into IgM-
producing plasma cells (Shapiro-Shelef and Calame, 2005). In contrast, when BCR on B cells 
binds to T-dependent antigens, they up-regulate CCR7 and migrate to the T-B border and 
encounter CXCR5+ antigen-specific TFH cells. The T–B interaction in the periphery of the B-cell 
follicle results in the initiation of proliferation at the boundary. A small fraction of B cells 
proliferate at the interface and re-enter the follicle to initiate the germinal center (GC) while 
others continue their proliferation as plasmablasts and migrate towards the medulla where they 
fully differentiate into plasma cells. In the early stages of the GC response, activated B cells 
undergo extensive proliferation in the dark zone of the GC. The dark zone, which is proximal to 
the T-cell area, contains the majority of proliferating B cells, called centroblasts. It is also 
presumed that somatic hypermutation is restricted to centroblasts. Centroblasts migrate to the 
light zone after finishing their proliferation, become centrocytes but may return to dark zones to 
undergo repeated somatic hypermutation and affinity maturation. The centrocytes expressing 
high affinity receptors to foreign antigen will be positively selected by antigen-presenting FDCs 
and antigen-specific CD4+ T cells. These B cells then become either memory cells or plasma 
cells (PC) producing high-affinity antibodies	   (Batista and Harwood, 2009)	   (Cyster, 2005). The 
centrocytes expressing low affinity receptors, however, will undergo apoptosis within the GC 
and be engulfed by macrophages. 
 
While the short-lived PC remain for several days in the medullary region of the LN before dying 
locally, the long-lived plasma cells frequently travel to the bone marrow (BM). In humans and 
mice, around 0.1 -1% of the bone marrow cells are PC	  (Terstappen et al., 1990). The survival of 
long-lived PC has been shown to involve several factors, both soluble and insoluble, that 
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constitute a niche for PC survival. These factors includes IL-6, CXCL12, CD44 ligands, 
granulocyte-macrophage colony-stimulating factor (GM-CSF), transforming growth factor-β 
(TGFβ) and TNFα. Besides, BM PC also require physical association with stromal cells to 
persist. PC may induce stromal cell production of IL-6, which then again enhances PC survival 
(Oracki et al., 2010). 
 
 
1.2.2 Response of the stromal cells during immune response 
 
During an immune response the size of the draining LN increases dramatically due to the 
massive trapping of naive lymphocytes and the proliferation of antigen-specific lymphocytes 
(Cyster and Schwab, 2012b) (Zhu and Fu, 2011). This implies a rapid and extensive remodeling 
of the various stromal cell structures that form the backbone of LN. I have previously discussed 
how HEV and LEC react to infection or immunization in order to regulate LN swelling. However, 
how the dense, rigid FRC network reacts to this rapid LN selling and its function during acute 
lymph node hyperplasia is only partially understood but of great importance for the successful 
initiation of adaptive immunity.  
 
The existing evidence suggests an increase in the FRC network size (Katakai et al., 2004a) 
(Tan et al., 2012), at least in part due to FRC proliferation	   (Chyou et al., 2011). DC were 
proposed to trigger FRC proliferation directly by expressing LT〈	  (Chyou et al., 2008)	  (Chyou et 
al., 2011). RANK-ligand was also suggested as growth signal for FRC (Hess et al., 2012). It was 
also reported that the FRC network around HEV might be disrupted (Tzeng et al., 2010) along 
with a transient loss of CCL19/21 and IL-7 expression	   (Mueller et al., 2007)	   (Scandella et al., 
2008). On the other hand, some functions of FRC during immune response were reported. It 
has been shown FRC can produce VEGF to promote endothelial cell growth during LN swelling	  
(Chyou et al., 2008). Gp38 expression on FRC was reported to maintain VE-cadherin 
expression on HEV by somehow interacting with CLEC-2 on platelets. FRC were thus proposed 
to be essential for the overall integrity of LN vascular structures during immune response	  
(Herzog et al., 2013). Meanwhile, FRC were also shown to prevent excessive T cell expansion 
during immune response by the production of iNOS and COX-2 (Siegert et al., 2011)	   (Lukacs-
Kornek et al., 2011) (Khan et al., 2011).  
 
 
1.3 The histology and physiology of intestine 
 
The intestines consist of the small and large intestine that are responsible for digesting food, 
absorbing nutrients, and expelling waste. The small intestine can be further subdivided into 
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duodenum, jejunum, and ileum while the large intestine includes cecum, proximal colon and 
distal colon. The duodenum is the beginning of the small intestine and receives gastric chyme 
from the stomach. One main function of the duodenum is to neutralize the acids contained in the 
gastric chyme. It is characterized by especially long villi compared to jejunum and ileum in mice 
(Brennan et al., 1999). The subsequent jejunum is the longest part of the small intestine, 
proximally half of it, and is mainly dedicated to the digestion and absorbtion of nutrients (sugars, 
amino acids, fatty acids), which are finally taken up by the blood and lymphatic vessels. The 
ileum is the last part of the small intestine and absorbs remaining nutrients, as well as bile acids 
and vitamin B12 produced by commensals present in the lumen of the ileum. The main function 
of the large intestine is to absorb the water and salts from the remaining material which 
becomes the feces (Ganong, 1995) (wikipedia). 
 
In human, the intestinal wall is composed of four concentric layers, in the following order starting 
from the luminal side: mucosa, submucosa, muscularis externa (the external muscular layer), 
and serosa. The mucosa is the innermost layer of the intestinal wall that surrounds the lumen 
and thus contacts directly the digested food (chyme) and the microbial flora present in the 
lumen. The mucosa is composed of a single layer of epithelial cells that separates the lumen 
from the body. The mucosa has a key role in digestion, absorption, and secretion of mucus. 
However, the epithelial cell layer is covered by a thick layer of mucus secreted by goblet cells 
which are scattered throughout the epithelium to protect it from direct contact with microbial 
organisms of the lumen. Right below the epithelial layer lays the lamina propria consisting of 
connective tissue and scattered lymphocytes and plasma cells. The submucosa consists of a 
dense irregular layer of connective tissue with large blood vessels, lymphatic vessels, and 
nerves. The muscularis externa is composed of an inner layer of circular muscle and an outer 
layer of longitudinal muscle to help intestinal wall movement. The serosa is the outermost 
connective tissue that separates the intestine from the peritoneal space (Figure 1.3) (Junqueira 
et al., 1995) (wikipedia).  
 
In order to increase the surface contacting the chyme, the surface of the mucosa displays 
permanent foldings named circular folds (also called plicae circulares) which are large valvular 
flaps projecting into the lumen. In mice, circular folds are only seen in proximal colon but not in 
small intestine and distal colon	   (Abdelrahman et al., 2012). Further, all the mucosal surfaces in 
the small intestine develop villi and crypt structures to increase the contact surface with food 
content while in the large intestine only crypts exist. Intestinal villi are small, finger-like 
projections that protrude from the epithelial lining of the intestinal wall into the lumen while 
intestinal crypts are narrow but deep invaginations into the intestinal wall and often harbor 
glands that secret digestive enzymes, Paneth cells that secret anti-microbial peptides, and 
epithelial stem cells (Figure 1.3). In addition, the luminal surface of the epithelial cells display 
microvilli which further increase the contact surface with the luminal content to increase the 
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efficiency of nutrient absorption. In each villus, there are many capillaries surrounding a single 
lacteal (lymph capillary). The capillaries allow collecting hydrophilic nutrients including amino 
acid and simple sugars into the blood stream while the lacteal is to collect more hydrophobic 
nutrients such as triglycerides and cholesterol into the lymph fluids. The absorption of nutrients 
and water in the intestine largely depends on passive diffusion (Ganong, 1995) (wikipedia).  
 
 
Figure 1.3 Schematic view of some of the salient features of the two major subdivisions of the intestine, and 
the four layers composed the intestinal wall. 
(Thomas Caceci, http://www.vetmed.vt.edu/education/curriculum/vm8054/Labs/Lab19/Lab19.htm) 
 
 
1.3.1 Intestinal microbiota and gut-associated lymphoid tissues (GALT) 
 
Throughout the gastrointestinal tract the surface of the epithelium is colonized by enormous 
numbers of of microorganisms (including bacteria, fungi, and protozoa) that are mutualistic with 
the host. In a human body, around 1014 bacteria can be found. The composition of this microbial 
community is host specific, evolving throughout an individual’s lifetime and susceptible to both 
exogenous and endogenous modifications. They are acquired from birth onward starting with 
the natural delivery by the mothers and later from the environment. Although humans and mice 
can survive without microbiota, the normal flora has been shown to be essential in providing 
nutrients, preventing the growth of harmful pathogens, training of the immune system and 
maintenance of normal host physiology	  (Sekirov et al., 2010). 
 
It is not surprising that in such a microorganism-rich environment the intestine develops various 
gut-associated lymphoid tissues (GALT) to protect the body. These include mesenteric LN 
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(mLN), Peyer’s patches (PP), isolated lymphoid follicles (ILF), and cryptopatches. These 
lymphoid tissues are the major sites for inducing immune responses to commensal or 
pathogenic bacteria. Besides these specialized GALT, the lamina propria and epithelium of the 
whole intestine are full of immune effector cells to protect the body from the intrusion by 
microbiota	   (Brandtzaeg et al., 2008). The lymphocytes which specifically reside within the 
epithelial barrier are named intraepithelial lymphocytes (IEL).  The development and activity of 
these immune cells in the GALT and lamina propria are tightly regulated by the microbiota and 
thus contribute to various types of autoimmune disease, infectious disease, and cancer	  (Round 
and Mazmanian, 2009) (Sekirov et al., 2010).  
 
 
1.3.2 Immune response in the intestine 
 
The immune response in the gut is mainly induced in the organized GALT, including mLN, PP, 
and ILF. The PP and ILF are believed to be major sites where the immune system encounters 
the gut antigen. The epithelium above the PP or ILF are called follicle-associated epithelium 
(FAE) which contains microfold cells (M cells) that are specialized to transport intact antigens 
from the lumen of the small intestine by transcytosis to APC (mostly DC) in the subepithelial 
dome (SED) found right below the FAE (Mowat, 2003). The APC carrying the antigen then 
migrate to the T cell zone or B cell follicle to prime T and B cells. Here activated B cells will 
undergo immunoglobulin class switch recombination (CSR) from IgM to IgA under the control of 
TGFβ, IL-10, retinoic acid (RA) and cellular signals delivered by DC and T cells	  (Fagarasan and 
Honjo, 2003).  
 
The activated T and B cells later exit the PP or ILF via lymphatic vessels that lead them to the 
mLN, where they may stay for a limited time for further differentiation. After leaving mLN they 
join again to the blood circulation via thoracic duct. Through the blood stream, these 
lymphocytes are programmed to home to the GALT as they express α4β7 to interact with 
MadCAM-1 which is highly expressed on the vasculature of the mucosal surface. The 
expression of CCR9 on these cells allows them to be attracted by CCL25 which is highly 
produced by the small intestine	  (Kunkel and Butcher, 2003). The homed activated lymphocytes 
distribute into different locations in the effector sites, i.e. LP and epithelium. B-cell blasts mature 
into IgA-producing plasma cells and remain in the lamina propria. CD4+ T cells also remain in 
the lamina propria, while CD8+ T cells migrate preferentially into the epithelial layer, although 
~40% of T cells in the lamina propria are CD8+ (Figure 1.4) (Mowat, 2003)	  (Eberl, 2005). 
 
CSR to IgA of activated B cells in the gut is traditionally believed to happen inside the PP in a T 
cell-dependent manner as mentioned above, or in ILF in a T cell-independent manner with the 
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presence of IL-6 and RA produced by epithelial cells and LP DC (Sato et al., 2003)	  (Mora et al., 
2006). However, Fagarasan et al. showed that CSR could also be observed in LP in a T cell-
independent manner	  (Fagarasan et al., 2001) (Kinoshita et al., 2001). The CSR to IgA in LP was 
shown to depend on TGFβ, TSLP, APRIL, and BAFF provided by eosinophils, epithelial cells, 
and LP DC (Chu et al., 2014)	  (Tezuka et al., 2007)	  (Cerutti, 2008). Recent findings suggest that 
LP stromal cells can be the source of TGF-β1, BAFF, APRIL, IL-6, and IL-10 for promoting IgA 
CSR	  (Fagarasan et al., 2010) (Pabst, 2012). 
 
Figure 1.4 The intestinal immune system.  
A single layer of epithelial cells separates the intestinal lamina propria from the gut flora. It is protected by a thick 
layer of mucus, bactericidal defensins, neutrophils and large amounts of antigen-specific secretory IgA. The intestinal 
immune system can be functionally divided into inductive sites, which include the mesenteric lymph nodes, Peyer’s 
patches (in the small intestine), colonic patches and isolated lymphoid follicles (ILF), and into effector sites, which 
include the epithelium and the lamina propria. In the epithelium, intraepithelial lymphocytes (IEL) monitor epithelial 
damage and might recognize microbial antigens. The lamina propria contains large numbers of T cells, IgA-producing 
plasma cells and macrophages. It also contains many DC, which migrate to mesenteric lymph nodes through the 
lymph and present antigens to T cells. The follicle-associated epithelium (FAE), which covers Peyer’s patches, 
contains Microfold (M) cells, which transport lumenal antigens to the sub-epithelial dome of Peyer’s patches for 
sampling by DC that can also sample antigens from apoptotic epithelial cells. ILF, similar to Peyer’s patches, contain 
B cells, DC and M cells (which are located in the adjacent FAE). HEV, high endothelial venule. (Eberl, 2005) 
 
 
1.3.3 Immune tolerance in the intestine 
 
During homeostasis, the immune cells in the gut are tolerant to food and commensal antigens. 
The CD4 T cells in the LP comprise TH1, TH2, TH17, as well as iTreg cells. A defective TH17 
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response can easily induce chronic inflammatory diseases, such as Crohn’s disease (Honda 
and Takeda, 2009). Therefore, iTreg are important to maintain peripheral tolerance. iTreg 
differentiate from naïve CD4 T cells during antigen priming in the presence of  TGFβ , a process 
which is greatly enhanced by retinoic acid (RA)	   (Allen et al., 2011)	   (Sakaguchi et al., 2008). 
Foxp3 is the signature transcriptional factor regulating the suppressive ability of Treg cells	  
(Shevach, 2006).  
 
The induction of iTreg cells in gut seems to be closely related to the DC that prime them. 
CD103+ DC in the LP of small intestine have been shown to be the major subset to induce iTreg 
due to their high production of TGFβ and RA	  (Sun et al., 2007). CD103+ DC was also shown to 
inhibit Th17 differentiation via TSLP expression while in turn enhancing Treg development	  
(Spadoni et al., 2012). Besides CD103+ DC, DC in the mLN that express COX-2 are shown to 
promote Treg differentiation by suppressing IL-4 production	  (Broere et al., 2009).  
 
 
1.3.4 Mesenchymal cells in the intestinal lamina propria  
 
Besides endothelial cells, there are many other types of mesenchymal cells in the small 
intestine reported, including fibroblasts, myofibroblasts, pericytes wrapping the vasculature, 
bone marrow–derived stromal stem cells, smooth muscle cells of the muscularis mucosae, and 
smooth muscle cells surrounding the lymphatic lacteals (Figure 1.5) (Powell et al., 2011). It is 
difficult to distinguish these mesenchymal cells from each other due to the lack of unique 
markers. Often a combination of several markers is required, such as α-SMA, desmin, vimentin, 
and CD90 (Table 1.2)	   (Pinchuk et al., 2010). Generally speaking, smooth muscle cells are 
highly positive in α-SMA and desmin, however, pericytes and some activated myofibroblasts are 
also positive for both markers (Table 1.2)	   (Link et al., 2007) thus making the identification of 
fibroblasts difficult from other cells. The ability to produce abundant extracellular matrix (ECM) 
can also be a good indicator for identifying fibroblasts from other mesenchymal cells. It has 
been shown gp38/podoplanin is expressed in the intestinal lamina propria by the non-epithelial 
and non-muscularis layers (Farr et al., 1992). Whether gp38 can serve as a fibroblast marker in 
the intestinal LP remains to be determined.  
 
 
1.3.5 Intestinal fibroblast contribution to immune response 
 
There are some studies suggesting intestinal LP fibroblasts can contribute to immune response 
or tolerance, most of them are done with cultured primary human colonic fibroblasts in vitro 
(Bega, 2012). Primary human colonic subepithelial fibroblasts were shown to up-regulate COX-
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2 and iNOS expression upon LPS and/or IL-17 treatment in vitro (Zhu et al., 2012)	  (Zhang et al., 
2005), reminiscent of FRC in the LN (Siegert et al., 2011). Myofibroblasts isolated from small 
intestine were also found to constitutively express iNOS mRNA and their expression can be 
further enhanced upon TNFα, IL-1β, or IFNγ treatment in vitro	  (Wu et al., 2013). Human colonic 
myofibroblasts were also shown to promote the expansion of Treg cells in vitro	   (Pinchuk et al., 
2007). Besides, α-SMA+CD90+ subepithelial myofibroblasts were proposed to be non-
professional APC as they constitutively express MHCII molecules in the normal colonic mucosa 
and stimulate T cell proliferation in a MHCII and CD80/86 co- stimulatory molecule dependent 
manner in vitro (Saada et al., 2006). How these intestinal fibroblasts contribute to immune  
 
Figure 1.5 Schematic representation of the epithelium and mesenchymal elements of the small intestinal 
villus-crypt axis. 
(a) Longitudinal representation of the villus and crypt showing the epithelium and lamina propria containing α-SMA+ 
subepithelial myofibroblasts and pericytes of the capillaries, mesenchymal stem cells, and smooth muscle associated 
with the lymphatic lacteal and the muscularis mucosae. Fibroblasts (α-SMA−) are shown, especially in the upper 
portion of the villus. (b) Cross sections through a villus show the lymphatic lacteal with associated smooth muscle. (c) 
A cross section through the crypts demonstrates the lymphatic pericytes. Panels b and c also show that the 
subepithelial myofibroblasts are essentially pericytes in subepithelial locations of the villus. (d) A higher power 
depiction of the myofibroblasts and pericytes with cytoplasmic processes that surround and support the capillaries. 
(e) A Peyer’s patch with its vascular, lymphatic, and stromal elements. (Powell et al., 2011) 
 
Table 1.2 Mesenchymal cell markers. 
 
Identification of the several cell populations in the small intestine. “+” positive, “-” negative and “±” low or negative 
expression (Bega, 2012)	  (Pinchuk et al., 2010) 
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response in vivo remains to be determined due to the technical restriction of isolating ex vivo 
fibroblasts from the intestine. However, a very recent paper showed the existence of a 
population of gp38+CD31-CD45-EpCAM- stromal cells in the small intestine that is involved in 
imprinting mucosal DC via the production of RA and GM-CSF. This process is dependent in vivo 
on commensals (Vicente-Suarez et al., 2014).  
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1.4 Aim of the thesis 
 
Overview of the project 
Fibroblastic reticular (FRC) networks can be found in all secondary lymphoid organs, including 
the lymph node (LN). Besides serving as scaffold for cell adhesion and migration, LN FRC 
contribute to naïve T cell homeostasis and function by providing chemoattractants and survival 
factors. New evidence suggests that LN FRC can restrain strong T cell expansion by expressing 
immune modulators dependent on the enzymes COX-1/2 and iNOS. Gene array data and 
unpublished data from our lab suggest that a subset of LN FRC may also provide survival 
factors for plasma cells. These findings raise the question whether the LN FRC network is 
modified during an ongoing immune response, or whether it is present within the gut lamina 
propria (LP) where scattered effector T cells and large numbers of plasma cells are present. 
While fibroblasts have been observed in the LP, their organization and function are poorly 
understood.  
 
Part I: Elucidate how the fibroblastic reticular cell network of the T zone changes in 
response to the rapid lymph node swelling occurring during adaptive immunity. 
LN grow strongly during immune response but at the start of this project it was not well 
understood how the rigid FRC network adapts to this massive increase in number of T cells: are 
FRC stretched, disrupted, activated or do they grow in number due to FRC proliferation? In case 
FRC develop an expanded network, what signals trigger their proliferation during LN swelling? 
Is there a particular cell population serving as FRC progenitor cells? Existing literatures imply a 
role of DC and LTαβ, in inducing expansion of FRC but the detailed mechanism is still missing. 
Also, it remains to be clarified whether FRC in activated LN keep their function for naïve 
lymphocytes, namely the expression of cytokines like IL-7, CCL19 and CCL21. (described in 
chapter 2) 
 
Part II: Isolation and characterization of fibroblasts in the intestinal lamina propria. 
Fibroblasts of the gut LP are poorly defined at the morphological, phenotypic and functional 
level. It raises the question whether sites of scattered effector lymphocytes like the LP also 
harbour an FRC-like network that may act as scaffold and organizer cell besides having 
potential roles in immune tolerance. In addition, the survival niche of plasma cells in the gut LP 
has not been defined. To address some of these open questions, I examined whether a 
fibroblast cell type is responsible for organizing a reticular network similar to LN and whether 
they may affect immune functions. As there was neither an established isolation protocol nor 
good surface markers for intestinal fibroblasts, my first aim was to establish good tools to study 
intestinal fibroblasts, including the identification of markers suitable for fibroblast staining, the 
development of isolation protocols for FACS staining and cell sorting, and the characterization 
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of LP fibroblast cell lines. Together, these approaches should allow a better characterization of 
the organization, phenotype and potential functions of intestinal fibroblasts. (described in 
chapter 3)   
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2. Mechanisms of FRC expansion during immune response in draining LN 
(Collaboration with T. Vogt) 
Results published in PNAS, 111(1):E109-18, 2014 
 
2.1 Results 
 
2.1.1 Lymph node hyperplasia is accompanied by rapid FRC activation and 
expansion.  
 
To study the behavior of stromal cells in an acute LN swelling model and associate it with the T 
cell response, ovalbumin (OVA)-specific TCR-transgenic CD8+ T cells (OT-1) and CD4+ T cells 
(OT-2) were adoptively transferred into mice that were then subcutaneously immunized with 
OVA antigen emulsified in an oil-in-water adjuvant, Montanide ISA-25 (Mont). A pool of 6 
draining LN was enzymatically digested to analyze both hematopoietic and stromal cells by flow 
cytometry. OVA-injection induced rapid and strong LN swelling, peaking on day 8 and declining 
thereafter (Figure 2.1A). While OVA-specific T cells strongly expanded, ~85% of cells found in 
swollen LN were naive host-derived naive (CD69- CD44-) T and B lymphocytes. Continuous in 
vivo BrdU labeling showed that proliferation was largely limited to OVA-specific T cells and a 
small B cell subset. The three major CD45- non-hematopoietic stromal cells, FRC, lymphatic 
endothelial cells (LEC) and blood endothelial cells (BEC) were distinguished based on their 
CD31 and gp38 expression (Figure 2.1B), as described previously	   (Link et al., 2007).  Analysis 
of their numbers revealed a gradual expansion of all three subsets starting on day 3 and 
reaching a 5-fold increased number on day 8-14 (Figure 2.1C), comparable to the 5-fold 
increase in lymphocyte number (Figure 2.1A). The stromal cell growth was at least in part due to 
proliferation as up to 70% of FRC, LEC and BEC incorporated BrdU within the first 8 days after 
immunization (Figure 2.1C, D). To examine if LN stromal expansion occurred also during 
infection, the protozoan parasite Leishmania major was inoculated in B6 mice and LN analyzed 
19 days post infection. A similar expansion of FRC, LEC and BEC was visible (Figure 2.1E), 
demonstrating that FRC expansion is a feature common to adaptive immunity induced by 
immunization or infection. (Data provided by T. Vogt) 
 
To define the sequence of early events in more detail, LN were analyzed 20 and 40 hours after 
OVA/Mont immunization. Trapping of naive lymphocytes started as early as 20 hours (Figure 
2.2A), while first OVA-specific T cell proliferation was detected at 40 hours (Figure 2.2B). 
Strikingly, an increase in FRC number and proliferation was already observed at 40 hours, in 
contrast to LEC and BEC which both entered cell cycle only around day 3.5 (Figure 2.2C, 2.1C). 
Surprisingly, FRC and LEC increased their size and granularity as early as 20 hours upon 
immunization, with a peak at 40 hours followed by a slow decrease over several weeks (Figure 
2.2D-G). FRC as well as lymphocyte numbers in activated LN remained higher than in the naïve 
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LN over 2 months after immunization, however, without evidence of increased turnover (Figure 
2.2H-I). (Collaborated with T. Vogt) 
 
 
Figure 2.1 FRC and endothelial cells expand rapidly during immune response in draining peripheral lymph 
nodes. (Data provided by T. Vogt) 
(A-D) Splenocytes from OT-1 (OVA-specific CD8+ TCR tg) and OT-2 (OVA-specific CD4+ TCR tg) C57BL/6 mice on 
a CD45.1+ background were transferred into C57BL/6 (CD45.2+) recipient mice which then received s.c. injections of 
OVA/Montanide (Mont) or PBS, along with BrdU administration. The six draining peripheral LN were isolated at the 
indicated time points after immunization, fully digested, and analyzed by flow cytometry. (A) Shown are the number 
(upper panel) and proliferation (BrdU incorporation; lower panel) of indicated cell populations from PBS-control (open 
circles) and OVA/Mont-immunized (closed circles) mice. (B) Representative dot plots of CD45-CD35- pre-gated 
stromal cells identifying FRC (gp38+CD31-), LEC (gp38+CD31+) and BEC (gp38-CD31+). (C) Representative 
histograms showing FRC stained with an antibody to BrdU (white) or an isotype-matched control (grey area) 8.5 days 
after PBS or OVA/Mont injection. (D) Number (upper panel) and proliferation (lower panel) of FRC, LEC and BEC at 
indicated time points after OVA/Mont immunization. (E) Wild type C57BL/6 mice were infected with Leishmania major 
in both footpads. On day 19, the two draining popliteal LN were isolated and enzymatically digested and analyzed as 
above. Data are mean ± SD, representative for 2-3 independent experiments, with n ≥ 3 mice per group. 
 
FRC lines have been shown to change their surface phenotype and function upon treatment with pro-
inflammatory molecules	   (Katakai et al., 2004a) (Vega et al., 2006)	   (Siegert et al., 2011). Consistent with 
these findings, the mean fluorescence index (MFI) of gp38 but not PDGF-Rα expression increased by 
200% within 40h and remained at this level until day 5.5 before declining sharply on day 8.5 (Figure 2.3A). 
The 50% increase in cell size can only partially explain the strong increase in gp38 surface expression, 
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Figure 2.2 FRC increase their size within 20 hours and proliferate within 40 hours after immunization. 
(Collaborated with T. Vogt) 
OT-1 and OT-2 splenocytes were transferred to WT mice followed by OVA/Mont immunization. (A) LN cellularity, 
FRC number and proliferation are shown 20 hours after OVA/Mont immunization. (B, C) Cell numbers and 
proliferation of lymphocytes (B) and stromal cells (C) were assessed by flow cytometry in the draining LNs at 40 
hours after immunization. (D-G) Representative histograms and kinetics for FSC (size; D, F) and SSC (granularity; E, 
G) of FRC (D, E) or LEC (F, G) at indicated time points after OVA/Mont immunization. The OVA/PBS ratio shows the 
FSC and SSC level of FRC or LEC from OVA/Mont- (closed circles) relative to PBS-injected (open circles) mice. (H-I) 
Cell numbers and proliferation of stromal cells (H) and lymphocytes (I) were assessed by flow cytometry in the 
draining LNs at 58 days after immunization. Data are mean ± SD, representative for 2-3 independent experiments, 
with n ≥ 3 mice per group. 
 
D
C
FSC-A
%
 o
f M
ax
Days after immunization
 O
V
A
/P
B
S
 ra
tio
 o
f F
S
C
C
el
l n
um
be
r (
x1
0 
 )
LN cellularity
PBS
FRC
OVA/Mont
BECLEC
40 h
%
 B
rd
U
+
C
el
l n
um
be
r (
x1
0 
 )
0.00 
0.02 
0.04 
0.06 
0.08 
0.10 
C
el
l n
um
be
r (
x1
0 
 )
**
**
0
20
40
60
80
0 
2 
4 
6 
8 
10 
LN cellularity
FRC BECLEC
0.000 
0.005 
0.010 
0.015 
0.020 
PBS
OVA/Mont
0 
2 
4 
6 
8 
10 
12 
0.000 
0.002 
0.004 
0.006 
0.008 
0.010 
0 
2 
4 
6 
8 
10 d58
***
%
 B
rd
U
+
H
0 200 400 600 800 1000
0
20
40
60
80
100
PBS 20h 40h
**
*
E
SSC-A
%
 o
f M
ax
O
VA
/P
BS
 ra
tio
 o
f S
SC
Days after immunization
0 200 400 600 800 1000
0
20
40
60
80
100
PBS 20h 40h
PBS OVA/Mont
0 
30 
60 
90 
120 
0.00 
0.01 
0.02 
0.03 
0.04 
0.05 
0 
10 
20 
30 
0.000 
0.005 
0.010 
0.015 
0 
2 
4 
6 
8 
10 
0.000 
0.002 
0.004 
0.006 
0.008 
0 
2 
4 
6 
8 
*
**
***6
C
el
l n
um
be
r (
x1
0 
 )6
6
6
0.9 
1.0 
1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
0 5 10 15 20 25 30 35 40 45 50 55 60 
**
*
**
*
** ** *
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
2.0 
2.2 
0 5 10 15 20 25 30 35 40 45 50 55 60 
PBS OVA/Mont
**
*
**
**
**
*
*
0
5
10
15
0
5
10
15
0
10
20
30
40
50
60
70
*
*** ***
******
*** ***
***
**
C
el
l n
um
be
r (
x1
0 
 )
Donor cells
 CD4
OT-2
+
Host-derived cells (CD45.1  )
_
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
%
 B
rd
U
+
PBS OVA/Mont40h
B
CD8
OT-1
+ CD4
T cells
+ CD8
T cells
+
B cells
6
0.00 
0.01 
0.02 
0.03 
0.04 
0.00 
0.03 
0.06 
0.09 
0.12 
A
0 
20 
40 
60 
80 
*
C
el
l n
um
be
r (
x1
0 
 )6
PBS OVA/Mont20h
0.000 
0.010 
0.020 
0.030 
0.040 
0 
1 
2 
3 
%
 B
rd
U
+
*
FRC numberLN cellularity FRC proliferation
C
el
l n
um
be
r (
x1
0 
 )6
F
FSC-A
%
 o
f M
ax
O
VA
/P
BS
 ra
tio
 o
f F
SC
Days after immunization
PBS 20h 40h
PBS OVA/Mont
0.8 
0.9 
1.0 
1.1 
1.2 
1.3 
0 5 10 15 20 25 30 35 40 45 50 55 60 
*
* **
* *
0.8 
0.9 
1.0 
1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
0 5 10 15 20 25 30 35 40 45 50 55 60 
PBS OVA/Mont
Days after immunization
O
VA
/P
BS
 ra
tio
 o
f S
SC
**
*
**
**
*
* **
G
0 200 400 600 800 1000
0
20
40
60
80
100
0 200 400 600 800 1000
0
20
40
60
80
100
SSC-A
%
 o
f M
ax
PBS 20h 40h
LEC
0.00 
0.05 
0.10 
0.15 
0.20 
0.25 
0.30 
0 
2 
4 
6 
8 
10 
0.00 
0.04 
0.08 
0.12 
0.16 
0 
10 
20 
30 
40 
50 
0 
2 
4 
6 
8 
10 
12 
0 
4 
8 
12 
16 
20 
0 
2 
4 
6 
8 
10 
12 
0 
5 
10 
15 
20 
25 
0 
10 
20 
30 
40 
0 
2 
4 
6 
8 
**
n.d
***
n.d
*** *** **
*
%
 B
rd
U
+
PBS
OVA/Mont
d58
I
Donor cells Host-derived cells (CD45.1  )-
 CD4
OT-II
+ CD8
OT-I
+ CD4
T cells
+ CD8
T cells
+
B cells
C
el
l n
um
be
r (
x1
0 
 )6
40h
LEC
FRC
FRC
d58
 30	  
 
 
Figure 2.3 FRC from swollen lymph nodes display an activated phenotype. (Collaborated with T. Vogt and L. 
Scarpelino) 
(A) Upper panel: representative histograms and mean fluorescence intensity (MFI) for the surface expression of gp38 
and PDGFRα on FRC in the LN of PBS- (black line) or OVA/Mont-injected (red-line) mice 5.5 days after immunization. 
Surface protein expression on CD45+ cells served as negative control (grey area). Lower panel: kinetics of surface 
gp38 expression on FRC at indicated time points after OVA/Mont immunization (closed circles) relative to PBS 
control (open circles). (B) Representative images showing the expression of the myofibroblast marker, α-SMA, in LN 
sections taken at the indicated time points after OVA/Mont immunization, as assessed by immunofluorescence 
labeling. Asterisks indicate HEVs surrounded by smooth muscle cells and open arrows indicate reticular FRC, which 
co-stained for PDGFRβ. Labeling, exposure time and image processing were kept identical for all time points shown. 
(C) mRNA expression of Il7, Ccl19, and Ccl21 were measured in stroma-enriched (white bars) and lymphocyte-
enriched (grey bars) fractions from draining LN at 0, 3.5 and 8.5 days after immunization, and normalized to two 
housekeeping genes, as described in materials and methods. (D) Representative images of in situ hybridization 
analysis showing Ccl19 and Ccl21 transcripts (green) in lymph node sections on day 0, 5.5, and 8.5 after OVA/Mont 
immunization, along with B220 antibody staining (red). The slides were treated equally (ISH development, exposure 
time for photos, processing of images). n ≥ 3 mice per group, data in A, B and D are representative for 2-3 
independent experiments. Showing mean ± SD. Scale bars represent 100 µm. n.s.: differences are statistically not 
significant. 
 
particularly at d5.5 when FRC show only a 25% size increase. Increased gp38 levels were also seen 
in splenic FRC after viral infection	   (Benedict et al., 2006)	   (Bekiaris et al., 2008), suggesting it 
may serve as an activation marker of FRC. Furthermore, α-smooth muscle actin (α-SMA), a 
known myofibroblast marker	   (Tomasek et al., 2002)	   (Link et al., 2007), was also induced upon 
immunization and peaked at day 5.5 (Figure 2.3B) suggesting FRC show signs of late activation 
which are distinct from proliferation or gp38 up-regulation. No significant changes were 
observed in transcripts for Il7, Ccl19 and Ccl21, neither by qPCR (Figure 2.3C) nor by in situ 
hybridization (Figure 2.3D), although a trend to lower transcript levels was observed on d5.5 
(Figure 2.3C). Similarly, no marked changes were observed for CCL21 protein expression as 
based on histological analysis (not shown). Together, these data demonstrate that upon 
immunization FRC are rapidly, yet transiently, activated while maintaining expression of 
cytokines important for naive T cell recirculation and survival. (Collaborated with T. Vogt and L. 
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Scarpellino) 
 
2.1.2 FRC network in the T zone preserves its architecture during immunization 
but expands into the medullary area.  
 
Next we assessed histologically whether LN swelling leads to alterations in the integrity and 
organization of the LN FRC network. On day 8.5 as well as at earlier time points the 
organization of the FRC and matrix network in the central T zone was comparable to naïve LN, 
including the reticular morphology of FRC and their association with conduits (Figure 2.4A, B; 
not shown). These conduits remained fully functional in activated LN, with efficient lymph flow 
towards HEV and no evidence of fluid leakage (Figure 2.4C). 3D analysis of the central T zone 
indicated a comparable spacing of the FRC network in inflamed and naïve LN, fitting 
approximately 5-10 lymphocytes within a 2D plane (Figure 2.4D). Also comparable were the 
length of the total FRC network in a given volume or of individual FRC (Figure 2.4E). However, 
a strong increase in the volume covered by gp38+ FRC networks was observed, both in the 
expanded T zone and medulla (Figure 2.4F). More detailed analysis of medullary cords 
revealed a 3D sponge-like network of laminin+ fibers enwrapped by reticular cells with an FRC-
like phenotype (gp38+CD31- LYVE-1-) that was much more pronounced in activated than naive 
LN (Figure 2.4G). These results demonstrate the astonishing capacity of the matrix and FRC 
network to adapt rapidly to the massive organ growth, while preserving some of its principal 
characteristics. (Data provided by T. Vogt and S. Favre) 
 
 
2.1.3 Locating the BrdU+ proliferating FRC in swollen LN 
 
The kinetic of BrdU incorporation in FRC shown in Figure 1C indicates that only 60-70% of FRC 
have undergone proliferation at the peak of acute LN swelling while their number has increased 
5-fold. If one assumes that these fibroblasts have divided at least twice it suggests that only a 
small subset of FRC have proliferative capacity. We therefore asked whether BrdU+ FRC were 
found in specific zones only, like in the strongly enlarged medullary cords. However, it is very 
difficult to identify BrdU+ FRC in the presence of abundant proliferating lymphocytes in 
immunized LN with immunofluorescence (IF) microscopy.  In order to visualize these 
proliferating FRC and their distribution in the LN, mice were irradiated to deplete highly 
proliferating lymphocytes on day 7 after OVA/Mont immunization and then BrdU and gp38 of LN 
were detected by IF. In LN of lethally irradiated mice (900 rad), there were few T and B cells left 
and the stromal compartment seemed to be maintained. In contrast, LN of sub-lethally irradiated 
mice (450 rad) still showed a considerable number of lymphocytes and were therefore not 
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Figure 2.4 Expanding FRC network preserves its usual structure and function while extending into medullary 
cords. (Data provided by T. Vogt and S. Favre) 
Immunofluorescence microscopy of cryostat sections (A, B, F) or 80 µm-thick vibratome sections (C-D, G) from 
draining LN of PBS or OVA/Mont-immunized mice were labeled with the indicated antibodies. (A) B220+ B cells and 
CD3+ T cells indicate B and T zones, respectively. LYVE-1 stains lymphatic vessels. Consecutive sections show FRC 
(gp38+CD35) and FDC (gp38+/-CD35+) networks as well as the laminin+ basement membranes of vessels and 
conduits. (B) Higher magnification of the T zone showing CD31+ HEV (asterisks) and reticular FRC (gp38+) wrapped 
around fibronectin-positive conduits (open arrows); conduits are composed of collagen-I+ (Col-I) fibrils surrounded by 
a laminin+ basement membrane. (C) Texas (Tx) Red-dextran was injected s.c. 3.5 days after OVA/Mont immunization, 
draining LN isolated 30 min thereafter followed by their processing for histological labeling. Open arrows highlight 
TxRed-dextran+ conduits surrounded by gp38+ FRC; asterisk shows a HEV with a perivascular space rich in TxRed-
dextran. (D) Vibratome sections of the LN T zone in PBS and OVA/Mont-immunized mice demonstrating a similar 
density and architecture of the gp38+ FRC network in the two settings. B220+ B cells are shown as size comparison. 
(E) Filament tracer software was used to quantify the total network length and the segment length of individual FRC 
in images derived from gp38-labeled vibratome sections (mean ± SD), as shown in D. (F) FRC growth during immune 
response occurs in T zones as well as medullary cords. Serial 8 µm sections were made of entire naive or d8.5 
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OVA/Mont-activated lymph nodes. Every 10th section was labeled with markers for FRC (gp38+ Lyve1-), FDC 
(CD35+gp38+/-) and lymphatic vessels (gp38+Lyve1+). Digital images taken of the same lymph node section were 
stitched together to visualize the entire LN cross-section and sequential sections of the same LN are shown in a 
column. FDC-rich areas indicate the B zones (B), FRC-rich regions the T zone (T) as well as the medullary cords (M) 
identified by a high density of lymphatic vessels. One representative example out of three investigated naïve or 
activated LN is depicted. Scale bar represents 500 µm and is representative for both image series. (G) 80 µm thick 
vibratome sections showing medullary cords displaying extensive gp38+ reticular FRC networks wrapping around 
laminin+ conduits and connecting with CD31high HEV. The cords are demarcated by a thin layer of CD31intgp38+ 
lymphatic endothelium. Data are representative for 2-3 experiments with at least 2 mice and 6 LN per mouse. Scale 
bars represent 100 µm except for figure F. 
 
 
Figure 2.5 BrdU+ FRC were found all over the T Zone and medulla.  
WT mice having received OT-1 and OT-2 cells were immunized with OVA/Mont and from then onward supplied with 
BrdU-containing drinking water. 7 days after immunization, the immunized mice were then irradiated either with 450 
rad or 900 rad, rested for 2 days before sacrifying them and preparing the tissues for immunofluorescence (IF) 
staining. (A) IF images of LN from mice having received 450 (upper panel) or 900 (lower panel) rad of irradiation to 
visualize B (B220+) or T (CD3+) cells and the stroma compartment (gp38+ FRC, CD35+ FDC, Lyve-1+ LEC) after 
irradiation. (B) Confocal images of BrdU co-staining with gp38 and Lyve-1 on LN of mice having received 900 rad of 
irradiation. Left: no BrdU Ab was added as negative control. Stars indicate the location of the central T zone. (C) 
Confocal images are shown in higher magnification to visualize BrdU+gp38+ FRC (open arrows) in the central T zone 
(left), around HEV (center), and in medullary cords (right). Some BrdU+ LEC are also found in medullary cords (right, 
closed arrow). 
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adequate (Figure 2.5A). In mice irradiated with 900rda, BrdU-positive cells were found 
throughout the whole LN but seemed to be most abundant in central T zones near the HEV 
(Figure 2.5B, stars). Confocal microscopy with high magnification showed BrdU+gp38+ cells,  
which are presumably proliferating FRC, can be found in the T zone (Figure 2.5C, left), around 
HEV (Figure 2.5C, middle), as well as inside the medullary cords (Figure 2.5C, right). In 
summary, there is no clear segregation of zones dominated by BrdU- versus BrdU+ FRC.  
 
 
2.1.4 Dendritic cells are required to initiate FRC growth during LN swelling with 
partial dependency on MyD88 signals.  
 
To elucidate the sequence of events that control FRC proliferation we first examined the relative 
role of innate versus adaptive immunity. To this end, we injected OVA/Mont or Montanide alone 
into WT mice that had or had not received OT T cells. Surprisingly, injection of Montanide 
induced lymphocyte trapping as well as FRC proliferation (Figure 2.6A), indicating inflammatory 
signals are sufficient to trigger both processes in the absence of notable lymphocyte activation. 
While not required, adaptive immunity as induced by OVA/Mont led to a stronger lymphocyte 
trapping and FRC expansion than Montanide, especially when OVA-specific T cells were 
present (Figure 2.6A). Given that these activated lymphocytes start to be detectable only at 40h 
after OVA/Mont immunization, only the later FRC expansion appears to be sustained by signals 
present during adaptive immunity. Migratory DC are known to transmit antigen and inflammatory 
signals to LN and thereby start the swelling process (MartIn-Fontecha et al., 2003)	   (Webster et 
al., 2006). Indeed, mice depleted of DC showed a strongly reduced lymphocyte trapping and T 
cell expansion on day 3 after OVA/Mont immunization (Figure 2.6B-D)	   (Webster et al., 2006). 
Strikingly, the number and proliferation of FRC were also much reduced (Figure 2.6D), 
indicating a requirement for DC, consistent with a recent report	  (Chyou et al., 2011). Since both 
migratory and LN-resident DC are depleted in CD11c-DTR mice, we investigated whether 
transfer of migratory DC is sufficient to trigger FRC expansion. When LPS-matured bone 
marrow-derived DC (BMDC) with or without OVA protein were injected into WT mice, they 
efficiently induced LN swelling and FRC expansion (Figures 2.6E, 2.7A). Similar results were 
obtained with CpG-matured BMDC (Figure 2.7A). These results demonstrate that migratory DC 
can induce LN swelling as well as FRC expansion, with a potential contribution by adaptive 
immunity elicited by OVA or bovine serum proteins present in the medium. However, BMDC are 
not direct inducer cells for LN swelling and FRC expansion, as BMDC transfer into mice 
depleted of endogenous DC had hardly any effect on lymphocyte trapping and FRC expansion 
(Figure 2.7B), suggesting migratory DC require LN-resident DC to trigger both processes. 
(Collaborated with T. Vogt) 
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To explore whether Myd88-dependent signaling via Toll like receptor (TLR) or IL-1 cytokine 
family receptors (IL-1/18/33) was required in migratory DC, MyD88 knockout (KO) BMDC 
matured with either LPS or CpG were injected, but surprisingly they triggered a comparable 
 
 
Figure 2.6 DC are required for FRC growth during immune response. (Collaborated with T. Vogt) 
(A) Mice having received OT T cells (closed circle) or without (open circle) were immunized with PBS, Montanide 
(Mont) or OVA/Mont and draining LN analyzed 5.5 days after immunization using flow cytometry. Statistics were 
calculated on the pool of all data points. (B-D) CD11c- diphtheria toxin receptor (DTR) transgenic (tg) or non-
transgenic (ntg) littermate mice received OT T cells, then one injection of DT one night before s.c. immunization with 
OVA/Mont or PBS. Draining LN were analyzed by flow cytometry on day 3 after immunization. Depletion efficiency of 
DC (B) and number and proliferation of OT T cells (C) were assessed. DC were identified as CD11c+ MHCII+ CD19- 
TCRβ- cells. (D) Total LN cellularity, FRC number and FRC proliferation were assessed. (E) Wild type (WT) mice 
having received OT T cells were immunized s.c. with 1x106   BMDC activated by 0.1 µg/ml LPS. The BMDC were 
either pulsed with OVA antigen (BMDC+OVA) or without OVA (BMDC). Mice were sacrificed and LN were analyzed 
by FACS 5.5 days after immunization for total LN cellularity, FRC number and FRC proliferation. Data are mean ± SD, 
representative for 2-3 independent experiments, with n ≥ 2 mice per group. 
 
FRC expansion as WT BMDC (Figure 2.7A). In contrast, when WT BMDC were injected into 
MyD88 KO mice, lymphocyte trapping and FRC expansion was reduced relative to WT mice 
(Figure 2.7C). Interestingly, MyD88 KO bone marrow chimera experiments suggested that 
MyD88 in both hematopoietic and non-hematopoietic compartment are involved in the induction 
of FRC proliferation (Figure 2.7D). Meanwhile, the reduction of FRC expansion was not 
observed in mice deficient in signaling via TLR2, TLR4, IL-1, IL-33 (T1-Fc) or deficient in IL-1/18 
processing (caspase-1 KO) (Figure 2.7E) suggesting redundancy among these pathways or 
alternative pathways. Similarly, cytokines induced downstream of TLR signals, including the 
STAT-1-dependent IFNαβ and IFNγ, showed no limiting role in this process, nor did the other 
TLR adaptor molecule, TRIF (Figure 2.7E). Together, the data indicate that endogenous cells, 
possibly DC or FRC, may respond to TLR or IL-1R signaling via MyD88 to detect danger signals, 
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eventually leading to FRC proliferation. (Collaborated with T. Vogt) 
 
 
Figure 2.7 DC and MyD88-dependent signals regulate FRC growth during immune response. (Collaborated 
with T. Vogt) 
Mice were immunized s.c. and draining LN analyzed for total LN cellularity, FRC number and proliferation by flow 
cytometry. (A) WT mice were immunized s.c. with WT or MyD88 KO BMDC activated either with LPS or CpG without 
loading of OVA antigen and analyzed on day 5.5 days after immunization. (B) CD11c-DTR transgenic (tg) or non-
transgenic (ntg) littermate mice were treated with a single dose of DT and then immunized s.c. with PBS or WT 
BMDC activated with CpG without OVA antigen. LN were analyzed 3 days after immunization. (C) WT or MyD88 KO 
mice were immunized with WT BMDC activated with CpG without loading of OVA antigen and LN analyzed on day 5. 
(D) Lethally irradited, WT or MyD88 KO bone marrow-reconstituted WT and MyD88 KO recipients were immunized 
with CpG-activated WT BMDC and LN 5.5 days later. T test was calculated relative to the WT -> WT group. (E) Role 
of various signaling pathways related to MyD88 in FRC expansion on day 5 of the immune response to s.c. injection 
of BMDC or ova/mont. Investigated were the indicated knockout, transgenic (T1-Fc), or inhibitor-treated (α-IL-1β and 
anakinra as soluble IL-1 receptor) mice and compared to WT control mice. Data are mean ± SD, either compiled from 
several experiments or representative of at least 2 experiments with n≥ 2 mice per experiment.  
 
 
2.1.5 Naive lymphocyte accumulation is required and sufficient to trigger FRC 
growth.  
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As we had noted that the increase in FRC numbers closely followed the increase in hypothesis 
that inflammatory DC trigger FRC growth indirectly by inducing naive lymphocyte trapping. In 
support of this hypothesis, immunization of lymphocyte-deficient RAG2 KO mice with activated 
 
BMDC did not trigger FRC growth (Figure 2.8B), despite the presence of endogenous DC. To 
further test this model, we induced lymphocyte trapping in the absence of inflammatory signals 
by injecting WT mice with IL-7 / α-IL7 complexes that induce abundant homeostatic T cell  
 
Figure 2.8 The increase in FRC numbers follows closely the one of total lymphocytes during LN swelling 
(Collaborated with T. Vogt) 
Flow cytometric analysis of the six draining LN after immunization. (A) Mice having received OT cells were 
immunized with OVA/Mont and the number of FRC and total cells were analyzed at the indicated time points.  The 
fold increase was calculated by dividing cell numbers from OVA-immunized LN to that from naïve LN. (B) WT or T/B-
cell-deficient (RAG2 KO) mice were immunized s.c. with PBS or WT BMDC activated with CpG without OVA antigen 
and sacrificed on day 5.5. (C, D) WT mice received i.p. injections of 200 µl of IL-7 / α-IL-7 immune complexes or PBS 
on day 0, 1, 2, and 3 and analyzed on day 5.5. Cell numbers and proliferation of FRC (C), lymphocytes and dendritic 
cells (D) are shown. (E) Representative histogram showing the surface expression of activation markers of CD4+ 
(upper row) and CD8+ T cells (lower row) after IL-7 / α-IL-7 immune complexes treatment. (F, G) Representative dot 
plot showing the gating of the two major DC subsets, resident DC (rDC) and migratory DC (mDC) (F) and the fold 
increase of DC numbers in IL-7 / α-IL-7 versus PBS injected mice (G). Data are mean ± SD, either compiled from 
several experiments or representative of at least 2 experiments with n≥ 3 mice per experiment. 
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proliferation	   (Boyman et al., 2008). Within 5 days the number of total LN cells and T cells 
increased several fold (Figure 2.8C-D) in the absence of significant T cell activation (Figure 
2.8E). An increase in B cells as well as resident and migratory DC was also noted (Figure  
2.8D,F and G). Importantly, strong FRC expansion was also observed in this setting (Figure 
2.8C) indicating that an increase in naive lymphocytes due to LN trapping may be sufficient to 
drive FRC proliferation with no need for inflammatory signals or adaptive immunity. 
(Collaborated with T. Vogt) 
 
 
2.1.6 Lymphotoxin-αβ /LIGHT signals drive the later FRC growth phase. 
 
To further examine which molecular signals delivered by lymphocytes or DC trigger FRC 
expansion, we tested inflammatory and growth factor signals known to regulate stromal cell 
activation and proliferation (Noss and Brenner, 2008) (Zhu and Fu, 2011). Deficiency in the 
 
 
Figure 2.9 Role of LTβR and various mesenchymal cell growth factors in FRC expansion during immune 
response (Collaborated with T. Vogt) 
Flow cytometric analysis of six draining LN after immunization. (A) Knockout mice or WT mice treated with inhibitors 
(TNFR1-Fc, anti-PDGFRα; Nilotinib and Imatinib as pharmacological inhibitors of PDGFR signaling, and AAL993 as 
pharmacological inhibitor of VEGFR signalling) were analyzed. Nilotinib (open circles) and Imatinib (open triangles) 
were pooled together. Shown are percentages indicating the total LN cellularity, FRC number and proliferation of 
knockout or inhibitor-treated mice relative to WT control mice 5.5 days after immunization. n = 1-3, showing mean ± 
SD. (B, C) Mice having received OT T cells were injected with LTβR-Fc or control (ctrl) IgG and then immunized with 
OVA/Mont or PBS followed by the flow cytometric analysis of six draining LN 3 days (B) or day 5.5 (C) after 
immunization. (D) Representive histogram (left) and mean fluorescence intensity (MFI; right) for the surface 
expression of LTbR on FRC in LN of PBS- (black line) or OVA/Mont-injected (dashed line) mice. Surface protein 
expression on CD45+ cells served as negative control (grey area). 
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pathways of TNFα, LTα3, PDGF or VEGF signaling did not strongly affect FRC expansion 
(Figure 2.9A). Notably, however, LTβR-Fc treatment which blocks LTαβ and LIGHT led to a 
marked reduction in the fold increase of FRC numbers and proliferation despite normal LN  
swelling on day 5.5 but not day 3 (Figure 2.9B,C), pointing to a role for LTαβ or LIGHT only in 
the later phase of FRC expansion. Consistent with this finding, FRC were found to express  
 
 
Figure 2.10 Roles of various hematopoietic cell types in providing LTβR signaling for FRC expansion during 
immune response (Collaborated with T. Vogt) 
Flow cytometric analysis of six draining LN after immunization for total LN cellularity, FRC number and proliferation 
(A-E, G) or DC numbers and OT T cell numbers (F). (A-E) Mice having received OT T cells (A, C) or not (B, D, E) 
were immunized with OVA/Mont (A-D) or BMDC (E) and analyzed on day 5.5 after immunization. The following mice 
were analyzed: (A) Bone marrow chimeric WT mice having received either bone marrow from WT or RORγ KO mice 
(LTi-deficient); (B) WT versus TCRβδ KO (T cell deficient) mice; (C) WT versus JH KO (B cell deficient) mice; (D) WT 
versus T/B-cell-deficient (RAG2 KO) mice. (E) WT mice were immunized s.c. with WT or LTβ KO BMDC activated 
with LPS but without loading of OVA antigen. (F-G) OT T cells were adoptively transferred into CD11c-DTR 
transgenic (tg) or non-transgenic (ntg) littermate mice which were then  immunized s.c. with OVA/Mont and received 
a single dose of DT 3 days after immunization. Data are pooled from 2 independent experiments that are represented 
by circles and triangles. The displayed figures are either representative of or compiled from at least two experiments. 
n ≥ 3; showing mean ± SD. 
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with T. Vogt) 
 
Several hematopoietic sources of LTαβ/LIGHT have been described which could be responsible 
for stimulating the second growth phase of LTβR-expressing FRC, including lymphoid tissue 
inducer (LTi) cells, lymphocytes and DC (Schneider et al., 2004) (Moussion and Girard, 2011). 
Lack of LTi cells in RORγ KO bone-marrow chimera mice did not alter FRC expansion upon 
OVA/Mont immunization (Figure 2.10A). Surprisingly, mice deficient in either T (TCRβδ KO) or B 
(JH KO) cells showed also normal FRC proliferation (Figure 2.10B,C). This is in stark contrast to 
RAG2 KO mice that failed to show FRC expansion upon immunization with OVA/Mont (Figure 
2.10D), reminiscent of our observations upon BMDC transfer (Figure 2.8B). To test a role of 
LTαβ/LIGHT on DC two approaches were taken. LTβ-deficient BMDC injected into WT mice 
induced a normal FRC expansion (Figure 2.10E). 
 
Similarly, DC depletion starting on day 3 of the response, when T cell expansion has become 
largely DC independent	   (Prlic et al., 2006) (Figure 2.10F), did not alter markedly FRC numbers 
and proliferation (Figure 2.10G). Both experiments exclude DC as the critical source of 
LTαβ/LIGHT. Together, our findings point to a key role of T and B lymphocytes in providing 
signals for the early and late FRC growth phase, including possibly LTαβ/LIGHT and 
mechanical stress signals. (Collaborated with T. Vogt) 
 
 
2.1.7 T/B cells, DC, and Macrophages can promote the proliferation/ survival of a 
FRC line in vitro. 
 
Next I examined whether FRC proliferation or survival can be enhanced by the presence of 
lymphocytes or DC. To that end I used a FRC cell line, called pLN2 and established from naive 
peripheral LN (Siegert et al., 2011), and co-cultured it with BMDC, dendritic cells, ex vivo 
lymphocytes, or peritoneal macrophages. After two days of co-culture, the number of pLN2 co-
cultured with various hematopoietic cells was significantly higher than when pLN2 were cultured 
alone (Figure 2.11A, B), suggesting these hematopoietic cells are supporting FRC proliferation 
or survival, consistent with the findings obtained in vivo (Figures 2.7 and 2.10, Peduto 2009). 
Co-culture of MyD88 KO- or LTβ KO- BMDC with pLN2 also promoted FRC proliferation/survival 
to a similar extent as WT BMDC (Figure 2.11B). Together with our in vivo data, these data 
suggest that neither MyD88 nor LTβ are essential in activated migratory DC to induce FRC 
proliferation (Figure 2.7A). Although I have not formally tested it, it seems plausible that LTβ 
signals are provided by naive lymphocytes (Figure 2.10). 
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Figure 2.11 Co-culture of various hematopoietic cells enhance FRC line growth in vitro 
(A, B) The FRC cell line, pLN2, was co-cultured with various hematopoietic cells. Number of pLN2 were measured 
after 2-3 days of co-culture using flow cytometry. The ratios indicated in the x-axis labels are number of the indicated 
cell type versus pLN2. The statistics were calculated in relation to ‘pLN2 alone’. n ≥ 3; showing mean ± SD, The 
displayed figures are representative of at least two experiments. 
 
 
 
2.2 Discussion 
 
In this study we provide a comprehensive analysis of FRC number, phenotype and function, 
and correlate it with the antigen-specific T cell response over time. Rather than being disrupted 
or functionally altered, we show that FRC increase in size and number to cover a much larger 
volume while maintaining their vital functions. Within less than one day FRC become activated 
in a process dependent on naive lymphocyte trapping induced by DC. In a later phase activated 
lymphocytes further enhance this FRC expansion, presumably in a LTαβ/LIGHT-dependent but 
DC-independent manner.  
 
FRC get activated at the onset of LN swelling and T cell priming, with first signs of activation 
after 20 hours. It suggests that FRC can sense either the increase in lymph flow, inflammatory 
cytokines or local DC early in the response. Alternatively, they may sense mechanical stress or 
other signals like hypoxia due to the large number of recently trapped naive lymphocytes. FRC 
proliferation initiated 40h after immunization, with 50-70% of FRC having incorporated BrdU at 
the peak of LN swelling, comparable to previous findings with CFA immunizations	  (Chyou et al., 
2011) (Tan et al., 2012). Therefore, the strong expansion of the FRC network is largely due to 
local cell proliferation.  
 
To visualize these proliferating FRC during LN swelling, we stained BrdU on lymphocyte-
depleted swollen LN. Although the preliminary data suggest BrdU+ FRC seems to be allover the 
T zone and medulla instead of showing patches of BrdU+ cells in certain regions, this might due 
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to the relatively late time point of analysis (9 days after immunization) when 60-80% of FRC are 
BrdU+. A recent paper published by Castagnaro et al. showed that subsets of splenic 
mesenchymal cells derived from the Nkx2-5+Islet1+ lineage could be the local precursor 
responsible to regenerate FRC networks after viral infection (Castagnaro et al., 2013). They 
also suggest the idea that resident precursor cells may exist in SLO. Our observations do not 
exclude a contribution by circulating fibroblasts or trans-differentiation from other cell types, that 
may either directly differentiate into FRC or serves as a progenitor cells (Benezech et al., 2012) 
(Reilkoff et al., 2011) (Gil-Ortega et al., 2013). Given that we did not see any striking 
morphological alteration of the existing FRC network, the expansion must go along with 
enhanced matrix synthesis in the new areas, as the conduit network appears to remain 
functional throughout the growing T zone	  (Gretz et al., 2000).  
 
In contrast to previous reports investigating mostly the spleen	   (Mueller et al., 2007)	   (Scandella 
et al., 2008), we observed only a moderate and very transient decrease in relative transcript 
levels of Il7, Ccl19 and Ccl21 during immune response suggesting most FRC in the LN T zone 
maintain not only their structural but also functional characteristics. The precise function of 
medullary FRC, though, remains to be established as they co-localize with plasma cells rather 
than T cells. Medullary FRC also localize next to LEC, suggesting they may promote lymphatic 
vessel growth by providing VEGF. Consistent with earlier reports	  (Angeli et al., 2006)	  (Liao and 
Ruddle, 2006)	   (Chyou et al., 2008) we observed a strong increase in both LEC and BEC 
numbers and proliferation during LN swelling. Therefore, LN hyperplasia is associated not only 
with an increase in lymphocyte numbers but also with an equivalent increase in all three major 
stromal cell populations that provide the organ infrastructure and organization, both for naive 
and activated lymphocytes. Therefore we postulate that the generation of a protective adaptive 
immune response strongly depends on the efficient expansion of the FRC network that provides 
the niches for the rapid selection, expansion and differentiation of antigen-specific lymphocytes. 
 
How is FRC proliferation triggered during LN swelling? We observed a strong dependence of 
FRC expansion on migratory and resident DC, although at present we cannot formally exclude a 
role for subcapsular sinus macrophages which are also depleted upon injection of DT into 
CD11c-DTR mice	   (Probst et al., 2005). Comparable findings were reported by Lu and 
colleagues using CD11c-DTR and CCR7 KO mice	   (Chyou et al., 2011). They concluded that 
migratory DC transmit signals to CCR7-negative resident DC which then directly trigger FRC 
growth. We obtained several lines of evidence supporting an alternative model, in which 
lymphocyte numbers control FRC expansion with only an indirect role for DC: First, FRC 
numbers followed closely the number of total lymphocytes during LN swelling but showed no 
clear correlation with activated T cell numbers. Second, 3 days after DC depletion we observed 
a 40-70% decrease in lymphocyte numbers which correlated with the reduction in FRC numbers. 
This observation is consistent with reports showing that resident DC regulate naive lymphocyte 
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recirculation and LN cellularity by modifying HEV	   (Girard et al., 2012). Third, we and others	  
(Chyou et al., 2011) saw FRC expansion in immunized WT but not RAG2 KO mice, indicating 
that activated DC are ineffective in promoting FRC growth in the absence of lymphocytes. Forth, 
DC depletion after successful T cell priming did not interfere with FRC expansion. Fifth, 
homeostatic T cell expansion induced by IL-7/α-IL-7 immune complexes was sufficient to trigger 
FRC growth by inducing LN swelling without the help of activated migratory DC or inflammatory 
signals. In conclusion, we propose a model in which migratory DC transmit a signal to resident 
DC that then trigger HEV/LEC changes leading to naive lymphocyte trapping which is critical for 
mediating FRC expansion (Figure 2.12). Only in a later phase activated lymphocytes appear to 
further boost FRC expansion. 
 
Figure 2.12 Proposed model describing the events leading to the expansion remodeling of the LN FRC 
network during immune response.  
Inflammatory signals trigger the activation of local DC which then migrate to the next draining lymph node to alert 
LN-resident (endogenous) DC. Activated DC are known to trigger the activation and later the proliferation of both 
LEC and HEV, presumably by LTα3/LTαβ signals (Girard et al., 2012; Webster et al., 2006), thereby inducing 
within 12h increased immigration of naive lymphocytes and decreased emigration, collectively termed 
lymphocyte trapping. This early LN swelling, possibly along with lymph-based inflammatory signals, triggers FRC 
activation (at 20 h) and later FRC proliferation (at 40 h) independently of the adaptive immune response, either 
due to mechanical stress signals and/or molecular signals that may include MyD88 and PDGF. Soon thereafter 
the cognate lymphocytes get activated by antigen-presenting DC, expand and differentiate within the T zone 
microenvironment. This adaptive immune response leads to increased LTαβ/LIGHT expression by lymphocytes 
reinforcing FRC growth eventually leading to a strongly enlarged FRC network extending into the medullary cords. 
VEGF released by FRC (Chyou et al., 2011) may act like a positive feedback loop acting on HEV and possibly 
medullary LEC, leading to further trapping of naive lymphocytes and further FRC growth. In summary, FRC are 
highly reactive and adapt their numbers rapidly to the number of lymphocytes thereby preserving and extending 
the functional scaffold of the T zone.  
 
The second positive regulator of FRC expansion we identified is LTβR, as LTβR-Fc partially 
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inhibited FRC expansion by blocking the two ligands LTαβ and LIGHT. As LIGHT also binds to 
HVEM, a role for this alternative receptor cannot be formally ruled out. Given that this pathway 
shows little effects on stromal cell biology, we favor a model involving the LTαβ-LTβR pathway	  
(Ware, 2008).  
 
In vitro co-culture of the FRC cell line pLN2 with various hematopoietic cells suggests DC, T, B 
cells, and macrophages can all promote pLN2 growth. In vivo, naive lymphocytes and NK cells 
express low levels of LTαβ which are strongly up-regulated during activation	   (Schneider et al., 
2004). Recirculating LTαβ+VEGF+ B cells are known to contribute to stromal cell growth	  (Ngo et 
al., 2001)	   (Angeli et al., 2006) but surprisingly B lymphocytes were not required in our 
experimental setting, nor were T lymphocytes. Migratory DC were proposed to express LTαβ 
and VEGF and thereby could regulate the growth of HEV and LEC once they have homed into 
the T zone, both in homeostasis and immune response	   (Girard et al., 2012). LTαβ+ DC also 
stimulate HEV-proximal FRC to express more CCL21 and VEGF which may then indirectly 
increase lymphocyte recirculation and vessel growth	   (Wendland et al., 2011)	   (Tzeng et al., 
2010)	   (Ngo et al., 1999). Here we show that LN FRC numbers in homeostasis depend on both 
DC and B cells, but without a limiting role for LTβR ligands. In contrast, upon immunization we 
observed a requirement for DC in combination with either T or B lymphocytes for FRC 
proliferation to occur, leading us to propose that DC trigger this process via naive lymphocyte 
trapping. As LTβR-Fc inhibited only the later phase of FRC expansion, a role for LTαβ 
expression by DC or LTi cells appears less likely and may be rather due to activated 
lymphocytes expressing high levels of LTαβ and LIGHT in this later phase of the response	  
(Schneider et al., 2004). Similarly, HEV expansion during LCMV infection is dependent on 
activated LTαβ+ B cells	   (Kumar et al., 2010). Interestingly, non-cognate B cells provide LTβR 
signals to remodel the medullary cords during immune response	   (Abe et al., 2012). Therefore, 
the later LTαβ/LIGHT-dependent growth phase of FRC may occur predominantly in that zone 
with contributions by naive B cells.  
 
Besides chemical signals there may be also physical signals triggering FRC expansion. 
Fibroblasts are known to be mechanosensitive	   (Tomasek et al., 2002). Given that FRC form a 
network throughout the T zone it is conceivable that early in the response FRC sense the 
physical pressure of trapped lymphocytes	   (Link et al., 2007). In addition, FRC may detect the 
increase in lymph flow within conduits which accompanies skin inflammation	  (Roozendaal et al., 
2008). Indeed, FRC lines can respond to fluid flow with increased proliferation and CCL21 
expression	  (Tomei et al., 2009). The incoming lymph could allow within minutes the transport of 
pro-inflammatory mediators from inflammatory sites to LN T zones	   (Roozendaal et al., 2008) 
possibly explaining the observed FRC activation after 20 hours and the partial MyD88 
dependence of this process. Consistent with LN FRC being early sensors of infection, 12 hours 
after LPS injection in vivo LN FRC showed marked transcriptional changes	   (Malhotra et al., 
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2012). Similarly, FRC lines responded rapidly to pro-inflammatory cytokines such as IL-1, IFNαβ, 
IFNγ and TNFα in vitro	  (Katakai et al., 2004b)	  (Siegert et al., 2011). In vivo, a recent paper also 
showed that the VEGF production of FRC could be enhanced by IL-1β produced by CD11c+ DC 
or monocytes (Benahmed et al., 2014). While FRC size, granularity and gp38 expression were 
up-regulated within hours after immunization intracellular α-SMA expression peaked 2-4 days 
later suggesting different stages in FRC activation and possibly function.  
 
In conclusion, our data demonstrate that FRC are early sensors of inflammation and rapidly 
adapt structurally and functionally to accommodate more lymphocytes in inflamed LN. It seems 
likely that several cells and signals collaborate to regulate FRC numbers in the T zone and 
medulla and thereby the number of lymphocyte niches, as summarized in our model (Figure 
2.12). Whether the opposite process of LN shrinking is regulated by the absence of those 
positive signals or by specialized anti-inflammatory factors remains an exciting open question of 
high clinical relevance. 
 46	  
3. Isolation and characterization of stromal cells in the intestinal lamina propria 
(Collaboration with S. Siegert) 
 
3.1 Results 
 
3.1.1 Identification of a reticular fibroblast network in the intestinal lamina propria  
 
In secondary lymphoid organs fibroblast populations organize hematopoietic cells into different 
microenvironments by providing a scaffold for adhesion and migration, besides actively 
recruiting hematopoietic cells by means of chemokine production. Currently it is unclear how 
hematopoietic cells that are scattered throughout the intestinal lamina propria (LP) are 
organized, and whether there is an underlying fibroblast network comparable to secondary 
lymphoid organs. Still today, fibroblasts are often identified as ‘lineage-negative’ or desmin/α-
SMA+ populations as there is still a lack of specific surface markers to characterize these cells. 
On the other hand it is well accepted that fibroblasts do serve as major ECM-producing cells in 
the body and collagen production may be used as primary fibroblast marker. To identify 
fibroblasts potentially present within the lamina propria, we used a Collagen-Iα1-GFP transgenic 
mouse model in which the collagen-Iα1-expressing cells express a cytoplasmic GFP reporter. 
On the other hand, gp38 has been used as a surface marker in the LN and spleen to identify 
specific subsets of fibroblasts with immune functions. To test if gp38 is also expressed by some 
fibroblasts in the LP we first co-stained gp38 on sections of different parts of the intestine from 
Col-GFP mice.  Histological analysis showed that there is an abundance and high density of 
both GFP+ and gp38+ cells in the LP of all gut parts investigated. Many gp38+ cells appear to co-
localize with GFP+ cells throughout the intestinal LP (Figure 3.1A, open arrows). LEC that form 
collecting lymphatic vessels and central lacteals found within the villi express Lyve-1 and gp38 
but are low for CD31, while blood vessels could be identified by high CD31 expression and lack 
of Lyve-1 and gp38 staining (Figure 3.1B, closed arrows, photo courtesy of S. Siegert). To 
examine more carefully the fibroblast network along with the lacteal found within each villus of 
the small intestine, confocal images were taken at high magnification to show that GFP+ cells 
are not co-localizing with Lyve-1+gp38+ LEC in the central lacteal (Figure 3.1B, closed arrows, 
photo courtesy of S. Siegert) but correspond to reticular Lyve-1- cells expressing gp38 at the cell 
membrane and localizing both next to lacteals, throughout the LP of the villi, including along the 
basement membrane below the epithelial barrier thereby forming a continuous 3-dimensional 
cell network (Figure 3.1B, open arrows). Therefore, these data strongly suggest that there are 
many gp38+ ECM-producing fibroblasts in the intestinal LP which form a scaffold potentially 
involved in the organization of local hematopoietic cells. 
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Figure 3.1 Histological identification of FRC-like fibroblasts and vessels in the intestinal lamina propria. 
Microscopic analysis of murine gut tissues stained for stromal cell markers. (A) Sections of small and large intestine 
of Collagen-Iα1-GFP mice were stained with gp38 and DAPI and analyzed by fluorescence microscopy. Open arrows 
indicate villi of the LP where numerous  gp38+ and Col-GFP+ cells can be observed. (B, images provided by S. 
Siegert) Left: Representative images showing blood vessels (CD31+) and central lacteals (CD31+Lyve-1+, closed 
arrows) inside the LP of the villi in the small intestine of WT mice. Middle and right: confocal images showing the 
surface expression of gp38 on Col-GFP+ cells in the LP (open arrows) of the small intestine. 
 
 
3.1.2 Isolation of stromal cells from intestine and phenotypic characterization by 
FACS 
 
In order to study these gp38+ fibroblasts (FB) localized in the LP in more detail we first 
established an isolation protocol for stromal cells to analyze them by flow cytometry. To reach 
this aim my colleagues (H. Bega, S. Siegert, J. Bernier-Latmani) and I started out with a 
protocol for LP lymphocyte isolation (provided by N. Harris, EPFL) and started to modify many 
parameters to improve the isolation efficiency for stromal cells. In most tested procedures the 
following aspects were done the following way (see materials and methods for more details): 
The intestine was excised from CO2-euthanized mice and the attached mesenteries and 
Payer’s patches were removed. The intestine was opened longitudinally and the intestinal 
content was flushed out. To detach the epithelium tissues were incubated in an EDTA-
containing solution. After washing out EDTA and epithelial cells with PBS the remaining intact 
tissues were cut into small pieces and digested with an enzyme solution. After digestion, the 
suspension was meshed through a filter and cells were centrifuged.  
 
Different conditions tested:  
A
G
FP
gp
38
D
AP
I
duodenum jejunum ileum proximal colon
B CD31 Lyve-1 GFP gp38 Lyve-1 GFP gp38 Lyve-1
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1. EDTA concentration during epithelium detachment: 1 – 10 mM 
2. EDTA incubation time during epithelium detachment: 10 – 40 min 
3. Mechanical force to get rid of epithelial cells: stirring or shaking while EDTA incubation, or 
scratch out most epithelium after incubation. 
4. Avoid air or bubble contact or not 
5. Type of digestion enzymes used: collagenase 4, 8, D, and blendzyme 1, 3; enzyme 
concentrations used 
6. Mechanical force during enzymatic digestion: stirring, shaking, or pipetting.  
 
Before I explain the outcome of these different trials, I wish to explain first how we assessed the 
outcomes by flow cytometric analysis. Figure 3.2A depicts a representative analysis of a cell 
suspension from small intestine showing the gating strategy used to identify stromal cell subsets. 
First, the gating for the FSC and SSC of the cells was performed based on the size of 
lymphocytes to exclude red blood cells (RBC) and dead cells or apoptotic bodies that are 
smaller than lymphocytes. Only cells bigger than lymphocytes were considered as healthy or 
living cells, especially for stromal cells that should be bigger than lymphocytes. The gated cells 
were then stained with dead cell exclusion dye, like DAPI, 7AAD (depicted in Fig. 2A) or Aqua, 
to exclude dead cells. As a further way to exclude RBC besides their small cell size, we gated 
on Ter-119- FSCint/high cells. The living non-RBC cells were then subjected to EpCAM and CD45 
labeling, which identify most epithelial and hematopoietic cells, respectively. Non-epithelial, non-
hematopoietic cells were then further characterized for CD31 and gp38 expression, as 
previously shown for LN stromal cells. Also in the intestine, four different stromal cell 
populations could be distinguished based on CD31 and gp38 expression which based on our 
histological analysis should correspond to LEC (gp38+CD31+), BEC (gp38-CD31+), gp38+ FRC-
like stromal cells (gp38+FB), and poorly characterized double negative cells (DN). 
 
During the first few trials on small and large intestine, we found that the survival rate of the cells 
differs a lot depending on the origin of cells, and depending on the speed of preparation and 
analysis. Cells isolated from the colon showed a general survival rate of 60 – 90% (Figure 3.2B, 
upper panel) whereas the survival rate of total cells from small intestine was very poor (14.5%). 
However, most identified hematopoietic and stromal cell types in the small intestine had a 
survival rate of 50 – 80% (Figure 3.2B, lower panel), raising the question which type of cells 
died during the isolation process. To find out what these DAPI+ cells are in the sample of small 
intestine, we analyzed them with their surface markers and found that these DAPI+ cells express 
low to intermediate level of most of the markers stained (Figure 3.2C upper panel), probably due 
to their higher autofluorescence in these channels or their stickiness for antibodies. On one 
hand this makes the identification of cell types among these DAPI+ cells very difficult as they do 
not have a clear positive and negative population – the staining patterns are smeared – which is  
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Figure 3.2 Flow cytometric identification and analysis of fibroblasts and vascular cells isolated from the 
intestinal lamina propria. 
Small and large intestines were isolated, fully digested, labeled with various markers and analyzed by flow cytometry. 
(A) Representative dot plots showing the gating strategy of intestinal cell suspensions: size of nucleated cells, intact 
membrane integrity as a readout for living cells (7AAD-) and absence of the . red blood cell (RBC) marker Ter-119,  
EpCAM is specifically expressed by epithelial cells and CD45+ by hematopoietic cells. Non-hematopoietic, non-
epithelial cells were further divided into gp38+ fibroblasts (gp38+ FB), gp38+CD31+ lymphatic endothelial cells (LEC), 
CD31+ blood endothelial cells (BEC), and double negative cells (DN). (B) Survival rate of various cell types from 
colon and small intestines using a preliminary isolation protocol, using 1.5 mg/ml collagenase 8 for 2 times of 20 
minutes incubation plus pipetting. ‘Total cells’ represents all cells which are equal or bigger than lymphocytes.  
Different cells are gated based on their surface marker expression and then subjected to DAPI staining. (C) 
Comparison of various surface markers expressed on DAPI+ (dead cells, upper panel) and DAPI- (living cells, lower 
panel) cells of the small intestine. (D, data provided by S. Siegert) Representative dot plots of cells from the small 
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intestine showing low to intermediate staining levels for 7AAD as well as other markers. (E) FSC and SSC profiles of 
various cell types isolated from the small intestine and pregated on live (DAPI-) cells.  
 
 
very different from DAPI- cells (Figure 3.2C, lower panel) that show a clear separation. On the  
other hand since most live cells possess at least one marker that is expressed at levels above 
those observed for DAPI+ cells they are mostly DAPI- and can be still analyzed in a meaningful 
way. In general, fast preparation and analysis of the intestinal cells allowed to get the highest 
yield of live stromal cells, but there were considerable variations from one experimental day to 
another. 
 
Another issue we encountered was that even dyes used for dead cell exclusion worked 
sometimes inefficiently. As shown in figure 2D (upper plot) the majority of cells showed low to 
intermediate staining levels for 7AAD and were sometimes not clearly separated from 7AAD+ 
cells, resulting in a poor separation of the different cell populations (Figure 3.2D, lower panel) 
(data provided by S. Siegert). This situation cannot be improved by using higher concentration 
of 7AAD or shift to DAPI (unpublished data). As a further readout of cell viability we checked the 
cell size (FSC) and granularity (SSC) of DAPI- stromal cells which could be clearly separated 
into different stromal cell subsets (FB, LEC, BEC). Surprisingly, they are smaller and more 
granular than most lymphocytes (Figure 3.2E). This raised the concern that these ‘events’ may 
in fact represent fragments of stromal cells that have lost their nucleus. Another possibility is 
that the dead cell exclusion dye alone is sometimes not sufficient enough to identify live cells. 
Thus, these technical issues had to be addressed first before evaluating the performance of 
different isolation protocols.  
 
To improve the identification of truly live cells, I applied another viability dye besides 7AAD, 
namely calcein-AM. Calcein-AM is an acetomethoxy derivate of calcein that is cell permeable. 
After entering living cells, esterases inside living cells can cleave the acetomethoxy group from 
calcein that is not membrane permeable and will be trapped inside the cells (Figure 3.3). 
 
 
Figure 3.3 Chemical structure and application of calcein-AM for 
labeling living cells. 
Calcein-AM is a membrane permeable dye. After entering cells, the 
active cytoplasmic esterase cuts off the AM group, dequenching the 
fluorescent calcein molecule that is now no more membrane-
permeable and thus trapped in the living cells. Dead cells lack active 
esterase and thus fail to cleave calcein-AM.  
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As dead cells lack active esterase, they won’t be labeled by this dye. So in contrast to 7AAD, 
calcein-AM stains living cells only. To test these reagents I first used cells from digested LN as 
these cells show reproducibly higher viability than those from the intestine. The combination of 
calcein-AM and 7AAD allowed the clear separation of living (calcein-AM+ 7AAD-) and dead 
(calcein-AM-7AAD+) LN cells, for both non-hematopoietic and hematopoietic cell subsets (Figure 
3.4A). Similarly, when applying the same staining to gp38+ FB isolated from the ileum, 30% of 
cells were clearly dead (calcein-AM-7AAD+) and a comparable fraction was clearly alive 
(calcein-AM+7AAD-). Comparison of the FSC-SSC profile of these two populations showed that 
living cells are much bigger than dead cells (Figure 3.4B), which is consistent with the literature. 
However, there also a considerable fraction (37.9% in Figure 3.4B, upper right) of calcein-AM- 
and 7AAD- cells which were not prominent in LN isolates. These cells showed an intermediate 
cell size, suggesting that they are probably in the process of dying (Figure 3.4B) and would be 
missed by a simple 7AAD staining. Therefore, the addition of calcein-AM as a second dead cell 
discrimination component is useful to investigate the performance of different isolation 
conditions for intestinal cells.  
 
Among all the different factors tested, it seemed that the type and concentration of digestion 
enzyme used and the duration of the incubation are very critical parameters for achieving a 
good recovery and viability of stromal cells from small intestine. For example, when digestions 
using 3 mg/ml of collagenase 4 and 8 were compared, I obtained more truly living cells with 
digestions using collagenase 4 rather than 8, for both stromal cells (Figure 3.4C) and 
hematopoietic cells (Figure 3.4D). In addition, the level of calcein-AM staining in living cells was 
higher for collagenase 4 digested tissues, making the identification of live cells more reliable. 
This experiment also suggests that a digestion of 20 min along with repetitive pipetting during 
the time of incubation is optimal when considering both stromal cell recovery and survival. 
However, pipetting may also harm some hematopoietic cells as calcein-AM staining is reduced 
(Figure 3.4C, D). In conclusion, we have decided to use for the followup work a 20 min, 3 mg/ml 
of collagenase 4 digestion along with some gentle pipetting described in materials and methods. 
This protocol allows for the isolation of various stromal cell types with more than 50% of the 
cells being 7AAD- and around 20 – 70% being calcein-AM+7AAD- (Figure 3.4E). In addition, 
many CD45+ cells types can be isolated with the same protocol, including αβ T cells, γδ T cells, 
IgA+ plasma cells, granulocytes (Gø), F4/80+ macrophages (Mø), and various subsets of DC 
(Figure 3.4F). 
 
 
3.1.3 Phenotypic characterization of intestinal stromal cells by FACS 
 
To confirm that the isolated CD45-CD31-gp38+ cells are indeed fibroblasts and not lymphatic 
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endothelial cells which also express gp38 a reporter mouse strain for lymphatic endothelial cells, 
namely Prox-1-mOrange2, was used (provided by T. Petrova, Dep. of Oncology, UNIL). Within 
this mouse strain, the lymphatic endothelial cell specific promoter Prox1 drives expression of the  
A CD45+ cellsFRC LEC BEC
0 102 103 104 105
<Pacific Blue-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
0.5 0.964
97.70.819
0 102 103 104 105
<Pacific Blue-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
36.7 9.48
49.24.59
0 102 103 104 105
<Pacific Blue-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
49.6 3.07
42.15.26
0 102 103 104 105
<Pacific Blue-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
84.9 0.978
10.73.72
B
 ly
m
ph
 n
od
e
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
31.1 4.18
26.737.9
0 50K 100K 150K 200K 250K
FSC-A
0
50K
100K
150K
200K
250K
SS
C
-A
0 50K 100K 150K 200K 250K
FSC-A
0
50K
100K
150K
200K
250K
SS
C
-A
0 50K 100K 150K 200K 250K
FSC-A
0
50K
100K
150K
200K
250K
SS
C
-A
ileum FB7AAD+ ‘dead cells’
calcein-AM+ ‘living cells’
7AAD- calcein-AM-
 ‘dying cells’?
C
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
58.8 6.01
11.224
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
49.6 4.13
1333.3
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
49.7 2.34
8.3939.6
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
28.4 8.83
46.416.4
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
31.1 4.19
26.837.9
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
28.4 3.14
2543.3
20 min 20 min + pipeting 30 min
co
lla
ge
na
se
 8
co
lla
ge
na
se
 4
ileum FB
D
20 min 20 min + pipeting 30 min
ileum hematopoietic cells
co
lla
ge
na
se
 8
co
lla
ge
na
se
 4
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
3.92 1.05
45.849.2
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
5.26 1.18
12.181.5
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
6.82 1.19
15.376.7
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
0.69 1.03
78.120.2
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
2.47 2.02
28.467.1
0 102 103 104 105
<Pacific Blue-A>: Calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
2.77 1.76
26.469
E
0102 103 104 105
<eFluor450-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
4.84 13.3
74.77.16
0102 103 104 105
<eFluor450-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
37.8 12.8
42.86.56
0102 103 104 105
<eFluor450-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
33.6 9.19
29.128.1
0102 103 104 105
<eFluor450-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
31.3 7.8
16.844.1
0102 103 104 105
<eFluor450-A>: calcein-AM
0
102
103
104
105
<P
E-
C
y5
-A
>:
 7
AA
D
28.8 29.9
36.64.69
CD45+ cells FB LEC BECepithelial cells
ile
um
/je
ju
nu
m
 53	  
 
Figure 3.4 Flow cytometric determination of cell survival through the use of calcein-AM or 7AAD labeling 
versus cell size or granularity. 
A-D and F were done with a preliminary protocol established by me while E was done with a protocol established by 
S Siegert and J Bernier-Latmani. (A) Representative dot plots showing calcein-AM and 7AAD labeling of the indicated 
lymph node cell populations to clearly distinguish dead (7AAD+ calcein-AM-) from live cells (7AAD- calcein-AM+). (B) 
Fibroblasts (FB) from ileum that are 7AAD+, calcein-AM+ or double negative, were further analyzed for their FSC (cell 
size) and SSC (granularity) profile. (C, D) Comparison of cell survival of FB (C) or hematopoietic cells (D) isolated 
from ileum after digestion with either collagenase 4 or 8 and by varying the digestion time. Cell survival was analyzed 
using calcein-AM and 7AAD. (E) Survival rate of various cell types from ileum/jejunum pool with a digestion protocol 
established by S Siegert and J Bernier-Latmani described in materials and methods. (F) Various types of 
hematopoietic cells identified with the preliminary protocol, including γδ T and αβ T cells (upper middle), IgA 
producing PC (upper right, with intracellular staining, ICS), granulocytes (Gø, lower far left), CD11b+F4/80+ 
macrophages (Mø, lower central left), and Gr-1-F4/80-CD11c+MHCII+ DC that can be further subsets by their 
expression of CD11b or CD103 (lower central right and right). 
 
fluorochrome mOrange2, thus allowing the validation of our FB versus LEC gating. Around 90% 
of the CD31+gp38+ LEC were found to express mOrange2 in the small intestine, with hardly any 
mOrange2 observed in the other stromal cell types investigated (Figure 3.5A upper panel). 
Similar data were obtained for LN stroma (Figure 3.5A lower panel). In the LN, it has been 
shown that most FRC express PDGFRα with minimal staining in other stromal cell types (Figure 
3.5A, lower panel). Stromal cells of the small intestine showed a similar phenotype with 
PDGFRα being only on FRC while a subset of gp38+CD31- lacked this marker (Figure 3.5A, 
lower panel). These data confirmed that, like in the LN, the CD31+gp38+ cells identified in the 
intestine are indeed LEC with CD31-gp38+ cells being of a different, presumably mesenchymal 
lineage. Next, isolates from small intestine and LN of collagen-Iα1-GFP reporter mice were 
used to validate the fibroblast identity of CD31-gp38+ cells. Indeed, over 80% of these cells in 
both intestine and LN express GFP, but there is more heterogeneity in the expression level 
within the intestine than the LN.  Approximately 60% of LEC from both sites also express lower 
levels of GFP (Figure 3.5B). These data suggest that the CD31-gp38+ stromal cells are the main 
producers of collagen-I and comparable to FRC found inside LN. 
 
To further characterize the different stromal cell subsets within the intestine, we stained for 
common stromal cell markers. Around 60 – 90% of FB in both small and large intestine highly 
F
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express PDGFRα (Figure 3.6A and Figure 3.5A) with 25% in the small intestine expressing 
CD34 (Figure 3.6B). Using histological analysis we found that these CD34+ FB may be mainly 
arranged around the crypts (Figure 3.6C, open arrows) but not in the villi. As expected, CD34 is 
also expressed by BEC, as shown by both FACS and IF (Figure 3.6B and 3.6C, closed arrows). 
 
 
Figure 3.5 Validation of intestinal stromal cell identification procedure using cell lineage reporter mice. 
Stromal cells were isolated from small intestine (upper panels) or LN (lower panels) of either Prox-1-mOrange2 (A) or 
Collagen-Iα1-GFP (B) reporter mice and analyzed by flow cytometry. (A) Validation of LEC staining using the LEC 
reporter mice Prox-1-mOrange2. Representative histograms showing mOrange2 expression in the indicated cell 
populations from WT (grey area) or Prox-1-mOrange2 reporter (red line) mice. (B) Validation of FB staining using the 
fibroblast reporter mice Collagen-Iα1-GFP. Representative histograms showing GFP expression of stromal cells from 
WT (grey area) or Col-GFP reporter (red line) mice.  
 
Next we investigated the expression level of desmin and α-SMA on intestinal stromal cells. In 
former publications it has been shown by histology that desmin is expressed on dermal 
fibroblast and LN FRC (Kalluri and Zeisberg, 2006) (Link et al., 2007) whereas α-SMA is  
mainly expressed in myofibroblasts, including in human LP (Powell et al., 2011). To that end we 
performed intracellular staining for these two markers followed by flow cytometric analysis. Our 
FACS results depicted in Figure 3.6D indicate that in both small and large intestine, 20 – 30% of 
the CD31-gp38+ FB are α-SMA positive, suggesting that there may be a subset of 
myofibroblasts. Interestingly, most α-SMAhighdesminhigh cells were observed in the DN 
population (CD31-gp38-), raising the possibility that the majority of the DN cells could be muscle  
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Figure 3.6 Further phenotypic characterization of intestinal stromal cells 
The indicated stromal cell populations from ileum or colon were further characterized by antibody labeling and 
analyzed either flow cytometry on cell suspensions (A, B, D) or immunofluorescence microscopy of thin cryosections 
(C, E). (A) Histograms of surface PDGFRα (red line) expression on isolated stromal cells from ileum (upper panel) 
and proximal colon (lower panel). PDGFRα expression on CD45+ cells was taken as negative control (grey area). (B) 
Histograms of CD34 expression in the indicated stromal cells of the ileum (red line) versus no antibody control (grey 
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area). (C, provided by S. Siegert) Ileum sections stained for gp38 and CD34 protein. Open arrows indicate 
CD34+gp38+ cryptic FB and closed arrows indicate CD34+ blood vessel cells. (D) Intracellular staining for α-SMA and 
desmin in the indicated stromal cells isolated from ileum (upper panel) and proximal colon (lower panel). (E, provided 
by S. Siegert) Ileum sections stained for gp38, α-SMA, and desmin. Closed arrows indicate α-SMA+desmin+gp38- 
muscle cells and open arrows indicate α-SMA+desmin+gp38+ central lacteal and rare triple-positive FB. There are 
also α-SMA+desmin-gp38+ and α-SMA-desmin+gp38+ FB detectable in the LP. The gp38+ fibroblasts in isolated 
lymphoid follicles (ILF, stars) seem to be α-SMA-desmin+. 
 
cells either isolated from muscularis mucosae (Figure 3.6E, closed arrows) or the lacteal-
associated smooth muscle (Figure 3.6E, open arrows). Given that there was not a perfect 
concordance of flow cytometric and histology data, more work is needed to firmly establish 
these notions. Of note, similar to the LN, gp38+ FB in the isolated lymphoid follicles (ILF) of the 
small intestine are α-SMA-desmin+ (Figure 3.6E, stars).  
 
In summary the data show that around 80% of the gp38+ FB we isolate from the small intestine 
express PDGFRα, around 25% of them are CD34+ - most probably cryptic FB - and around 30% 
are α-SMA+ myofibroblasts that are possibly around the lacteal. Further we propose that the 
majority of DN cells isolated are probably muscle cells. All together these data demonstrate that 
FB in the intestine are very heterogeneous in their protein expression profile and location 
suggesting also diverse functions for each subset.  
 
 
3.1.4 Elucidating possible functions of intestinal gp38+ fibroblasts 
 
To elucidate the possible functions of intestinal gp38+ FB, we first determined if they express the 
chemokine CCL19 as do the gp38+ LN FRC to mediate the recruitment and survival of T cells. 
CCL19-cre X ROSA-EYFP mice were used as CCL19 reporter mice and their LN and intestine 
analyzed by histology for EYFP expression along with staining for α-SMA and DAPI. In these 
mice all cells having expressed at one point CCL19 are genetically tagged to express EYFP, in 
a process called cell fate mapping. As reported before, there are many EYFP+ cells throughout 
the T zone of LN (Chai et al., 2013), however no EYFP+ cells are found in the LP of both the 
small and large intestine (Figure 3.7A) with the exception of reticular cells found in the isolated 
lymphoid follicles (ILF) indicating their role in recruiting naïve lymphocytes to the ILF (Figure 
3.7A, arrows). Based on these data we suggest that the FB in the LP have other functions than 
recruiting naïve lymphocytes to the LP, consistent with the presence of effector rather than 
naive lymphocytes in these sites.  
 
Our preliminary evidence suggests that effector T cells, DC, macrophages and IgA+ plasma 
cells localize within the FB network of the small intestine suggesting these FB may help to 
regulate the survival or activity of these hematopoietic cells (unpublished data). LN FRC have 
been shown to attenuate the proliferation of primed T cells via iNOS and COX expression 
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Figure 3.7 Gene expression analysis on different gut parts and in various sorted intestinal stromal cells. 
(A) IF images of LN, ileum and colon from CCL19-cre X ROSA-EYFP mice showing EYFP (green) co-stained with α-
SMA (red) and DAPI (blue). Closed arrow indicates an isolated lymphoid follicle (ILF). (B) mLN and tissues from 
different parts of the intestine were analyzed by qRT-PCR for mRNA expression of the indicated genes (normalized 
with two housekeeping genes). Pro. Colon: proximal colon; dis. colon: distal colon. (C) gp38+CD31-FB, CD31+EC 
(including BEC and LEC), CD11b/c+ macrophages(Mø) or DC, and EpCAM+ epithelial cells were sorted from the 
small intestine and analyzed by qRT-PCR for mRNA expression of the indicated genes (normalized with two 
housekeeping genes). Bars: average values. FB: gp38+ fibroblasts; diamond: CD34+ FB; square: CD34- FB; EC: 
endothelial cells.  
 
(Siegert et al., 2011), and to modulate their homing profile (Hammerschmidt et al., 2008). Given 
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that the gut environment is constantly exposed to gut commensals and food, potent 
mechanisms must be in place to dampen immune responses to non-harmful antigens. In 
addition, the LP is the site where most plasma cells (PC) reside, most notably of the IgA isotype. 
As there is preliminary evidence for LN FRC expressing PC survival genes, including BAFF, 
April and IL-6 (Malhotra et al., 2012), intestinal fibroblasts may have a similar role in 
the maintenance of IgA+ PC. Therefore, transcripts for some candidate genes were measured 
by qRT-PCR, initially on whole tissue lysates from distinct parts of the intestine to identify the 
regions of highest interest. Compared to the mLN, the gut tissues produce two fold less COX-1 
but instead 2-3 folds more COX-2 regardless of the different location in the gut. The relative 
level of expression for both COX enzymes is comparable suggesting both enzymes may be 
involved in immune regulation allover the gut. Interestingly, iNOS expression varies up to 600 
fold depending on their location in the gut. In general, iNOS expression is highest in the lower 
part of the small intestine, possibly correlating with the higher bacterial load in the ileum and 
jejunum than in duodenum (Figure 3.7B, upper panel). The levels of BAFF and APRIL mRNA in 
the gut are similar to the level of the mLN. In contrast, the relative expression of IL-6 (~0.0005) 
in the various gut parts is much lower than the ones of APRIL (~1.5) and BAFF (~0.15) in the 
gut, and is five fold less than in the mLN (Figure 3.7B, lower panel). These data suggest BAFF 
and APRIL are more likely to act as PC survival factors for PC in the LP than IL-6.  
 
Based on this gross analysis of gene expression we decided to focus on the ileum as this site 
combines high commensal load, high numbers of IgA+ PC and prominent expression of immune 
regulatory and PC survival genes. To analyze the cell types that produce the different factors, 
including the FB, the lower part of the small intestine was digested and various cell populations 
sorted by flow cytometry: gp38+ fibroblasts (FB), CD31+ endothelial cells (EC, including LEC 
and BEC), CD11b+ or CD11c+ macrophages plus DC (Mø/DC), and EpCAM+ epithelial cells. 
Using qRT-PCR first the purity of FB was checked by analyzing collagen-Iα1 transcripts. 
Consistent with the FACS data of Col-GFP reporter mice, gp38+ FB produce ~300 folds more 
collagen-I than all other cell type investigated, indicating also that the sorted cell populations 
were of high purity. COX-1 mRNA was found mainly in Mø/DC; 2 fold more than in FB and 40 
fold more than in epithelial cells while COX-2 mRNA level were similar among different cells. In 
contrast, epithelial cells seems to be the major source of iNOS as they express 10 times more 
than EC and 200 fold more than Mø/DC with minimal amounts being detected in FB (Figure 
3.7C, upper panel). APRIL and IL-6 are produced fairly equally in most of the cell types tested. 
BAFF is mainly produced by FB as is CXCL12 (Figure 3.7C, lower panel). These data suggest 
that FB could be more important in supporting survival and recruitment of PC than other cell 
types present in the small intestine.  
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3.1.5 mRNA expression in primary cell lines established from intestinal digests 
 
The study of intestinal FB function would be facilitated by the availability of intestinal FB cell 
lines. As such lines had been established previously in the lab by culturing the digested cell 
suspension or whole tissue from either small or large intestine (done by H. Bega and S. Siegert), 
their transcript expression level was investigated for six out of the eight investigated genes and 
compared to the sorted ex vivo cells (Figure 3.8). While the expression of IL-6, COX-1/ 2, and 
CXCL12 in cell lines is comparable to sorted intestinal FB, expression of APRIL and BAFF are 
largely lost in the cultured cell lines, similar to the LN FRC line pLN2. Besides, the expression 
level of different genes varies among individual cell lines but appears to be independent of their 
anatomical origin of small versus large intestine (Figure 3.8). 
 
  
Figure 3.8 Gene expression analysis in stromal cell lines established from small and large intestine.  
Primary stromal cell lines established by outgrowth of adherent cells from suspensions of total small intestine (3 lines) 
or total colon (4 lines) were analyzed by qRT-PCR for mRNA expression of the indicated genes (normalized with two 
housekeeping genes). As comparison a FRC cell line generated previously from LN (pLN2) was included in this 
analysis. The dashed lines and numbers indicate the mRNA level measured in ex vivo FB sorted from small intestine 
(as shown in Figure 3.7C).  
 
 
3.2 Discussion 
 
The gut LP is a lymphoid tissue where immune cells are found in a scattered arrangement. 
Whether a fibroblast network exists in these sites similar to the lymphoid organs was not known 
at the start of this study. Also unclear was the potential function of such fibroblasts. In this part 
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of the thesis, we established markers useful for the study of fibroblasts and used them to show 
that fibroblasts are very abundant inside the LP and organize in a network-like fashion 
throughout the LP of all gut parts, thereby localizing next to most immune cells. In order to allow 
a more extensive phenotypic and functional analysis we have developed a protocol for isolating 
stromal cells from intestinal LP, both from the small and large intestine. Similar to the LN FRC, 
most of the LP FB also express gp38, PDGFRα, and collagen-I. However their function appears 
to be very different, as they don’t produce much CCL19 and IL-7. Instead they express more 
BAFF, APRIL, and CXCL12 compared to LN TRC and other intestinal cells, suggesting a role in 
regulating IgA+ PC survival or development in the small intestine. 
 
Compared to LN, the digestion of intestinal tissue proofed to be very tricky as LP stromal cells 
are shielded off by epithelial and smooth muscle layers. In addition, especially for the small 
intestine, there is an abundance of mucus, food content, bacteria, anti-microbial peptides, and 
digestion enzymes in the gut lumen and possibly the tissue that might interfere with the 
digestion process and may cause cell death during the digestion or staining process. Indeed, 
the performance of digestion varies dramatically among individual experiments. Furthermore, 
the abundant stromal and myeloid cells show high autofluorescence in most of the channels 
used for flow cytometry, especially after they have died, making FACS compensation and 
analysis very difficult. Finally, since there are highly heterogeneous cell populations in the 
intestine, the distribution of cell size and granularity varies dramatically which make duplet 
exclusion or even cell counting difficult. To overcome these difficulties, a lot of efforts were 
made to avoid misjudgement, including the combined use of dead cell exclusion dye (7AAD) 
and viable cell dye (calcein-AM).  By using 7AAD and calcein-AM, I could show that collagenase 
8 which is widely used currently is quite harmful for both hematopoietic and stromal cells in 20 
minutes digestion when compared to collagenase 4. Interestingly, a recent paper published also 
uses collagenase 4 in a 20 min digestion protocol to isolate successfully intestinal fibroblasts 
(Vicente-Suarez et al., 2014).  
 
By using Col-GFP transgenic mice as a bona-fide fibroblast reporter, we verified gp38 is a good 
marker for most of the intestinal fibroblasts, although it seems some of the intestinal FB are low 
in gp38 and some gp38+ cells are low for GFP, both by FACS and by IF. The recent paper 
describing LP FB in mouse small intestine also using gp38 as FB marker (Vicente-Suarez et al., 
2014). Similar to the LN FRC, most of the intestinal FB are positive for PDGFRα. Besides, the 
intestinal FB around the crypt are positive for CD34. In conclusion, gp38 is a reasonable 
fibroblast marker for the gut but there may be considerable heterogeneity in the fibroblast 
population. What the differences are in function between LN FRC, CD34+ and CD34- intestinal 
FB remains to be explored.  
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In contrast to findings on human gut fibroblasts, it seems the subepithelial myofibroblasts are 
absent or less differentiated in mouse small intestine by IF as α-SMA signals were virtually 
absent below the epithelial barrier (Powell et al., 2011). One possibility is that the α-SMA signal 
is quite low in these myofibroblasts compared to smooth muscle cells and thus needs longer 
exposure time to visualize it. However, with FACS, there seems to be 20-30% of intestinal FB 
which are positive for α-SMA, but the IF suggest these gp38+α-SMA+ cells may mostly localize 
close to the lacteals instead of the epithelium. But since these experiments didn’t include 
costaining with Lyve-1 or CD31, it is not possible to conclude whether these cells are actually 
LEC, smooth muscle cells associated with the lacteal, or myofibroblasts localizing close to the 
lymphatics. Higher resolution IF microscopy will be needed to confirm it, including costains of α-
SMA with Lyve-1, CD31, gp38 or Col-GFP.  
 
In contrast to LN FRC, intestinal FB don’t express high levels of CCL19, CCL21 and IL-7 
transcripts (unpublished data) which raises the question what function they may have for the 
neighboring immune, vascular and epithelial cells. Most fibroblasts were found to associate with 
various matrix proteins (not shown) suggesting they may be the source of it. Consistent with it, I 
found high levels of collagen-Iα1 transcripts in sorted FB but not other cell types. In the 
following we screened for cytokines and enzymes potentially expressed by intestinal FB, by 
focusing initially on transcripts previously found in various fibroblast types (Malhotra et al., 2012). 
LN FRC were shown to produce iNOS and COX-2 which both have a role in dampening CD8 T 
cells proliferation (Siegert et al., 2011)	  (Lukacs-Kornek et al., 2011) (Khan et al., 2011). Indeed, 
LP FB also produce COX-1 and COX-2 at a level comparable to macrophages and DC. In 
contrast, iNOS in the intestine is mainly produced by epithelial cells with iNOS expression levels 
following the amount of microflora in the lumen, with iNOS playing a role in the defense against 
infections (Mirza et al., 2011).  
 
In contrast to the LN where medullary FRC are shown to support PC survival by producing IL-6 
(manuscript in preparation), BAFF and APRIL are much more abundant and might be more 
important in supporting PC survival and function in the small intestine. However, the LP FB cell 
lines seems to lose their BAFF/APRIL expression after culturing, ex vivo LP FB cell sorted might 
be tested to co-culture with PC for supporting their survival. Further more, conditional knockout 
mice can be generated by using PDGFRα-cre X BAFF/APRILflox/flox to study their contribution on 
PC function. On the other hand, the recent paper showing LP FB can produce retinoic acid (RA) 
to imprint mucosal DC for gut tropism (Vicente-Suarez et al., 2014). Interestingly, RA also can 
promote IgA plasma cell CSR (Fagarasan et al., 2010). Thus LP FB can also contribute to T-
independent IgA CSR by producing RA. To test this hypothesis, IgA CSR of B cells after 
stimulating with LPS in the presence of TGFβ can be measured when co-culturing with LP FB, 
and see if adding RALDH inhibitor, DEAB, can inhibit this phenomenon.  
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In conclusion, we are able to isolate the LP FB from intestine and characterize them by FACS 
and qPCR. Current data suggest the LP FB could be important in regulating PC function in the 
small intestine. To study this possibility, LP FB cell lines that maintain BAFF and APRIL 
expression or conditional knockout mice will be needed to address this question. The 
contribution of RA produced by LP FB to PC functions remains to be clarified.   
 63	  
4. General discussion and perspectives 
 
In chapter 2, we describe how the FRC network expands along with LN swelling and the extent 
of FRC expansion correlates nicely with LN cellularity. The signals that trigger FRC expansion 
involve LTβR signaling probably provided by B and T lymphocytes, reminiscent of LTi cell and 
LTo cell interaction during LN development. The functions of different subsets of FRC seem to 
be tightly related to the lymphocytes they contact. TRC express abundant CCL19/21 and IL-7 
which are important for naïve T cell homeostasis while FRC observed in the medullary zone 
(MedFRC) were recently shown by Hsin-Ying Huang in our lab (unpublished) to express high 
levels of IL-6, APRIL, and BAFF to sustain plasma cell survival in the medullary zone. These 
findings suggest that effector lymphocytes may also depend on the FRC network for their 
development and function. Especially resident cells like the medullary plasma cells may rely on 
a specific FRC niche for their retention and survival. It is not clear yet to what extent activated T 
cells use this network for their proliferation, differentiation and migration. How the differentiation 
and finally the function of different FRC subsets are being determined remains a promising area 
for future research. Is it programmed in the progenitor cells that reside in the different area of 
the LN or is there a common progenitor cell and the function of different FRC is induced by the 
lymphocytes and innate immune cells they encountered? What are the signals required? These 
questions ask for a careful analysis of LN FRC heterogeneity in development, homeostasis and 
immunity.  
 
In chapter 3 we have described a dense FRC-like network expressing collagen-I within the gut 
LP where mostly effector lymphocytes and myeloid cells localize. Indeed, a careful scanning 
electron-microscopic study of the rat jejunum from 1985 has already revealed a typical 
fibroblastic reticular structure in the villi different from those surrounding the crypts	  (Takahashi-
Iwanaga and Fujita, 1985). Together with the limited human studies I am tempted to suggest 
that human LP contain a similar FRC network which has been conserved in evolution of 
vertebrates that have an adaptive immune system. In future, studies should be undertaken to 
validate additional fibroblast markers that work on human gut tissue. Given that several 
fibroblast markers have been established for human LN	  (Link et al., 2011), they should be 
tested on LP tissue. In addition, cell sorting and cell line experiments could provide insight into 
the function of FP in human gut. Whether a conduit system exists in the LP fibroblastic reticular 
structure comparable to LN and spleen is still unclear and merits also further investigation, such 
as by using small fluorescent molecules that may resist acids and degrading enzymes if given 
orally.  
 
The finding of a LP FB network raised the possibility that effector lymphocytes, including IgA+ 
plasma cells, may rely on a similar cell as scaffold, organizer and regulator. The finding that 
these LP express abundant transcripts for the PC survival factors APRIL and BAFF are 
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suggestive, and reminiscent of MedFRC in activated LN. More direct experiments using 
cocultures and conditional deletion of these factors in LP FB are needed to further support this 
hypothesis. 
 
LP FB also produce COX-1 and COX-2 that may contribute to immune tolerance to commensals. 
In future it should be of interest to see whether COX and possibly iNOS are induced in FP upon 
colitis induction or pathogen insult, and whether their deletion has any impact on the disease 
course. To this end, good genetic tools need to be established to delete genes selectively within 
LP FB versus other cell types. Preliminary evidence by our lab suggests that Collagen-I-Cre or –
CreERT2 mice may be a useful tool with some deletion in other cell types as well. Alternatively, 
coculture experiments using ex vivo cells or cell lines could be used. 
 
Of note, Vicente-Suarez et al. recently showed in germfree mice that adding microbiota induces 
RALDH expression preferentially among stromal cells within gut LP. The stromal cell phenotype 
(CD31-Epcam-Pdpn+) and distribution throughout the villi suggests these are the same FB I 
described in my thesis. Interestingly, they identified FB as being the major cell type showing a 
constitutive expression of enzymes metabolizing vitamin A. These findings indicate that the 
environment, including nutrients, have a direct impact on the function of local FB. In addition, 
the observed the frequent co-localization of FB with CD11c+CD103+DC, and conditioning of 
these DC by the FB induced RA production in a GM-CSF dependent manner. These data 
represent the first published evidence for gut FB having an impact on immune cells other than 
providing extracellular matrix proteins (Vicente-Suarez et al., 2014). They are fully consistent 
with our preliminary evidence of immunomodulatory cytokines being expressed in LP FB. In 
future it should be interesting to delete RALDH enzymes from FB in vivo to test their effects on 
DCs and the balance of Treg-Th17 cells which is RA-dependent. 
 
A phenotypical and functional comparison of LN FRC and LP FB are shown in Table 4.1. 
 
Table 4.1 Comparison of lymph node FRC and lamina propria FB 
 
 
 Phenotype Subsets mRNA expression Functions 
LN FRC 
gp38+ 
PDGFRα+ 
Col1α1-GFP high 
α-SMA+ (after 
activation) 
MRC 
TRC 
MedFRC 
 
IL-7, CCL19, CCL21, 
COX-2, BAFF, 
APRIL, IL-6, 
CXCL12, iNOS (after 
activation) 
Conduit; naïve T 
cell survival and 
attraction; 
attenuation of T 
cell expansion; 
PC survival 
LP FB 
gp38+ 
PDGFRα+ 
Col1α1-GFP high 
CD34+ crypt FB 
CD34- villi FB 
α-SMA+/- FB 
COX-1/2, BAFF, 
APRIL, CXCL12 
RALDH  
 
T cell tolerance?  
PC survival? 
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Little is currently known on the heterogeneity of gut FB. While crypt and villi FB showed different 
phenotypes (CD34), preliminary data showed no obvious difference in the expression of mRNA 
examined except for COX-1 (Figure 3.7). Whether the expression of CD34 on the cryptic FB 
correlates with the difference in the network structure or other functions remains to be 
elucidated. In contrast to LN, where clear compartments are visible, the LP consists of scattered 
cells that show only limited organization into specialized zones.  However, there is some 
evidence that DC are more often concentrated in the tips of villi, while IgA+ PC are found 
preferentially in the middle. The base of the villi, adjacent to epithelial stem cells, may represent 
yet another area where gp38+ FB form a network. A promising area of future research is to 
further characterize the function and heterogeneity of LP FB, by comparing their transcriptome 
to that of activated LN FRC subsets or skin fibroblasts. Such an approach would allow to identify 
tissue- and region-specific specialization in function of FRC. Similar to LN, the cells and signals 
leading to FB differentiation need to be established. An interesting candidate is represented by 
LTβ which is an important cytokine for LN FRC development	  (Chai et al., 2013).  
 
The function of gp38 on LN FRC has been investigated and showed their contribution to HEV 
integrity and DC motility via interaction with CLEC-2 on platelets (Herzog et al., 2013) and DC 
(Acton et al., 2012), respectively. The functions of gp38 on LP FB are not yet known. The 
transcription of gp38 can be upregulated on synoviocytes or keratinocytes by several pro-
inflammatory cytokines as well as TGFβ	   (Astarita et al., 2012). Indeed, expression of gp38 on 
activated LN FRC and LP FB are higher than naïve LN FRC (data not shown). Activation of 
gp38 results in cytoskeletal rearrangements which may increase the cells to move and invade 
tissues	   (Astarita et al., 2012) thus forming a more flexible network that can adapt to physical 
stretch or space demands in a quick way, like in LN swelling or peristalsis of intestine, and 
facilitate the infiltration and residence of immune cells. Given that floxed Pdpn/gp38 mice have 
been reported, it would be of interest to delete it on gut FB and investigate its impact on FB in 
gut homeostasis or disease. 
 
Gp38+ (myo)fibroblasts are often found in chronic inflammatory sites, including cancer and 
autoimmune diseases	  (Peduto et al., 2009)	  (Pula et al., 2013)	  (Ekwall et al., 2011). These 
stromal cells may actually serve as the organizer cells for the newly formed lymphoid 
aggregates by producing chemokines and survival factors	  (Peduto et al., 2009). In addition, 
gp38 is highly expressed in the invasion front of the tumors	  (Pula et al., 2013). The manipulation 
of these fibroblasts may be the potential target to control chronic inflammation and cancer 
progression. Peduto et al. showed that myeloid cells play a role in regulating gp38+ stromal cells 
during the ontogeny of tertiary lymphoid tissue, with no role observed for MyD88, LTβ, and 
lymphocytes	  (Peduto et al., 2009), in contrast to our finding in the activated LN. This highlights 
the complexity of fibroblasts biology in various tissues and microenvironments. 
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In summary, FRC and FRC-like cells in LN and intestine, respectively, form dense reticular 
networks that are in direct contact with immune cells, including naïve lymphocytes, effector 
lymphocytes and dendritic cells. These specialized fibroblasts have the potential to provide both 
physical and chemical support to the function of immune cells, and therefore regulate immune 
response or tolerance. Similar gp38+ fibroblasts can be found in many inflammatory sites and 
were proposed to be involved in pathogenesis by supporting the local adaptive immune 
response	  (Peduto et al., 2009) (Link et al., 2011). A better understanding of the mechanisms of 
FRC development, expansion and functional specialization in LN and disease sites is likely to 
provide valuable clues to the identification of therapeutic molecules which may target the 
fibroblastic niche cells and thereby indirectly the adaptive immune response.  
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5. Materials and Methods  
 
5.1 Mice  
C57BL/6 mice were from Janvier. OT-1 and OT-2 mice were from Jackson Laboratory and 
bred onto a CD45.1+ C57BL/6 background. RAG2 KO, Caspase-1 KO and CD11c-DTR/GFP 
transgenic mice were from Jackson. MyD88 KO	   (Adachi et al., 1998), TRIF KO	   mice 
(Yamamoto et al., 2003), TLR2 KO mice (Takeuchi et al., 1999), and TLR4 KO mice 
(Hoshino et al., 1999) were kindly provided by S. Akira (Osaka); T1-Fc mice (Senn et al., 
2000) by D. Pinschewer	   (Geneva), RORγ KO (Sun et al., 2000) by D. Littman (New York);	  
LTβ KO mice (Koni et al., 1997) by M. Heikenwälder; and IFNαR1 KO (Muller et al., 1994) 
by H. Acha-Orbea (Lausanne). STAT1 KO and JH KO mice were from Taconic; TCRβδ KO 
and TNF-R1 KO were from Jackson. 
 
5.2 Mouse treatments 
106 OT-1 and 106 OT-2 splenocytes were injected i.v. 24 h before immunization. OVA 
protein (Sigma) was dissolved in PBS and then mixed with Montanide ISA 25 (Seppic) in a 
3:1 ratio by vortexing. Mice received six s.c. injections (50 µg OVA each) in areas drained by 
axial, brachial and inguinal lymph nodes. Alternatively, bone-marrow derived dendritic cells 
(BMDC) were generated as described previously (Vogt et al., 2009) and activated with 0.1 
µg/ml LPS (Sigma) or 5 µg/ml CpG (ODN1668, Trilink) for 16 h prior to injection. BMDCs 
were labeled using 2 µM CFSE (Invitrogen), resuspended in PBS and 106 BMDC were 
injected were injected each site s.c. as described above. For BrdU administration, mice were 
injected with 100 µl of 10 mg/ml BrdU in PBS and then kept on BrdU-containing drinking 
water (0.8 mg/ml). For IL-7 / α-IL-7 immune complex injection, anti-human IL-7 antibodies 
(M25, 50 µg/ml) were mixed with mouse IL-7 (10 µg/ml) by the same volume and delivered 
i.p. each mouse 200 µl on day 0, 1, 2, and 3. To deplete DC, diphtheria toxin (DT, Sigma) 
dissolved in PBS was injected once i.p. at 4 ng/g body weight 16 hours before immunization. 
For Leishmania major infection, 3x106 stationary LV39 L. major promastigotes were injected 
s.c. into the hind limb footpads. For LTαβ/LIGHT blocking, 200 µg of mLTβR-Fc or control 
human IgG1 antibody (Biogen) were injected one day before immunization and then 100 µg 
every two days intraperitoneally. For PDGFRα blocking in vivo, 200 µg of anti-
PDGFRα (APA5, hybridoma kindly provided by S.-I. Nishikawa) and control IgG2a antibody 
(2A3, BioXCell) were injected intraperitoneally one day before immunization, and then 100 
µg every two days. For IL-1β blocking, 200 µg of neutralizing antibody (Novartis 
Pharmaceuticals) were injected intraperitoneally one day before and one day after 
immunization. For Anakinra (soluble IL-1R; Kineret), WT mice were injected intraperitoneally 
200 µg Anakinra every 12 hours. Imatinib (Novartis) was dissolved in water and injected i.p. 
50 µg/g everyday. Nilotinib (Manley et al., 2010) and AAL993 (Manley et al., 2002) (both 
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from Novartis) were dissolved in N-methylpyrrolidinone (NMP) and diluted 1/10 in PEG300 
to give mice every day p.o. 150 mg/kg or 100 mg/kg, respectively. For bone-marrow chimera 
mice, CD45.1+ or .2+ recipients were lethally γ-irradiated (2x 450 rad in 3 h interval) and then 
injected i.v. with 107 total BM cells from CD45.1+ WT mice, MyD88 KO or RORγτ KO mice. 
Chimeras were analyzed 8 weeks after reconstitution. All animal experiments were 
authorized by the Swiss Federal Veterinary Office.  
 
5.3 Isolation of LN stromal cells 
Peripheral LN (axillary, brachial, inguinal) or mesenteric LN were dissected from CO2-
euthanized mice and then opened with 26-gauge needles. For FRC isolation, LNs were 
digested in 1.5 ml of RPMI-1640 (Invitrogen) containing collagenase 4 (3	   mg/ml, 
Worthington), DNase I (40 µg/ml, Roche) and 2% (v/v) Fetal Bovine Serum (FBS; PAA) at 
37 °C for 30 min with gentle stirring. The suspension was then gently pipetted to break up 
remaining aggregates until no visible fragments remained. Viable cells were counted using 
trypan blue staining prior to antibody labeling. 
 
5.4 Isolation of gut lamina propria stromal cells 
14 cm of lower small intestine (containing ileum and part of the jejunum) was excised from 
CO2-euthanized mice and the attached mesenteries and Payer’s patches were removed. 
The intestine was opened longitudinally and the intestinal content was flushed out. To 
detach the epithelium tissues were incubated in 30 ml of PBS containing 10 mM EDTA, 2% 
FBS, 1 mM sodium pyruvate (Sigma-Aldrich), and 20 mM HEPES at 37 °C with stirring. 30 
min after incubation, epithelium was detached by vigorously shacking. The supernatant was 
discard and the remaining tissue was washed with excess PBS for 3 times. The remaining 
intact tissues were then cut into small pieces and digested with 3 mg/ml of collagenase 4 
(Worthington) in 10 ml DMEM containing 10% FBS (Sigma-Aldrich), 50 µg/ml DNase 
(Roche), and 2 mM CaCl2 (Sigma-Aldrich) at 37 °C with stirring. 20 min after digestion, the 
suspension was gently pipetted for a few times. The suspension, and quite often some 
undigested pieces were then meshed through a filter and cells were centrifuged. 
 
5.5 Cell staining, flow cytometry and FACS sorting 
Cells are blocked with 2% normal mouse serum (Sigma) for 20 min on ice and then stained 
with antibodies in PBS containing 2% FBS, 2 mM EDTA and 0.1% (w/v) NaN3 for 30 min on 
ice. Biotin-conjugated primary antibodies were detected with streptavidin. Dead cells were 
excluded using 7-AAD or DAPI (Invitrogen). BrdU (Sigma) administration to mice as well as 
surface-staining (using doubled antibody concentrations) and fixation of cells were as 
described before (Link et al., 2007), except that cells were incubated with 70 Kunitz U/ml 
DNase I (Roche) for 45 min at 37°C and with FITC-conjugated anti-BrdU mAb or an isotype-
matched control mAb (Becton Dickinson) for 60 min at room temperature. For calcein-AM 
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staining, cells are incubated with 2 µM calcein-AM (eBioscience) in 100 µl of PBS containing 
2% FBS for 30 min in room temperature prevented from light. Data were acquired on a 
LSRII (Becton Dickinson) and analyzed with FlowJo software (TreeStar). FACS cell sorting 
is performed on Aria II (Becton Dickinson) and cells are sorted into RLT buffer (Qiagen) 
directly for RNA isolation. Antibodies used for flow cytometry are listed in Table 5.1.  
 
5.6 Immunofluorescence (IF) staining and imaging 
Cryostat sections (8-10 µm) of Tissue-Tek OCT (Sakura)-embedded LN or intestine were 
collected on Superfrost/Plus glass slides (Fisher Scientific) then air dried overnight, fixed in 
ice-cold acetone for 10 min and rehydrated in PBS. Sections were quenched using 0.3% 
H2O2 in PBS, blocked using 0.1% BSA and 1-4% animal serum in PBS followed by a 
streptavidin-biotin blocking kit (Vector Laboratories), as described before (Link et al., 2007). 
Stainings were performed for 60 min at room temperature using antibodies listed in Table 
5.2. For gp38, the staining was revealed using HRP-conjugated secondary reagents 
followed by Tyramide Signal Amplification (Molecular Probes Kit #22) according to the 
manufacturer’s instructions, but using a borate buffer (0.1 M in PBS, pH 8.5) for tyramide 
dilution. Images were acquired on Leica DM5500 microscope with a Leica DFC320 camera 
or on a DM IRE2 microscope with laser scanning confocal head TCS SP2 AOBS (Leica). To 
visualize functional conduits, 20 µl of TexasRed-labeled 10 kDa dextran (Invitrogen) was 
injected subcutaneously at 5 mg/ml into the footpad and mice sacrificed after 30 min. LN 
were then removed and fixed in 4% PFA at 4°C for 2 h, then saturated in 30% sucrose for 3 
h at 4°C before embedding in Tissue-Tek OCT (Sakura) and freezing in an ethanol dry ice 
bath.  
 
5.7 Visualizing the conduit system by IF 
To visualize functional conduits, 20 µl of TexasRed-labeled 10 kDa dextran (Invitrogen) was 
injected subcutaneously at 5 mg/ml into the footpad and mice sacrificed after 30 min. LN 
were then removed and fixed in 4% PFA at 4°C for 2 h, then saturated in 30% sucrose for 3 
h at 4°C before embedding in Tissue-Tek OCT (Sakura) and freezing in an ethanol dry ice 
bath. The sections were then stained with the IF procedure described above. 
 
5.8 Visualizing BrdU+ FRC by IF 
Mice received OT1 and OT2 cells are immunized with OVA/Mont and supplied with BrdU 
administration. Seven days later, mice were irradiated with sub-lethal (450 rad) or lethal 
dose (2x450 rad) and two days later the mice were sacrificed and LN were embedded. For 
visualizing BrdU by IF, sections were fixed with 1% PFA, following by the antigen retrieval 
which is done by boiling the slides in citrate buffer (10 mM citric acid and 10 mM trisodium 
citrate) at 85 °C for 20 min. The sections were then stained with normal IF procedure 
described above. 
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5.9 Isolation of ex vivo hematopoietic cells and cell culture  
pLN2 cells were generated by S. Siegert	  (Siegert et al., 2011). For isolating ex vivo T, B, and 
DC, spleens were meshed through 40 µm strainer, and the cell suspension were panned 
with CD19-coated plate. The attached cells are B cells. The rest of cells are subjected to 
dynabeads (Dynabeads FlowComp Flexi, Invitrogen) conjugated with anti-CD11c antibody 
(N418) to purify DC according to the user manual. The flowthrough after DC purification 
were taken as T cell. For isolating peritoneal macrophages, 5 ml PBS containing 10% FBS 
was injected to the peritoneal cavity with 26G needle and the mouse was shacked to detach 
the peritoneal Mø. The PBS that contained Mø was then collected with pipette. The cells 
were cultured at 37°C with 4.5% CO2 in RPMI medium containing 10% FBS, (PAA), 10mM 
HEPES (Sigma), 50IU/ml penicillin, 50 µg/ml streptomycin (Sigma). 
 
5.10 Vibratome sections 
Isolated LN were fixed overnight at 4°C in freshly prepared 1% PFA in PBS, washed, 
embedded in 4% low-gelling agarose (Sigma) in PBS and 100-200 µm sections cut using a 
vibratome (Microm HM 650V). Sections were blocked with 1% BSA for 1 h and stained for at 
least 3-12 h with the antibodies listed in Table 5.2. Subsequently sections were washed 
extensively in PBS and embedded using Elvanol (Mowiol, Calbiochem). Images were taken 
with a Zeiss Axio Imager upright microscope. 3D-image reconstructions were made with 
Imaris software and segment length was assessed using the FilamentTracer plugin (both 
from Bitplane). 
 
5.11 RNA isolation and quantitative RT-PCR analysis 
For fractionated LN samples, LN were mashed through a 40 µm filter using a plunger, with 
the filtered cells being the soluble fraction and the remaining white matter being the non-
soluble fraction. For whole tissue lysate from different part of intestines, around 0.5 cm of the 
tissue are cut from each part of the intestine for RNA isolation. RNA of tissue and cell lines 
were extracted using TRIzol reagent (Invitrogen). RNA of sorted cells is extracted with 
RNeasy Micro Kit (Qiagen). First-strand cDNA synthesis (Superscript II; Invitrogen) was 
performed according to the manufacturer’s instructions using random nonamer primers 
(Microsynth). cDNA was purified with the NucleoSpin Extract II Kit (Macherey-Nagel) and 
individual transcripts assessed by quantitative PCR using the Light Cycler-FastStart 
DNAMaster SYBR Green I kit (Roche Diagnostics) on a Light Cycler 2.0 machine (Roche 
Diagnostics). Efficiency-corrected gene expression of target genes was normalized with the 
geometric mean of expression of two housekeeping genes, hypoxanthine guanine 
phosphoribosyl transferase (hprt1) and TATA-binding protein (tbp). Primer sequences 
(Microsynth) were listed in Table 5.3. 
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5.12 In situ hybridization 
The Ccl19, Ccl21, and Il7 ‘riboprobe’ were cloned and used as described previously (Link et 
al., 2007). In brief: Frozen sections (8 µm in thickness) were fixed in 4% (wt/vol) 
paraformaldehyde, washed in PBS, incubated with prehybridization solution followed by an 
overnight incubation at 60 °C with sense or antisense digoxigenin-labeled ‘riboprobes’. After 
several washes, sections were incubated with sheep anti-digoxigenin antibody followed by 
alkaline phosphatase–coupled donkey anti-sheep antibody. The color reaction was achieved 
using nitro blue tetrazolium (Bio-Rad) and 5-bromo-4-chloro-3-indolylphosphate (Sigma), 
followed by antibody staining for B220 and laminin. Hybridization signals were imaged using 
transmission microscopy and false-colored in green. 
 
5.13 Statistical analysis 
Statistical significance was determined using an unpaired two-tailed Student’s t-test for unequal 
variances. P values are indicated as * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and n.s. for 
¨statistically not significant¨. 
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5.14 Reagents 
 
Table 5.1 Antibodies used for flow cytometric analysis   
 
Target Species Clone Conjugate Vendor 
α-SMA Mouse 1A4 FITC Sigma 
BrdU Mouse 3D4 FITC BD Pharmingen 
CD4  Rat GK1.5 PE BioLegend 
CD4  Rat RM4-5 eFluor 450 eBioscience 
CD8α Rat 53-6.7 PE-Cy7 BioLegend 
CD11b Rat M1/70 Alexa 700 eBioscience 
CD11c Arm. Hamster N418 PE eBioscience 
CD11c Arm. Hamster N418 PE-Cy5 BioLegend 
CD11c Arm. Hamster N418 PE-Cy5.5 BioLegend 
CD19 Rat ID3 BV605 BD Horizon 
CD19 Rat 6D5 PE-Cy5.5 BioLegend 
CD25 Rat PC61 PE eBioscience 
CD31 Rat 390 PE BioLegend 
CD34 Rat RAM34 Alexa 700 eBioscience 
CD35 Rat eBlo8D9 PE-Cy7 eBioscience 
CD44 Rat IM7 Biotin eBioscience 
CD45 Rat 30-F11 PE-Cy7 eBioscience 
CD45 Rat 30-F11 PE-Cy7 BioLegend 
CD45.1 Mouse A20.1 Alexa647 Hybridoma, ATCC 
CD45R 
(B220) 
Rat RA3-6B2 PE-Texas Red BD Pharmigen 
CD62L Rat MEL-14 FITC Biolegend 
CD69 Arm. Hamster H1.2F3 FITC eBioscience 
CD103 Rat M290 Biotin Hybridoma, ATCC 
CD140a 
(PDGFRα) 
Rat APA5 Biotin eBioscience 
CD140a 
(PDGFRα) 
Rat APA5 PE BioLegend 
CD326 
(EpCAM) 
Rat G8.8 eFluor 450 eBioscience 
CD326 
(EpCAM) 
Rat G8.8 FITC Hybridoma, ATCC 
Desmin Rabbit  None Progen 
F4/80 Rat F4/80 FITC Hybridoma, ATCC 
gp38  Syrian 
Hamster 
8.1.1 Alexa 647 Hybridoma, 
Developmental 
Studies Hybridoma 
Bank 
Gr-1 Rat RB6-8c5 APC- eFluor 780 eBioscience 
IgA Rat 11-44-2 FITC Southern Biotech 
LTβR Rat 3C8 Biotin eBioscience 
MHCII Rat M5/114.15.2 Alexa 647 Hybridoma, ATCC 
Streptavidin   APC Biolegend 
Streptavidin   PE-Texas Red Invitrogen 
TCRβ Arm. Hamster H57-597 APC-eFluor 780 eBioscience 
TCRβ Arm. Hamster H57-597 PE eBioscience 
TCRγδ Arm. Hamster GL-3 APC BioLegend 
Ter119 Rat Ter-119 BV605 BioLegend 
Ter119 Rat Ter-119 PE-Cy5.5 eBioscience 
Ter119 Rat Ter-119 PE-Cy7 BioLegend 
VCAM-1 Rat M/K2.7 Biotin Hybridoma 
All hybridomas from ATCC were obtained from American Type Culture Collection, Manassas, 
USA and purified and conjugated using standard protocols. 
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Table 5.2 Antibodies used for in situ hybridization or immunofluorescence staining of 
vibratome- or cryostat-sections  
	  	  
Target Species Clone Conjugate Vendor 
α-SMA Mouse 1A4 Cy3 Sigma 
B220 Rat RA3-6B2 None Hybridoma 
CD3ε Armenian 
hamster 
145-2C11 None Hybridoma 
CD31 Rat GC-51 None Hybridoma 
CD34 Rat RAM34 None eBioscience 
CD35 (CR1) Rat 8C12 None Hybridoma 
Collagen-I Goat #1200-01S None Southern Biotech 
(Birmingham, USA) 
Desmin Rabbit  None Progen 
Digoxigenin Sheep  None Roche 
Fibronectin Rabbit  None Sigma 
Goat IgG Donkey  Alexa 488 Molecular probes 
GFP Rabbit  None Invitrogen 
gp38 Syrian hamster 8.1.1 None Developmental 
Studies Hybridoma 
Bank 
Hamster IgG Goat  Alexa 488 Molecular probes 
Laminin Rabbit 046K4766 None	   Sigma 
LYVE-1 Rabbit #103-PA50 None	   RELIATech 
(Wolfenbüttel, 
Germany) 
Rabbit IgG Donkey  Cy3 Jackson 
ImmunoResearch 
Laboratories 
Rabbit IgG Donkey  Alexa 488 Molecular probes 
Rabbit IgG Donkey  Alexa 647 Molecular probes 
Rat IgG Chicken  Alexa 647 Molecular probes 
Rat IgG Donkey  Alexa 488 Molecular probes 
Rat IgG Donkey  Cy3 Jackson 
ImmunoResearch 
Laboratories 
Sheep IgG Donkey  Alkaline 
phosphate 
Jackson 
ImmunoResearch 
Laboratories 
Syrian hamster 
IgG 
Goat  Cy3 Jackson 
ImmunoResearch 
Laboratories 
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Table 5.3 Primers used for quantitative RT-PCR 
 
 
 
Target Forward Reverse 
April GGTGGTATCTCGGGAAGGAC CCCCTTGATGTAAATGAAAGACA 
Baff AGACGCGCTTTCCAGGGACC TAGTCGGCGTGTCGCTGTCTG 
Ccl19 CTGCCTCAGATTATCTGCCAT GTCTTCCGCATCATTAGCAC 
Ccl21 ATCCCGGCAATCCTGTTCTC GGTTCTGCACCCAGCCTTC 
Collagen-Iα1 GCTCCTCTTAGGGGCCACT CCACGTCTCACCATTGGGG 
Cox-1 CCAGAGTCATGAGTCGAAGGAAG CCTGGTTCTGGCACGGATAG 
Cox-2 TGGTGCCTGGTCTGATGATG GTGGTAACCGCTCAGGTGTTG 
Cxcl12 TGCATCAGTGACGGTAAACCA TTCTTCAGCCGTGCAACAATC 
Hprt1 GTTGGATATGCCCTTGAC AGGACTAGAACACCTGCT 
Il6 ATGGATGCTACCAAACTGGAT TGAAGGACTCTGGCTTTGTCT 
Il7 GTGCCACATTAAAGACAAAGAAG GTTCATTATTCGGGCAATTACTATC 
Inos GTTCTCAGCCCAACAATACAAGA GTGGACGGGTCGATGTCAC 
Tbp CCTTCACCAATGACTCCTATGAC CAAGTTTACAGCCAAGATTCAC 
 75	  
6. References 
 
Abdelrahman, M.A., Marston, G., Hull, M.A., Markham, A.F., Jones, P.F., Evans, J.A., and Coletta, P.L. (2012). High-
Frequency Ultrasound for in Vivo Measurement of Colon Wall Thickness in Mice. Ultrasound Med Biol 38, 432-442. 
Abe, J., Ueha, S., Yoneyama, H., Shono, Y., Kurachi, M., Goto, A., Fukayama, M., Tomura, M., Kakimi, K., and 
Matsushima, K. (2012). B cells regulate antibody responses through the medullary remodeling of inflamed lymph 
nodes. International Immunology 24, 17-27. 
Acton, S.E., Astarita, J.L., Malhotra, D., Lukacs-Kornek, V., Franz, B., Hess, P.R., Jakus, Z., Kuligowski, M., Fletcher, 
A.L., Elpek, K.G., et al. (2012). Podoplanin-Rich Stromal Networks Induce Dendritic Cell Motility via Activation of the 
C-type Lectin Receptor CLEC-2. Immunity 37, 276-289. 
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., and Akira, S. (1998). 
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150. 
Aguzzi, A., Kranich, J., and Krautler, N.J. (2014). Follicular dendritic cells: origin, phenotype, and function in health 
and disease. Trends Immunol 35, 105-113. 
Allen, S., Turner, S.J., Bourges, D., Gleeson, P.A., and van Driel, I.R. (2011). Shaping the T-cell repertoire in the 
periphery. Immunol Cell Biol 89, 60-69. 
Anderson, A.O., and Anderson, N.D. (1975). Studies on the structure and permeability of the microvasculature in 
normal rat lymph nodes. Am J Pathol 80, 387-418. 
Angeli, V., Ginhoux, F., Llodra, J., Quemeneur, L., Frenette, P.S., Skobe, M., Jessberger, R., Merad, M., and 
Randolph, G.J. (2006). B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization 
(vol 24, pg 203, 2006). Immunity 25, 689-689. 
Asperti-Boursin, F., Real, E., Bismuth, G., Trautmann, A., and Donnadieu, E. (2007). CCR7 ligands control basal T 
cell motility within lymph node slices in a phosphoinositide 3-kinase independent manner. Journal of Experimental 
Medicine 204, 1167-1179. 
Astarita, J.L., Acton, S.E., and Turley, S.J. (2012). Podoplanin: emerging functions in development, the immune 
system, and cancer. Front Immunol 3, 283. 
Bajenoff, M., Egen, J.G., Koo, L.Y., Laugier, J.P., Brau, F., Glaichenhaus, N., and Germain, R.N. (2006). Stromal cell 
networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25, 989-1001. 
Bajenoff, M., and Germain, R.N. (2009). B-cell follicle development remodels the conduit system and allows soluble 
antigen delivery to follicular dendritic cells. Blood 114, 4989-4997. 
Batista, F.D., and Harwood, N.E. (2009). The who, how and where of antigen presentation to B cells. Nature Reviews 
Immunology 9, 15-27. 
Bekiaris, V., Timoshenko, O., Hou, T.Z., Toellner, K., Shakib, S., Gaspal, F., McConnell, F.M., Parnell, S.M., Withers, 
D., Buckley, C.D., et al. (2008). Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine 
cytomegalovirus infection. J Immunol 180, 6768-6776. 
Benahmed, F., Chyou, S., Dasoveanu, D., Chen, J., Kumar, V., Iwakura, Y., and Lu, T.T. (2014). Multiple CD11c+ 
cells collaboratively express IL-1beta to modulate stromal vascular endothelial growth factor and lymph node 
vascular-stromal growth. J Immunol 192, 4153-4163. 
Benedict, C.A., De Trez, C., Schneider, K., Ha, S., Patterson, G., and Ware, C.F. (2006). Specific remodeling of 
splenic architecture by cytomegalovirus. PLoS Pathog 2, e16. 
Benezech, C., Mader, E., Desanti, G., Khan, M., Nakamura, K., White, A., Ware, C.F., Anderson, G., and Caamano, 
J.H. (2012). Lymphotoxin-beta Receptor Signaling through NF-kappaB2-RelB Pathway Reprograms Adipocyte 
Precursors as Lymph Node Stromal Cells. Immunity 37, 721-734. 
Boyman, O., Ramsey, C., Kim, D.M., Sprent, J., and Surh, C.D. (2008). IL-7/Anti-IL-7 mAb complexes restore T cell 
development and induce homeostatic T cell expansion without lymphopenia. Journal of Immunology 180, 7265-7275. 
Brandtzaeg, P., Kiyono, H., Pabst, R., and Russell, M.W. (2008). Terminology: nomenclature of mucosa-associated 
lymphoid tissue. Mucosal Immunol 1, 31-37. 
Brennan, P.C., McCullough, J.S., and Carr, K.E. (1999). Variations in cell and structure populations along the length 
of murine small intestine. Cells Tissues Organs 164, 221-226. 
Broere, F., du Pre, M.F., van Berkel, L.A., Garssen, J., Schmid-Weber, C.B., Lambrecht, B.N., Hendriks, R.W., 
Nieuwenhuis, E.E.S., Kraal, G., and Samsom, J.N. (2009). Cyclooxygenase-2 in mucosal DC mediates induction of 
regulatory T cells in the intestine through suppression of IL-4. Mucosal Immunol 2, 254-264. 
Castagnaro, L., Lenti, E., Maruzzelli, S., Spinardi, L., Migliori, E., Farinello, D., Sitia, G., Harrelson, Z., Evans, S.M., 
Guidotti, L.G., et al. (2013). Nkx2-5(+)Islet1(+) Mesenchymal Precursors Generate Distinct Spleen Stromal Cell 
Subsets and Participate in Restoring Stromal Network Integrity. Immunity 38, 782-791. 
Cerutti, A. (2008). The regulation of IgA class switching. Nature Reviews Immunology 8, 421-434. 
 76	  
Chai, Q., Onder, L., Scandella, E., Gil-Cruz, C., Perez-Shibayama, C., Cupovic, J., Danuser, R., Sparwasser, T., 
Luther, S.A., Thiel, V., et al. (2013). Maturation of Lymph Node Fibroblastic Reticular Cells from Myofibroblastic 
Precursors Is Critical for Antiviral Immunity. Immunity 38, 1013-1024. 
Chen, Q., Fisher, D.T., Clancy, K.A., Gauguet, J.M., Wang, W.C., Unger, E., Rose-John, S., von Andrian, U.H., 
Baumann, H., and Evans, S.S. (2006). Fever-range thermal stress promotes lymphocyte trafficking across high 
endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol 7, 1299-1308. 
Chu, V.T., Beller, A., Rausch, S., Strandmark, J., Zanker, M., Arbach, O., Kruglov, A., and Berek, C. (2014). 
Eosinophils Promote Generation and Maintenance of Immunoglobulin-A-Expressing Plasma Cells and Contribute to 
Gut Immune Homeostasis. Immunity 40, 582-593. 
Chyou, S., Benahmed, F., Chen, J.F., Kumar, V., Tian, S., Lipp, M., and Lu, T.T. (2011). Coordinated Regulation of 
Lymph Node Vascular-Stromal Growth First by CD11c(+) Cells and Then by T and B Cells. Journal of Immunology 
187, 5558-5567. 
Chyou, S., Ekland, E.H., Carpenter, A.C., Tzeng, T.C.J., Tian, S., Michaud, M., Madri, J.A., and Lu, T.T. (2008). 
Fibroblast-type reticular stromal cells regulate the lymph node vasculature. Journal of Immunology 181, 3887-3896. 
Cohen, J.N., Guidi, C.J., Tewalt, E.F., Qiao, H., Rouhani, S.J., Ruddell, A., Farr, A.G., Tung, K.S., and Engelhard, 
V.H. (2010). Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent 
direct antigen presentation. Journal of Experimental Medicine 207, 681-688. 
Cyster, J.G. (2005). Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annual 
Review of Immunology 23, 127-159. 
Cyster, J.G., and Schwab, S.R. (2012a). Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs. 
Annual Review of Immunology, Vol 30 30, 69-94. 
Cyster, J.G., and Schwab, S.R. (2012b). Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. 
Annu Rev Immunol 30, 69-94. 
Eberl, G. (2005). Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway? Nat 
Rev Immunol 5, 413-420. 
Ekwall, A.K.H., Eisler, T., Anderberg, C., Jin, C.S., Karlsson, N., Brisslert, M., and Bokarewa, M.I. (2011). The 
tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial 
lining layer in rheumatoid arthritis. Arthritis Res Ther 13. 
Endres, R., Alimzhanov, M.B., Plitz, T., Futterer, A., Kosco-Vilbois, M.H., Nedospasov, S.A., Rajewsky, K., and 
Pfeffer, K. (1999). Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by 
radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 189, 159-168. 
Fagarasan, S., and Honjo, T. (2003). Intestinal IgA synthesis: Regulation of front-line body defences. Nature Reviews 
Immunology 3, 63-72. 
Fagarasan, S., Kawamoto, S., Kanagawa, O., and Suzuki, K. (2010). Adaptive Immune Regulation in the Gut: T Cell-
Dependent and T Cell-Independent IgA Synthesis. Annual Review of Immunology, Vol 28 28, 243-273. 
Fagarasan, S., Kinoshita, K., Muramatsu, M., Ikuta, K., and Honjo, T. (2001). In situ class switching and 
differentiation to IgA-producing cells in the gut lamina propria. Nature 413, 639-643. 
Farr, A., Nelson, A., and Hosier, S. (1992). Characterization of an Antigenic Determinant Preferentially Expressed by 
Type-I Epithelial-Cells in the Murine Thymus. J Histochem Cytochem 40, 651-664. 
Flanagan, K., Moroziewicz, D., Kwak, H., Horig, H., and Kaufman, H.L. (2004). The lymphoid chemokine CCL21 
costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells. Cell Immunol 231, 75-84. 
Fletcher, A.L., Lukacs-Kornek, V., Reynoso, E.D., Pinner, S.E., Bellemare-Pelletier, A., Curry, M.S., Collier, A.R., 
Boyd, R.L., and Turley, S.J. (2010). Lymph node fibroblastic reticular cells directly present peripheral tissue antigen 
under steady-state and inflammatory conditions. J Exp Med 207, 689-697. 
Friedman, R.S., Jacobelli, J., and Krummel, M.F. (2006). Surface-bound chemokines capture and prime T cells for 
synapse formation. Nat Immunol 7, 1101-1108. 
Fu, Y.X., Huang, G., Wang, Y., and Chaplin, D.D. (1998). B lymphocytes induce the formation of follicular dendritic 
cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med 187, 1009-1018. 
Gil-Ortega, M., Garidou, L., Barreau, C., Maumus, M., Breasson, L., Tavernier, G., Garcia-Prieto, C.F., Bouloumie, A., 
Casteilla, L., and Sengenes, C. (2013). Native Adipose Stromal Cells Egress from Adipose Tissue In Vivo: Evidence 
During Lymph Node Activation. Stem Cells 31, 1309-1320. 
Girard, J.P., Moussion, C., and Forster, R. (2012). HEVs, lymphatics and homeostatic immune cell trafficking in 
lymph nodes. Nat Rev Immunol 12, 762-773. 
Goldrath, A.W., Bogatzki, L.Y., and Bevan, M.J. (2000). Naive T cells transiently acquire a memory-like phenotype 
during homeostasis-driven proliferation. Journal of Experimental Medicine 192, 557-564. 
Gonzalez, M., Mackay, F., Browning, J.L., Kosco-Vilbois, M.H., and Noelle, R.J. (1998). The sequential role of 
lymphotoxin and B cells in the development of splenic follicles. J Exp Med 187, 997-1007. 
 77	  
Gretz, J.E., Anderson, A.O., and Shaw, S. (1997). Cords, channels, corridors and conduits: critical architectural 
elements facilitating cell interactions in the lymph node cortex. Immunol Rev 156, 11-24. 
Gretz, J.E., Norbury, C.C., Anderson, A.O., Proudfoot, A.E.I., and Shaw, S. (2000). Lymph-borne chemokines and 
other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional 
barrier limits access to the lymphocyte microenvironments in lymph node cortex. Journal of Experimental Medicine 
192, 1425-1439. 
Hall, J.G., and Morris, B. (1965). The immediate effect of antigens on the cell output of a lymph node. Br J Exp Pathol 
46, 450-454. 
Hammerschmidt, S.I., Ahrendt, M., Bode, U., Wahl, B., Kremmer, E., Forster, R., and Pabst, O. (2008). Stromal 
mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. Journal of Experimental 
Medicine 205, 2483-2490. 
Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A., and Nagata, S. (2002). Identification of a factor 
that links apoptotic cells to phagocytes. Nature 417, 182-187. 
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., and Nagata, S. (2004). Autoimmune 
disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304, 1147-1150. 
Hay, J.B., and Hobbs, B.B. (1977). The flow of blood to lymph nodes and its relation to lymphocyte traffic and the 
immune response. J Exp Med 145, 31-44. 
Henrickson, S.E., and von Andrian, U.H. (2007). Single-cell dynamics of T-cell priming. Curr Opin Immunol 19, 249-
258. 
Herzog, B.H., Fu, J.X., Wilson, S.J., Hess, P.R., Sen, A., McDaniel, J.M., Pan, Y.F., Sheng, M.J., Yago, T., Silasi-
Mansat, R., et al. (2013). Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. 
Nature 502, 105-+. 
Hess, E., Duheron, V., Decossas, M., Lezot, F., Berdal, A., Chea, S., Golub, R., Bosisio, M.R., Bridal, S.L., Choi, Y., 
et al. (2012). RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation. Journal of Immunology 
188, 1245-1254. 
Honda, K., and Takeda, K. (2009). Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal 
Immunol 2, 187-196. 
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., and Akira, S. (1999). Cutting 
edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the 
Lps gene product. Journal of Immunology 162, 3749-3752. 
Jarjour, M., Jorquera, A., Mondor, I., Wienert, S., Narang, P., Coles, M.C., Klauschen, F., and Bajenoff, M. (2014). 
Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells. Journal of Experimental Medicine 
211, 1109-1122. 
Jawdat, D.M., Rowden, G., and Marshall, J.S. (2006). Mast cells have a pivotal role in TNF-independent lymph node 
hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. Journal of Immunology 
177, 1755-1762. 
Junt, T., Moseman, E.A., Iannacone, M., Massberg, S., Lang, P.A., Boes, M., Fink, K., Henrickson, S.E., 
Shayakhmetov, D.M., Di Paolo, N.C., et al. (2007). Subcapsular sinus macrophages in lymph nodes clear lymph-
borne viruses and present them to antiviral B cells. Nature 450, 110-+. 
Junt, T., Scandella, E., and Ludewig, B. (2008). Form follows function: lymphoid tissue microarchitecture in 
antimicrobial immune defence. Nat Rev Immunol 8, 764-775. 
Kaldjian, E.P., Gretz, J.E., Anderson, A.O., Shi, Y., and Shaw, S. (2001). Spatial and molecular organization of lymph 
node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells 
anchored to basement membrane-like extracellular matrix. Int Immunol 13, 1243-1253. 
Kalluri, R., and Zeisberg, M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6, 392-401. 
Katakai, T. (2012). Marginal reticular cells: a stromal subset directly descended from the lymphoid tissue organizer. 
Front Immunol 3, 200. 
Katakai, T., Hara, T., Lee, J.H., Gonda, H., Sugai, M., and Shimizu, A. (2004a). A novel reticular stromal structure in 
lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. International 
Immunology 16, 1133-1142. 
Katakai, T., Hara, T., Sugai, M., Gonda, H., and Shimizu, A. (2004b). Lymph node fibroblastic reticular cells construct 
the stromal reticulum via contact with lymphocytes. J Exp Med 200, 783-795. 
Katakai, T., Suto, H., Sugai, M., Gonda, H., Togawa, A., Suematsu, S., Ebisuno, Y., Katagiri, K., Kinashi, T., and 
Shimizu, A. (2008). Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. Journal of 
Immunology 181, 6189-6200. 
Khan, O., Headley, M., Gerard, A., Wei, W., Liu, L., and Krummel, M.F. (2011). Regulation of T cell priming by 
lymphoid stroma. PLoS One 6, e26138. 
 78	  
Kinoshita, K., Harigai, M., Fagarasan, S., Muramatsu, M., and Honjo, T. (2001). A hallmark of active class switch 
recombination: Transcripts directed by I promoters on looped-out circular DNAs. P Natl Acad Sci USA 98, 12620-
12623. 
Koni, P.A., Sacca, R., Lawton, P., Browning, J.L., Ruddle, N.H., and Flavell, R.A. (1997). Distinct roles in lymphoid 
organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6, 491-500. 
Kranich, J., Krautler, N.J., Heinen, E., Polymenidou, M., Bridel, C., Schildknecht, A., Huber, C., Kosco-Vilbois, M.H., 
Zinkernagel, R., Miele, G., and Aguzzi, A. (2008). Follicular dendritic cells control engulfment of apoptotic bodies by 
secreting Mfge8. Journal of Experimental Medicine 205, 1293-1302. 
Krautler, N.J., Kana, V., Kranich, J., Tian, Y., Perera, D., Lemm, D., Schwarz, P., Armulik, A., Browning, J.L., Tallquist, 
M., et al. (2012). Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150, 194-206. 
Kumar, V., Scandella, E., Danuser, R., Onder, L., Nitschke, M., Fukui, Y., Halin, C., Ludewig, B., and Stein, J.V. 
(2010). Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent 
pathway. Blood 115, 4725-4733. 
Kunkel, E.J., and Butcher, E.C. (2003). Plasma-cell homing. Nat Rev Immunol 3, 822-829. 
Lee, J.W., Epardaud, M., Sun, J., Becker, J.E., Cheng, A.C., Yonekura, A.R., Heath, J.K., and Turley, S.J. (2007). 
Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 8, 181-190. 
Liao, S., and Ruddle, N.H. (2006). Synchrony of high endothelial venules and lymphatic vessels revealed by 
immunization. J Immunol 177, 3369-3379. 
Link, A., Hardie, D.L., Favre, S., Britschgi, M.R., Adams, D.H., Sixt, M., Cyster, J.G., Buckley, C.D., and Luther, S.A. 
(2011). Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am 
J Pathol 178, 1662-1675. 
Link, A., Vogt, T.K., Favre, S., Britschgi, M.R., Acha-Orbea, H., Hinz, B., Cyster, J.G., and Luther, S.A. (2007). 
Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 8, 1255-1265. 
Lo, C.G., Xu, Y., Proia, R.L., and Cyster, J.G. (2005). Cyclical modulation of sphingosine-1-phosphate receptor 1 
surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. Journal of 
Experimental Medicine 201, 291-301. 
Lukacs-Kornek, V., Malhotra, D., Fletcher, A.L., Acton, S.E., Elpek, K.G., Tayalia, P., Collier, A.R., and Turley, S.J. 
(2011). Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool 
in lymph nodes. Nat Immunol 12, 1096-U1105. 
Luther, S.A., Tang, H.L., Hyman, P.L., Farr, A.G., and Cyster, J.G. (2000). Coexpression of the chemokines ELC and 
SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. P Natl Acad Sci USA 97, 12694-
12699. 
Magnusson, F.C., Liblau, R.S., Von Boehmer, H., Pittet, M.J., Lee, J.W., Turley, S.J., and Khazaie, K. (2008). Direct 
presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. 
Gastroenterology 134, 1028-1037. 
Malhotra, D., Fletcher, A.L., Astarita, J., Lukacs-Kornek, V., Tayalia, P., Gonzalez, S.F., Elpek, K.G., Chang, S.K., 
Knoblich, K., Hemler, M.E., et al. (2012). Transcriptional profiling of stroma from inflamed and resting lymph nodes 
defines immunological hallmarks. Nat Immunol 13, 499-510. 
Manley, P.W., Furet, P., Bold, G., Bruggen, J., Mestan, J., Meyer, T., Schnell, C.R., Wood, J., Haberey, M., Huth, A., 
et al. (2002). Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors. J Med Chem 
45, 5687-5693. 
Manley, P.W., Stiefl, N., Cowan-Jacob, S.W., Kaufman, S., Mestan, J., Wartmann, M., Wiesmann, M., Woodman, R., 
and Gallagher, N. (2010). Structural resemblances and comparisons of the relative pharmacological properties of 
imatinib and nilotinib. Bioorg Med Chem 18, 6977-6986. 
Marsland, B.J., Battig, P., Bauer, M., Ruedl, C., Lassing, U., Beerli, R.R., Dietmeier, K., Ivanova, L., Pfister, T., Vogt, 
L., et al. (2005). CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. 
Immunity 22, 493-505. 
MartIn-Fontecha, A., Sebastiani, S., Hopken, U.E., Uguccioni, M., Lipp, M., Lanzavecchia, A., and Sallusto, F. (2003). 
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp 
Med 198, 615-621. 
Matloubian, M., Lo, C.G., Cinamon, G., Lesneski, M.J., Xu, Y., Brinkmann, V., Allende, M.L., Proia, R.L., and Cyster, 
J.G. (2004). Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. 
Nature 427, 355-360. 
McLachlan, J.B., Hart, J.P., Pizzo, S.V., Shelburne, C.P., Staats, H.F., Gunn, M.D., and Abraham, S.N. (2003). Mast 
cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4, 
1199-1205. 
Mempel, T.R., Henrickson, S.E., and Von Andrian, U.H. (2004). T-cell priming by dendritic cells in lymph nodes 
occurs in three distinct phases. Nature 427, 154-159. 
 79	  
Mirza, H., Wu, Z.N., Kidwai, F., and Tan, K.S.W. (2011). A Metronidazole-Resistant Isolate of Blastocystis spp. Is 
Susceptible to Nitric Oxide and Downregulates Intestinal Epithelial Inducible Nitric Oxide Synthase by a Novel 
Parasite Survival Mechanism. Infect Immun 79, 5019-5026. 
Miyasaka, M., and Tanaka, T. (2004). Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. 
Nat Rev Immunol 4, 360-370. 
Mohr, E., Serre, K., Manz, R.A., Cunningham, A.F., Khan, M., Hardie, D.L., Bird, R., and MacLennan, I.C.M. (2009). 
Dendritic Cells and Monocyte/Macrophages That Create the IL-6/APRIL-Rich Lymph Node Microenvironments Where 
Plasmablasts Mature. Journal of Immunology 182, 2113-2123. 
Moon, J.J., Chu, H.H., Pepper, M., McSorley, S.J., Jameson, S.C., Kedl, R.M., and Jenkins, M.K. (2007). Naive 
CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. 
Immunity 27, 203-213. 
Mora, J.R., Iwata, M., Eksteen, B., Song, S.Y., Junt, T., Senman, B., Otipoby, K.L., Yokota, A., Takeuchi, H., 
Ricciardi-Castagnoli, P., et al. (2006). Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. 
Science 314, 1157-1160. 
Moussion, C., and Girard, J.P. (2011). Dendritic cells control lymphocyte entry to lymph nodes through high 
endothelial venules. Nature 479, 542-U273. 
Mowat, A.M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3, 331-341. 
Mueller, S.N., and Germain, R.N. (2009). Stromal cell contributions to the homeostasis and functionality of the 
immune system. Nature Reviews Immunology 9, 618-629. 
Mueller, S.N., Hosiawa-Meagher, K.A., Konieczny, B.T., Sullivan, B.M., Bachmann, M.F., Locksley, R.M., Ahmed, R., 
and Matloubian, M. (2007). Regulation of homeostatic chemokine expression and cell trafficking during immune 
responses. Science 317, 670-674. 
Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M., and Aguet, M. (1994). Functional role 
of type I and type II interferons in antiviral defense. Science 264, 1918-1921. 
Navarro, A., Perez, R.E., Rezaiekhaligh, M., Mabry, S.M., and Ekekezie, II (2008). T1alpha/podoplanin is essential 
for capillary morphogenesis in lymphatic endothelial cells. Am J Physiol Lung Cell Mol Physiol 295, L543-551. 
Navarro, A., Perez, R.E., Rezaiekhaligh, M.H., Mabry, S.M., and Ekekezie, I.I. (2011). Polarized migration of 
lymphatic endothelial cells is critically dependent on podoplanin regulation of Cdc42. Am J Physiol-Lung C 300, L32-
L42. 
Ngo, V.N., Cornall, R.J., and Cyster, J.G. (2001). Splenic T zone development is B cell dependent. Journal of 
Experimental Medicine 194, 1649-1660. 
Ngo, V.N., Korner, H., Gunn, M.D., Schmidt, K.N., Riminton, D.S., Cooper, M.D., Browning, J.L., Sedgwick, J.D., and 
Cyster, J.G. (1999). Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of 
homing chemokines in B and T cell areas of the spleen. J Exp Med 189, 403-412. 
Nolte, M.A., Belien, J.A.M., Schadee-Eestermans, I., Jansen, W., Unger, W.W.J., van Rooijen, N., Kraal, G., and 
Mebius, R.E. (2003). A conduit system distributes chemokines and small blood-borne molecules through the splenic 
white pulp. Journal of Experimental Medicine 198, 505-512. 
Noss, E.H., and Brenner, M.B. (2008). The role and therapeutic implications of fibroblast-like synoviocytes in 
inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 223, 252-270. 
Okada, T., and Cyster, J.G. (2007). CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph 
node. J Immunol 178, 2973-2978. 
Onder, L., Narang, P., Scandella, E., Chai, Q., Iolyeva, M., Hoorweg, K., Halin, C., Richie, E., Kaye, P., Westermann, 
J., et al. (2012). IL-7-producing stromal cells are critical for lymph node remodeling. Blood 120, 4675-4683. 
Oracki, S.A., Walker, J.A., Hibbs, M.L., Corcoran, L.M., and Tarlinton, D.M. (2010). Plasma cell development and 
survival. Immunol Rev 237, 140-159. 
Osada, M., Inoue, O., Ding, G., Shirai, T., Ichise, H., Hirayama, K., Takano, K., Yatomi, Y., Hirashima, M., Fujii, H., et 
al. (2012). Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting 
Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells. Journal of Biological Chemistry 287, 
22241-22252. 
Pabst, O. (2012). New concepts in the generation and functions of IgA. Nature Reviews Immunology 12, 821-832. 
Palframan, R.T., Jung, S., Cheng, G., Weninger, W., Luo, Y., Dorf, M., Littman, D.R., Rollins, B.J., Zweerink, H., Rot, 
A., and von Andrian, U.H. (2001). Inflammatory chemokine transport and presentation in HEV: a remote control 
mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194, 1361-1373. 
Peduto, L., Dulauroy, S., Lochner, M., Spath, G.F., Morales, M.A., Cumano, A., and Eberl, G. (2009). Inflammation 
recapitulates the ontogeny of lymphoid stromal cells. Journal of Immunology 182, 5789-5799. 
 80	  
Pham, T.H.M., Baluk, P., Xu, Y., Grigorova, I., Bankovich, A.J., Pappu, R., Coughlin, S.R., McDonald, D.M., Schwab, 
S.R., and Cyster, J.G. (2010). Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte 
egress and lymphatic patterning. Journal of Experimental Medicine 207, 17-27. 
Pham, T.H.M., Okada, T., Matioubian, M., Lo, C.G., and Cyster, J.G. (2008). S1P(1) receptor signaling overrides 
retention mediated by G alpha(i)-coupled receptors to promote T cell egress. Immunity 28, 122-133. 
Pinchuk, I.V., Beswick, E.J., Saida, J.I., Reyes, V.E., and Powell, D.W. (2007). Human colonic myofibroblasts 
promote the expansion of Cd4+Cd25high Foxp3+regulatory T cells. Gastroenterology 132, A397-A397. 
Pinchuk, I.V., Mifflin, R.C., Saada, J.I., and Powell, D.W. (2010). Intestinal mesenchymal cells. Curr Gastroenterol 
Rep 12, 310-318. 
Powell, D.W., Pinchuk, I.V., Saada, J.I., Chen, X., and Mifflin, R.C. (2011). Mesenchymal Cells of the Intestinal 
Lamina Propria. Annu Rev Physiol 73, 213-237. 
Prlic, M., Hernandez-Hoyos, G., and Bevan, M.J. (2006). Duration of the initial TCR stimulus controls the magnitude 
but not functionality of the CD8+ T cell response. J Exp Med 203, 2135-2143. 
Probst, H.C., Tschannen, K., Odermatt, B., Schwendener, R., Zinkernagel, R.M., and Van Den Broek, M. (2005). 
Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 141, 398-
404. 
Pula, B., Witkiewicz, W., Dziegiel, P., and Podhorska-Okolow, M. (2013). Significance of podoplanin expression in 
cancer-associated fibroblasts: A comprehensive review. Int J Oncol 42, 1849-1857. 
Randall, T.D., Carragher, D.M., and Rangel-Moreno, J. (2008). Development of secondary lymphoid organs. Annu 
Rev Immunol 26, 627-650. 
Randolph, G.J., Angeli, V., and Swartz, M.A. (2005). Dendritic-cell trafficking to lymph nodes through lymphatic 
vessels. Nature Reviews Immunology 5, 617-628. 
Randolph, G.J., Ochando, J., and Partida-Sanchez, S. (2008). Migration of dendritic cell subsets and their precursors. 
Annual Review of Immunology 26, 293-316. 
Reilkoff, R.A., Bucala, R., and Herzog, E.L. (2011). Fibrocytes: emerging effector cells in chronic inflammation. Nat 
Rev Immunol 11, 427-435. 
Repass, J.F., Laurent, M.N., Carter, C., Reizis, B., Bedford, M.T., Cardenas, K., Narang, P., Coles, M., and Richie, 
E.R. (2009). IL7-hCD25 and IL7-Cre BAC Transgenic Mouse Lines: New Tools for Analysis of IL-7 Expressing Cells. 
Genesis 47, 281-287. 
Roozendaal, R., and Mebius, R.E. (2011). Stromal Cell-Immune Cell Interactions. Annual Review of Immunology, Vol 
29 29, 23-43. 
Roozendaal, R., Mebius, R.E., and Kraal, G. (2008). The conduit system of the lymph node. International 
Immunology 20, 1483-1487. 
Roozendaal, R., Mempel, T.R., Pitcher, L.A., Gonzalez, S.F., Verschoor, A., Mebius, R.E., von Andrian, U.H., and 
Carroll, M.C. (2009). Conduits Mediate Transport of Low-Molecular-Weight Antigen to Lymph Node Follicles. 
Immunity 30, 264-276. 
Round, J.L., and Mazmanian, S.K. (2009). The gut microbiota shapes intestinal immune responses during health and 
disease (vol 9, pg 313, 2009). Nature Reviews Immunology 9, 600-600. 
Saada, J.I., Pinchuk, I.V., Barrera, C.A., Adegboyega, P.A., Suarez, G., Mifflin, R.C., Di Mari, J.F., Reyes, V.E., and 
Powell, D.W. (2006). Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. 
Journal of Immunology 177, 5968-5979. 
Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008). Regulatory T cells and immune tolerance. Cell 133, 
775-787. 
Sato, A., Hashiguchi, M., Toda, E., Iwasaki, A., Hachimura, S., and Kaminogawa, S. (2003). CD11b(+) Peyer's patch 
dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. Journal of Immunology 171, 3684-3690. 
Scandella, E., Bolinger, B., Lattmann, E., Miller, S., Favre, S., Littman, D.R., Finke, D., Luther, S.A., Junt, T., and 
Ludewig, B. (2008). Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells 
with stroma of the T cell zone. Nat Immunol 9, 667-675. 
Schluns, K.S., Kieper, W.C., Jameson, S.C., and Lefrancois, L. (2000). Interleukin-7 mediates the homeostasis of 
naive and memory CD8 T cells in vivo. Nat Immunol 1, 426-432. 
Schneider, K., Potter, K.G., and Ware, C.F. (2004). Lymphotoxin and LIGHT signaling pathways and target genes. 
Immunol Rev 202, 49-66. 
Sekirov, I., Russell, S.L., Antunes, L.C.M., and Finlay, B.B. (2010). Gut Microbiota in Health and Disease. Physiol 
Rev 90, 859-904. 
Senn, K.A., McCoy, K.D., Maloy, K.J., Stark, G., Frohli, E., Rulicke, T., and Klemenz, R. (2000). T1-deficient and T1-
Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus 
brasiliensis. Eur J Immunol 30, 1929-1938. 
 81	  
Shapiro-Shelef, M., and Calame, K. (2005). Regulation of plasma-cell development. Nature Reviews Immunology 5, 
230-242. 
Shevach, E.M. (2006). From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25, 195-201. 
Siegert, S., Huang, H.Y., Yang, C.Y., Scarpellino, L., Carrie, L., Essex, S., Nelson, P.J., Heikenwalder, M., Acha-
Orbea, H., Buckley, C.D., et al. (2011). Fibroblastic Reticular Cells From Lymph Nodes Attenuate T Cell Expansion 
by Producing Nitric Oxide. Plos One 6. 
Sinha, R.K., Park, C., Hwang, I.Y., Davis, M.D., and Kehrl, J.H. (2009). B Lymphocytes Exit Lymph Nodes through 
Cortical Lymphatic Sinusoids by a Mechanism Independent of Sphingosine-1-Phosphate-Mediated Chemotaxis. 
Immunity 30, 434-446. 
Sixt, M., Kanazawa, N., Seig, M., Samson, T., Roos, G., Reinhardt, D.P., Pabst, R., Lutz, M.B., and Sorokin, L. 
(2005). The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell 
area of the lymph node. Immunity 22, 19-29. 
Soderberg, K.A., Payne, G.W., Sato, A., Medzhitov, R., Segal, S.S., and Iwasaki, A. (2005). Innate control of adaptive 
immunity via remodeling of lymph node feed arteriole. P Natl Acad Sci USA 102, 16315-16320. 
Spadoni, I., Iliev, I.D., Rossi, G., and Rescigno, M. (2012). Dendritic cells produce TSLP that limits the differentiation 
of Th17 cells, fosters Treg development, and protects against colitis. Mucosal Immunol 5, 184-193. 
Steeber, D.A., Erickson, C.M., Hodde, K.C., and Albrecht, R.M. (1987). Vascular Changes in Popliteal Lymph-Nodes 
Due to Antigen Challenge in Normal and Lethally Irradiated Mice. Scanning Microscopy 1, 831-839. 
Stein, J.V., Rot, A., Luo, Y., Narasimhaswamy, M., Nakano, H., Gunn, M.D., Matsuzawa, A., Quackenbush, E.J., Dorf, 
M.E., and von Andrian, U.H. (2000). The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary 
lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of 
rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 191, 61-76. 
Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., and Belkaid, Y. (2007). Small intestine 
lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204, 
1775-1785. 
Sun, Z., Unutmaz, D., Zou, Y.R., Sunshine, M.J., Pierani, A., Brenner-Morton, S., Mebius, R.E., and Littman, D.R. 
(2000). Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288, 2369-
2373. 
Takahashi-Iwanaga, H., and Fujita, T. (1985). Lamina propria of intestinal mucosa as a typical reticular tissue. A 
scanning electron-microscopic study of the rat jejunum. Cell Tissue Res 242, 57-66. 
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., and Akira, S. (1999). Differential 
roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 
11, 443-451. 
Tan, K.W., Yeo, K.P., Wong, F.H.S., Lim, H.Y., Khoo, K.L., Abastado, J.P., and Angeli, V. (2012). Expansion of 
Cortical and Medullary Sinuses Restrains Lymph Node Hypertrophy during Prolonged Inflammation. Journal of 
Immunology 188, 4065-4080. 
Terstappen, L.W.M.M., Johnsen, S., Segersnolten, I.M.J., and Loken, M.R. (1990). Identification and Characterization 
of Plasma-Cells in Normal Human Bone-Marrow by High-Resolution Flow-Cytometry. Blood 76, 1739-1747. 
Tew, J.G., Wu, J.H., Fakher, M., Szakal, A.K., and Qin, D.H. (2001). Follicular dendritic cells: beyond the necessity of 
T-cell help. Trends Immunol 22, 361-367. 
Tezuka, H., Abe, Y., Iwata, M., Takeuchi, H., Ishikawa, H., Matsushita, M., Shiohara, T., Akira, S., and Ohteki, T. 
(2007). Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448, 929-
U927. 
Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R.A. (2002). Myofibroblasts and mechano-
regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349-363. 
Tomei, A.A., Siegert, S., Britschgi, M.R., Luther, S.A., and Swartz, M.A. (2009). Fluid Flow Regulates Stromal Cell 
Organization and CCL21 Expression in a Tissue-Engineered Lymph Node Microenvironment. Journal of Immunology 
183, 4273-4283. 
Turley, S.J., Fletcher, A.L., and Elpek, K.G. (2010). The stromal and haematopoietic antigen-presenting cells that 
reside in secondary lymphoid organs. Nature Reviews Immunology 10, 813-825. 
Tzeng, T.C., Chyou, S., Tian, S., Webster, B., Carpenter, A.C., Guaiquil, V.H., and Lu, T.T. (2010). CD11c(hi) 
dendritic cells regulate the re-establishment of vascular quiescence and stabilization after immune stimulation of 
lymph nodes. J Immunol 184, 4247-4257. 
Ushiki, T., Ohtani, O., and Abe, K. (1995). Scanning electron microscopic studies of reticular framework in the rat 
mesenteric lymph node. Anat Rec 241, 113-122. 
van de Pavert, S.A., Olivier, B.J., Goverse, G., Vondenhoff, M.F., Greuter, M., Beke, P., Kusser, K., Hopken, U.E., 
Lipp, M., Niederreither, K., et al. (2009). Chemokine CXCL13 is essential for lymph node initiation and is induced by 
retinoic acid and neuronal stimulation. Nat Immunol 10, 1193-U1178. 
 82	  
Vega, F., Coombes, K.R., Thomazy, V.A., Patel, K., Lang, W.H., and Jones, D. (2006). Tissue-specific function of 
lymph node fibroblastic reticulum cells. Pathobiology 73, 71-81. 
Vicente-Suarez, I., Larange, A., Reardon, C., Matho, M., Feau, S., Chodaczek, G., Park, Y., Obata, Y., Gold, R., 
Wang-Zhu, Y., et al. (2014). Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic 
cells. Mucosal Immunol. 
Vogt, T.K., Link, A., Perrin, J., Finke, D., and Luther, S.A. (2009). Novel function for interleukin-7 in dendritic cell 
development. Blood 113, 3961-3968. 
von Andrian, U.H., and Mempel, T.R. (2003). Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3, 867-
878. 
Ware, C.F. (2008). Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223, 
186-201. 
Webster, B., Ekland, E.H., Agle, L.M., Chyou, S., Ruggieri, R., and Lu, T.T. (2006). Regulation of lymph node 
vascular growth by dendritic cells. Journal of Experimental Medicine 203, 1903-1913. 
Wendland, M., Willenzon, S., Kocks, J., Davalos-Misslitz, A.C., Hammerschmidt, S.I., Schumann, K., Kremmer, E., 
Sixt, M., Hoffmeyer, A., Pabst, O., and Forstert, R. (2011). Lymph Node T Cell Homeostasis Relies on Steady State 
Homing of Dendritic Cells. Immunity 35, 945-957. 
Wilting, J., Papoutsi, M., Christ, B., Nicolaides, K.H., von Kaisenberg, C.S., Borges, J., Stark, G.B., Alitalo, K., 
Tomarev, S.I., Niemeyer, C., and Rossler, J. (2002). The transcription factor Prox1 is a marker for lymphatic 
endothelial cells in normal and diseased human tissues. Faseb J 16, 1271-+. 
Worbs, T., Mempel, T.R., Bolter, J., von Andrian, U.H., and Forster, R. (2007). CCR7 ligands stimulate the intranodal 
motility of T lymphocytes in vivo. Journal of Experimental Medicine 204, 489-495. 
Wu, J.F., Chitapanarux, T., Chen, Y.S., Soon, R.K., and Yee, H.F. (2013). Intestinal myofibroblasts produce nitric 
oxide in response to combinatorial cytokine stimulation. J Cell Physiol 228, 572-580. 
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., 
Takeda, K., and Akira, S. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. 
Science 301, 640-643. 
Yanagawa, Y., and Onoe, K. (2002). CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100, 
1948-1956. 
Yanagawa, Y., and Onoe, K. (2003). CCR7 ligands induce rapid endocytosis in mature dendritic cells with 
concomitant up-regulation of Cdc42 and Rac activities. Blood 101, 4923-4929. 
Yip, L.D., Su, L., Sheng, D.Q., Chang, P., Atkinson, M., Czesak, M., Albert, P.R., Collier, A.R., Turley, S.J., Fathman, 
C.G., and Creusot, R.J. (2009). Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens 
in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 10, 1026-U1107. 
Zhang, Z.B., Andoh, A., Inatomi, O., Bamba, S., Takayanagi, A., Shimizu, N., and Fujiyama, Y. (2005). Interleukin-17 
and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts. J 
Gastroen Hepatol 20, 619-627. 
Zhu, M.Z., and Fu, Y.X. (2011). The role of core TNF/LIGHT family members in lymph node homeostasis and 
remodeling. Immunol Rev 244, 75-84. 
Zhu, Y.T., Zhu, M., and Lance, P. (2012). iNOS signaling interacts with COX-2 pathway in colonic fibroblasts. Exp 
Cell Res 318, 2116-2127. 	  
 
 83	  
7. List of publications during PhD 
 
- Siegert S, Huang HY, Yang CY, Scarpellino L, Carrie L, Essex S, Nelson PJ, Heikenwalder M, 
Acha-Orbea H, Buckley CD, Marsland BJ, Zehn D, Luther SA  ¨Fibroblastic reticular cells from 
lymph nodes attenuate T cell expansion by producing nitric oxide¨  PLoS One 6(11):e27618, 
2011 
 
- Yang CY, Vogt TK, Favre S, Scarpellino L, Huang HY, Tacchini-Cottier F, Luther SA  
¨Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in 
reactive murine lymph nodes¨  Proc Natl Acad Sci  USA, 111(1):E109-18, 2014 
 
